User Image Cart Icon 0 Search Image
  • Home > Blog > Lowering Cholesterol Thru Fasting, Diet & Medicinal Plants

Lowering Cholesterol Thru Fasting, Diet & Medicinal Plants

  1. A boost in mitochondrial activity underpins theย cholesterolโ€“loweringย effect of annurca apple polyphenols on hepatic cells
  2. A Case of Acquired Ichthyosis Developed Duringย cholesterolโ€“loweringย Treatment
  3. A chalcone derivative, 1mโ€6, exhibits atheroprotective effects by increasingย cholesterolย efflux and reducing inflammationโ€induced endothelial dysfunction
  4. A chicken protein hydrolysate exerts antiโ€atherosclerotic effect beyond plasmaย cholesterolโ€loweringย activity in Apoeโˆ’/โˆ’ mice
  5. Aย cholesterolโ€“loweringย dietย does not produce adverse psychological effects in children: three-year results from theย dietary intervention study in children.
  6. Aย cholesterolโ€“loweringย gene maps to chromosome 13q
  7. Aย cholesterolโ€“loweringย VLP vaccine that targets PCSK9
  8. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliaryย cholesterolย saturation
  9. A comparison of clinical outcome studies amongย cholesterolโ€“loweringย agents
  10. A comparison of the LDL-cholesterolย loweringย efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized โ€ฆ
  11. A Contemporary Assessment of Lipidย loweringย Therapies and Low-density Lipoproteinย cholesterolย in Peripheral Artery Disease
  12. A Highย cholesterol-reducing Lactic Acid Bacterial Strain: Screening, Identification and Probiotic Potential Evaluation
  13. A Intervention Study onย cholesterolโ€“loweringย Effect of Phytosterol Ester
  14. A koleszterincsรถkkentรฉs nem a Szent Grรกl, de nem is az รถrdรถg mลฑve=ย cholesterolโ€“loweringย is not the Holy Grail, but neither is the work of the devil
  15. A laboratory based intervention to improve appropriateness of lipid tests and auditย cholesterolย loweringย in primary care
  16. A Lipid-loweringย dietย Combined with Exercise is Effective for Achieving Healthy Serumย cholesterolย in a Male with a Predisposition for Developing Hyperlipidemia โ€ฆ
  17. A lipidomic analysis approach to evaluate the response toย cholesterolโ€“loweringย food intake
  18. A long-term population study ofย cholesterolย loweringย by sitostanol ester margarine
  19. A mechanism for the action of unsaturated fat in reducing the serumย cholesterol.
  20. A mechanistic systems pharmacology model for prediction of LDLย cholesterolย loweringย by PCSK9 antagonism in human dyslipidemic populations
  21. A Mendelian Randomization Analysis Of Lipoprotein (A)ย loweringย And Cardiovascular Risk Stratified By Ldlย cholesterol, Gender, And Antiplatelet Therapy โ€ฆ
  22. A mini-review of human studies onย cholesterolโ€“loweringย properties of probiotics
  23. A model for evaluating the cost-effectiveness ofย cholesterolโ€“loweringย treatment
  24. A Model of Life Extension from Reducing Serumย cholesterol
  25. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoproteinย cholesterolโ€“loweringย ability of lovastatin 10, 20, and 40 mg/d with fluvastatin โ€ฆ
  26. A multidisciplinary study of the bioavilability andย cholesterolโ€“loweringย property of peptides from lupin protein
  27. A nanoโ€emulsion of lutein is more effective than regular lutein in reducingย cholesterolโ€induced liver injury in guinea pigs
  28. A national program forย loweringย high bloodย cholesterol
  29. A new feature on theย cholesterolโ€“loweringย landscape
  30. A New Perspective on the Development ofย cholesterolโ€“loweringย Products
  31. A new reality: achievingย cholesterolโ€“loweringย goals in clinical practice
  32. A pediatrician attends the National Institutes of Health Consensus Conference onย loweringย bloodย cholesterol
  33. A pharmacoeconomic evaluation of aggressiveย cholesterolย loweringย in Sweden
  34. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressiveย cholesterolย loweringย (MIRACL) study in the United Kingdom
  35. A pharmacoeconomic evaluation of the myocardial ischemia reduction with aggressiveย cholesterolย loweringย (MIRACL) study in Canada
  36. A PHARMACOECONOMIC REVIEW OFย cholesterolโ€“loweringย THERAPY INTERVENTIONS.
  37. A phase 1 study to evaluate the safety and LDLย cholesterolโ€“loweringย effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin โ€ฆ
  38. A pilot randomized controlled clinical trial to assess tolerance and efficacy of navy bean and rice bran supplementation forย loweringย cholesterolย in children
  39. A pilot study to assess food safety and potentialย cholesterolโ€“loweringย efficacy of Antrodia cinnamomea solid-state cultivated mycelium in healthy adults
  40. A promoter polymorphism inย cholesterolย 7ฮฑ-hydroxylase interacts with apolipoprotein E genotype in the LDL-loweringย response to atorvastatin
  41. A pulse-basedย dietย is effective for reducing total and LDL-cholesterolย in older adults
  42. A Quantitative Systems Pharmacology PhysioPDTM Platform to Investigate the Impact ofย cholesterolโ€“loweringย Therapies on Lipid Profiles and Plaque โ€ฆ
  43. A quantitative systems pharmacology platform to investigate the impact of alirocumab andย cholesterolโ€“loweringย therapies on lipid profiles and plaque characteristics
  44. A randomized clinical trial evaluating a proprietary mixture of Lactobacillus plantarum strains forย loweringย cholesterolย 1
  45. A randomized crossover study to evaluate LDL-cholesterolย loweringย effect of a generic product of simvastatin (Unison company) compared to simvastatin (Zocor) in โ€ฆ
  46. A randomized, double-blind, placebo-controlled trial investigatingย cholesterolโ€“loweringย effects and safety of yellow yeast rice in adults with mild to moderate โ€ฆ
  47. A randomized, placebo-controlled, double-blind crossover study to assess a unique phytosterol ester formulation inย loweringย LDLย cholesterolย utilizing a novel virtual โ€ฆ
  48. A rational policy for measuring andย loweringย cholesterol
  49. A retrospective cohort study of the potency of lipid-loweringย therapy and race-gender differences in LDLย cholesterolย control
  50. A review of availableย cholesterolโ€“loweringย medicines in South Africa
  51. A ruthenium derivative of quercetin with enhancedย cholesterolโ€“loweringย activity
  52. A spread containing bioactive milk peptides Ileโ€“Proโ€“Pro and Valโ€“Proโ€“Pro, and plant sterols has antihypertensive andย cholesterolโ€“loweringย effects
  53. A study of lactobacillus acidophilus as aย cholesterolย loweringย agent in hypercholesterolemic individuals.
  54. A STUDY ONย cholesterolย loweringย EFFECT OF PLEUROTUS SAJOR-CAJU MUSHROOM IN HYPERcholesterolEMIC RATS
  55. A study on screening ofย cholesterolโ€“loweringย lactic acid bacteria
  56. A survey ofย cholesterolย loweringย therapies and achievement of targets for cardiovascular prevention in type 2 diabetes in Italy
  57. A sustainable approach for the extraction ofย cholesterolโ€“loweringย compounds from an olive by-product based on CO 2-expanded ethyl acetate
  58. A synthetic farnesoid X receptor (FXR) agonist promotesย cholesterolย loweringย in models of dyslipidemia
  59. A test of two educational strategies forย loweringย bloodย cholesterolย at the worksite
  60. A Transcriptomics-Informed Genetic Association Study Identifies RHOA in Simvastatin-Induced Low-Density Lipoproteinย cholesterolย lowering
  61. A9125 Major Outcomes of Blood-pressure andย cholesterolย loweringย in High-risk Hypertensive Patients with a Highโ€“normal Level of Totalย cholesterol
  62. Ability of Lactobacillus plantarum JR64 isolated from noni juice inย loweringย cholesterolย in vivo
  63. Absolute benefit fromย cholesterolย loweringย in diabetic patients with coronary heart disease
  64. Abstract P088: Theย cholesterolโ€“loweringย Effect of Phytosterols across Different Dose Ranges: A Meta-analysis of Randomized Controlled Trials
  65. Acalypha Indica and Gemfibrozilย loweringย cholesterolย and Triglyceride Levels in High Fructose-cholesterolย dietย Induced Rats
  66. ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions byย cholesterolโ€“loweringย and direct effects in apolipoprotein E-deficient mice
  67. ACAT inhibitors: the search for novelย cholesterolย loweringย agents
  68. Achievement of LDL-cholesterolย target levels and other cardiovascular risk factor targets in patients with type 2 diabetes treated with lipid-loweringย medications โ€ฆ
  69. Acquired lecithin:ย cholesterolย acyltransferase deficiency as a major factor inย loweringย plasma HDL levels in chronic kidney disease
  70. Activation of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducingย cholesterolย efflux from human โ€ฆ
  71. Activation of liver X receptor decreases BACE1 expression and activity by reducing membraneย cholesterolย levels
  72. Activity of a streptococcalย cholesterolโ€“loweringย protein vs. hdl from apo ai-deficient mice in vitro and in vivo
  73. Activity of psyllium hydrophilic colloid for reducing serumย cholesterolย in sea quail fed aย dietย supplemented withย cholesterol.
  74. Activity of Sambiloto Extract (Andrographis paniculata Ness) in Reducing Total Bloodย cholesterolย Levels Hypercholesterolemia Rats
  75. Activity Test of Suji Leaf Extract (Dracaena angustifolia Roxb.) on in vitroย cholesterolย lowering
  76. Acuteย cholesterolย loweringย with LDL-apheresis improves endothelial function of the epicardial coronary artery in patients with hypercholesterolemia
  77. Acyl-CoA:ย cholesterolย acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to itsย cholesterolโ€“loweringย effect in ApoE* 3-Leiden mice
  78. Adding monounsaturated fatty acids to aย dietary portfolio ofย cholesterolโ€“loweringย foods in hypercholesterolemia
  79. Adding MUFA to aย dietary portfolio ofย cholesterolโ€“loweringย foods reduces apoAI fractional catabolic rate in subjects with dyslipidaemia
  80. Additive effect of homocysteineโ€andย cholesterolโ€loweringย therapy on endotheliumโ€dependent vasodilation in patients with cardiovascular disease
  81. Additive effect of plant sterol-ester margarine and cerivastatin inย loweringย low-density lipoproteinย cholesterolย in primary hypercholesterolemia
  82. Adeno-associated virus serotype 8 gene therapy leads to significantย loweringย of plasmaย cholesterolย levels in humanized mouse models of homozygous and โ€ฆ
  83. Adherence toย cholesterolโ€“loweringย diets
  84. AdipoRon Attenuates Wnt Signaling by Reducingย cholesterol-Dependent Plasma Membrane Rigidity
  85. Advance inย cholesterolโ€“loweringย effect of phytosterols [J]
  86. Advances inย cholesterolโ€“loweringย interventions
  87. Advances in techniques for reducingย cholesterolย in egg yolk: A review
  88. Advances in the effects study of theย cholesterol-reducing microbial [J]
  89. Aerobic exercise training selectively changes oxysterol levels and metabolism reducingย cholesterolย accumulation in the aorta of dyslipidemic mice
  90. After ENHANCE: is more LDLย cholesterolย loweringย even better?
  91. Aggressiveย cholesterolย loweringย delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors: NHLBI post coronary โ€ฆ
  92. Aggressive lipidย loweringย in postcoronary angioplasty patients with elevatedย cholesterolย (the Lovastatin Restenosis Trial)
  93. Aggressiveย loweringย of fibrinogen andย cholesterolย in the prevention of graft vessel disease after heart transplantation
  94. Air Force Membersโ€™ Guide for Reducingย cholesterolย Ratio
  95. Algal sterols are as effective as ฮฒ-sitosterol in reducing plasmaย cholesterolย concentration
  96. Alirocumab for low-density lipoproteinย cholesterolย lowering
  97. Allย cholesterolโ€“loweringย interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT
  98. Aloe-emodin exertsย cholesterolโ€“loweringย effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats
  99. Alternative approaches toย cholesterolโ€“loweringย therapy
  100. Alternative approaches toย loweringย cholesterol
  101. Amaranth oil increased fecal excretion of bile acid but had no effect in reducing plasmaย cholesterolย in hamsters
  102. Amaranth protein presentsย cholesterolโ€“loweringย effect
  103. AMPK enhances insulin-stimulated GLUT4 regulation viaย loweringย membraneย cholesterol
  104. An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-inducedย loweringย of blood totalย cholesterol
  105. An application of the transtheoretical model of behavior change to the adoption ofย cholesterolโ€“loweringย behaviors by college students.
  106. An audit of secondary prevention of ischaemic heart disease using aspirin andย cholesterolโ€“lowering
  107. An audit of the effectiveness of PCSK9 inhibition in reducingย cholesterolย in patients attending lipid clinics
  108. An economic evaluation of lovastatin forย cholesterolย loweringย and coronary artery disease reduction
  109. An educational intervention for reducing the intake ofย dietary fats andย cholesterolย among middle-aged and older women
  110. An Evaluation ofย cholesterolโ€“loweringย Effect of Soy Protein and Isoflavones on Postmenopausal Women and Hypercholesterolemic Humans.
  111. An evidence-based guide toย cholesterolโ€“loweringย guidelines
  112. An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasmaย cholesterolโ€“loweringย Activity in apoE โ€ฆ
  113. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of itsย cholesterolโ€“loweringย properties
  114. An in vivo assessment of theย cholesterolโ€“loweringย efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults
  115. An innovative lipid-loweringย approach to enhance attainment of low-density lipoproteinย cholesterolย goals
  116. An overview of trials ofย cholesterolย loweringย and risk of stroke
  117. An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents forย loweringย lowโ€density lipoproteinย cholesterol
  118. Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of โ€ฆ
  119. Analysis of plant sterol and stanol esters inย cholesterolโ€“loweringย spreads and beverages using high-performance liquid chromatographyโˆ’ atmospheric pressure โ€ฆ
  120. Angiographic trials testing the efficacy ofย cholesterolย loweringย in reducing progression or inducing regression of coronary atherosclerosis
  121. Animal models: newย cholesterolย raising andย loweringย nutrients
  122. Anti-hyperlipidemia of garlic by reducing the level of totalย cholesterolย and low-density lipoprotein: A meta-analysis
  123. Anti-inflammatory andย cholesterol-reducing properties of apolipoprotein mimetics: a review
  124. Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-ฮบB activity andย loweringย ofย cholesterol
  125. Anti-obesity andย cholesterolโ€“loweringย effects of germinated brown rice in rats fed with high fat andย cholesterolย diets
  126. Anti-obesity and LDL-cholesterolย loweringย effects of silkworm hemolymph in C57BL/6N mice fed high fatย diet
  127. Anti-obesity and lipidย loweringย effects of Cymodocea nodosa sulphated polysaccharide on highย cholesterol-fed-rats
  128. Antiamnesic effect of petroleum ether extract of Murraya Koenigii (Linn) leaves involving possible Anticholinesterase andย cholesterolย loweringย mechanism
  129. Antibacterial andย cholesterolย Reducing Lactic Acid Bacteria from Silk Worm(Bombyx mori) Gut Environment- A Review
  130. Antidiabetic andย cholesterolย loweringย activities of the stem bark of Ficus bengalensis L.
  131. Antihyperglycemic,ย cholesterolโ€“loweringย and HDL-raising effects of cumin (Cuminum cyminum) seeds in type-2 diabetes
  132. Antihyperlipidemic therapies targeting PCSK9: Novel therapeutic agents forย loweringย low-density lipoproteinย cholesterol
  133. Antihypertensive andย cholesterolโ€“loweringย effects of a spread containing bioactive peptides IPP and VPP and plant sterols
  134. Antiobesity andย cholesterolโ€“loweringย effects of bifidobacteria animalis DY-64 in rats fed a high-fat/high-cholesterolย diet
  135. Antiobesity andย cholesterolโ€“loweringย Effects of Dendropanax morbifera Water Extracts in Mouse 3T3-L1 Cells
  136. Antioxidant activity and lipid-loweringย effect of essential oils extracted from Ocimum sanctum L. leaves in rats fed with a highย cholesterolย diet
  137. Antioxidant activity and the potential forย cholesterolโ€loweringย of phenolic extract of Morus alba, Morus multicaulis, and Morus laevigata leaves from Yunnan (China)
  138. ANTIOXIDANT ACTIVITY,ย cholesterolย loweringย EFFECT AND CHEMICAL INVESTIGATION OF PO-SA (STEM)
  139. Antioxidant andย cholesterolย loweringย properties of 2, 6-di-t-butyl-4-[(dimethylphenylsilyl) methyloxy] phenol and derivatives: a new class of anti-atherogenic โ€ฆ
  140. Antioxidant andย cholesterolโ€“loweringย Effects of Lactic Acid Bacteria Isolated from Kelp Saccharina japonica Kimchi
  141. Antioxidant andย cholesterol-reducing Properties of Enterococcus gallinarum m661 [J]
  142. Antioxidant and Lipidย loweringย Effects of Elaeocarpus Ganitrus inย cholesterolย Fed Rabbits
  143. Antioxidant,ย cholesterolย reducing, immunomodulating and other health promoting properties of herbal enriched designer eggs
  144. Antioxidants andย cholesterol-reducing agents with antiatherogenic activity contained in plant raw materials
  145. Antioxidative andย cholesterolโ€“loweringย effects of lemon essential oil in hypercholesterolemia-induced rabbits
  146. Aortic vascular calcification:ย cholesterolย loweringย does not reduce progression in patients with familial hypercholesterolemiaโ€”or does it?
  147. ApoA-IV phenotype affectsย diet-induced plasma LDLย cholesterolย lowering.
  148. APOE genotype,ย cholesterolย level, lipid-loweringย treatment, and dementia: the Three-City Study
  149. APOE4 genotype exerts greater benefit inย loweringย plasmaย cholesterolย and apolipoprotein B than wild type (E3/E3), after replacement ofย dietary saturated fats with low โ€ฆ
  150. Apolipoprotein E mimetics andย cholesterolโ€“loweringย properties
  151. Apolipoprotein E promotes the regression of atherosclerosis independently ofย loweringย plasmaย cholesterolย levels
  152. Applicability ofย cholesterolโ€“loweringย primary prevention trials to a general population: the Framingham Heart Study
  153. Application of Actinomycetes in the Production of Pravastatin, a novelย cholesterolโ€“loweringย agent (in Japanese with English abstract)
  154. Application of Bile Salt Hydrolase Enzyme inย cholesterolย lowering
  155. Appropriate use ofย cholesterolโ€“loweringย therapy
  156. ARBITER 2: targeting HDL to retard atherosclerosis progression: Arterial Biology for the Investigation of the Treatment Effects of Reducingย cholesterolย (ARBITER) 2
  157. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducingย cholesterol: a randomized trial comparing the effects of atorvastatin and โ€ฆ
  158. Areย cholesterolย treatment targets a deterrent to optimal lipid-loweringย therapy?
  159. Areย cholesterolโ€“loweringย medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
  160. Are early clinical effects ofย cholesterolย loweringย mediated through effects on inflammation?
  161. Are oat products effectiveย cholesterolโ€“loweringย agents?
  162. Are plant-basedย diets efficacious inย loweringย total serumย cholesterolย and low-density lipoprotein levels?
  163. Are we aggressive enough inย loweringย cholesterol?
  164. Aronia berry polyphenol consumption reduces plasma total and low-density lipoproteinย cholesterolย in former smokers withoutย loweringย biomarkers of inflammation and โ€ฆ
  165. Arterial Stiffness Interferes with LDLโ€cholesterolย loweringย by Canola Oil in Persons with Mild Hypercholesterolemia
  166. ASGR1-a new target forย loweringย non-HDLย cholesterol
  167. Assess the effectiveness of cocoa powder in reducingย cholesterolย level among the hypertensive clients at the rural area, Medavakkam, Chennai
  168. Assess the effectiveness of cocoa powder in reducingย cholesterolย levels among the Hypertensive clients at the rural area, Medavakkam, Chennai.
  169. Assessing heart disease risk in primary care:ย cholesterolย loweringย should be just one part of a multiple risk factor intervention
  170. Assessing possible hazards of reducing serumย cholesterol
  171. Assessing the efficacy ofย cholesterolโ€“loweringย treatment.
  172. Assessing the genetic impacts of 144 candidate polymorphisms on the low-density lipoproteinย cholesterolย loweringย efficacy of atorvastatin in Han Chinese
  173. Assessment of probiotic, antifungal andย cholesterolย loweringย properties of Pediococcus pentosaceus KCCโ€23 isolated from Italian ryegrass
  174. Assessment of theย dietary intake in participants of theย cholesterolย loweringย Intervention Program.
  175. Assessment of the longer-term effects of aย dietary portfolio ofย cholesterolโ€“loweringย foods in hypercholesterolemia
  176. Association between calcific aortic stenosis and hypercholesterolemia: Is there a need for a randomized controlled trial ofย cholesterolโ€loweringย therapy?
  177. Association betweenย cholesterolย synthesis/absorption markers and effects ofย cholesterolย loweringย by atorvastatin among patients with high risk of coronary โ€ฆ
  178. Association between low-density lipoproteinย cholesterolโ€“loweringย genetic variants and risk of type 2 diabetes: a meta-analysis
  179. Association betweenย loweringย low-density lipoproteinย cholesterolย with pravastatin and primary prevention of cardiovascular disease in mild to moderate โ€ฆ
  180. Association of genetically enhanced lipoprotein lipaseโ€“mediated lipolysis and low-density lipoproteinย cholesterolโ€“loweringย alleles with risk of coronary disease and โ€ฆ
  181. Association ofย loweringย lowโ€density lipoproteinย cholesterolย with contemporary lipidโ€loweringย therapies and risk of diabetes mellitus: a systematic review and meta โ€ฆ
  182. Association of the TNF-ฮฑ-C-857T Polymorphism With Resistance to theย cholesterolโ€“loweringย Effect of HMG-CoA Reductase Inhibitors in Type 2 Diabetic Subjects
  183. Atherosclerosis, acute coronary events, andย cholesterolโ€“lowering: a new paradigm
  184. Atherosclerosis/Coronary Heart Disease: Short-termย cholesterolย loweringย Decreases Size and Severity of Perfusion Abnormalities by Positron Emission Tomography โ€ฆ
  185. Atorvastatin has cardiac safety at intensiveย cholesterolโ€reducing protocols for long term, yet its cancerโ€treatment doses with chemotherapy may cause cardiomyopathy โ€ฆ
  186. Atorvastatin increases HDLย cholesterolย by reducing CETP expression inย cholesterol-fed APOE* 3-Leiden. CETP mice
  187. Atorvastatin more effective in reducing LDLย cholesterol
  188. ATTENUATED RESPONSE OF LIPID PLAQUE TOย cholesterolย loweringย THERAPY IN DIABETIC PATIENT: AN OPTICAL COHERENCE TOMOGRAPHY โ€ฆ
  189. Attitude changes of general practitioners towardsย loweringย LDLย cholesterol
  190. Automated outreach to increase primary adherence toย cholesterolโ€“loweringย medications
  191. Azalanstat (RS-21607), a lanosterol 14ฮฑ-demethylase inhibitor withย cholesterolโ€“loweringย activity
  192. Bacterial production of the fungusโ€derivedย cholesterolโ€loweringย agent mevinolin
  193. Bacteroides sp. strain D8, the firstย cholesterol-reducing bacterium isolated from human feces
  194. Balance of unsaturated fatty acids is important to aย cholesterolโ€“loweringย diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors
  195. Baseline low-density lipoproteinย cholesterolย is an important predictor of the benefit of intensive lipid-loweringย therapy: a PROVE ITโ€“TIMI 22 (Pravastatin or Atorvastatin โ€ฆ
  196. Baseline low-density lipoproteinย cholesterolย predicts the hemoglobin A1c-loweringย effect of dapagliflozin in Japanese patients with type 2 diabetes mellitus
  197. Baseline low-density lipoproteinย cholesterolย to predict the extent of cardiovascular benefit from lipid-loweringย therapies: a review
  198. Beclobrate and eniclobrate hydrochloride, new diphenylmethane derivatives as agents forย loweringย cholesterolย and triglyceride levels. Part I: Synthesis and โ€ฆ
  199. Behavioral implications ofย loweringย cholesterolย levels: a double-blind pilot study
  200. Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-cholesterolย loweringย and
  201. Bempedoic acid forย loweringย LDLย cholesterol
  202. Bempedoic Acid: A Novel LDLย cholesterolโ€“loweringย Agent
  203. Beneficial effect ofย cholesterolโ€“loweringย therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
  204. Beneficial effects of aggressive low-density lipoproteinย cholesterolย loweringย in women with stable coronary heart disease in the Treating to New Targets (TNT) study
  205. Beneficial effects ofย cholesterolโ€“loweringย therapy in hyperlipidemia patients-A six months report
  206. Beneficial effects ofย cholesterolโ€“loweringย therapy on the coronary endothelium in patients with coronary artery disease
  207. Bene๏ฌcial effects of probioticย cholesterolโ€“loweringย strain of Enterococcus faecium WEFA23 from infants onย diet-induced metabolic syndrome in rats
  208. Benefits and risks ofย loweringย serumย cholesterol
  209. Benefits of lipidย loweringย on vascular reactivity in patients with coronary artery disease and averageย cholesterolย levels: a mechanism for reducing clinical events?
  210. Benefits of lipid-loweringย therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoproteinย cholesterol
  211. Benefits ofย loweringย cholesterolย in chronic kidney disease
  212. Benefits ofย loweringย cholesterolย in chronic kidney disease
  213. Benefits ofย loweringย cholesterolย in chronic kidney diseaseโ€“Authorsโ€™ reply
  214. Benefits of reducing low density lipoproteinย cholesterolย concentrations to< 100 mg/dL
  215. Berberine Analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structureโˆ’ activity relationships, andย cholesterolโ€“loweringย โ€ฆ
  216. Berberine, a naturalย cholesterolย reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway
  217. Beyondย cholesterolย lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome
  218. Beyondย cholesterolโ€“loweringย effects of plant sterols: clinical and experimental evidence of anti-inflammatory properties
  219. Beyond theย cholesterolโ€“loweringย effect of soy protein: a review of the effects ofย dietary soy and its constituents on risk factors for cardiovascular disease
  220. Bezalip has been shown to be more effective than Clofibrate in reducingย cholesterol, triglyceride, LDL ai VLDL and in raising the protective factor HDL1, 2
  221. Bile acid binding resin improves hepatic insulin sensitivity by reducingย cholesterolย but not triglyceride levels in the liver
  222. Bile tolerance, Bile Deconjugation andย cholesterolย reducing properties of Lactobacillus strains isolated from traditional fermented foods
  223. Biochemical basis for aย cholesterolโ€“loweringย activity of 2-[2โ€ฒ-(1โ€ฒ, 3โ€ฒ-dioxolane)]-2-methyl-4-(2โ€ฒ-oxo-1โ€ฒ-pyrrolidinyl)-6-nitro-2H-1-benzopyran (SKP-450), a novel โ€ฆ
  224. Biochemical characterization ofย cholesterol-reducing Eubacterium.
  225. Biological evaluation of biscuits prepared from citrus peels as aย loweringย cholesterol
  226. Biologics inch towardย cholesterolโ€“loweringย market
  227. Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoproteinย cholesterolย lowering
  228. Blepharoptosis andย cholesterolโ€“loweringย Medications: A Retrospective Study
  229. Blockage of hydroxyl group partially abolishes theย cholesterolโ€“loweringย activity of ฮฒ-sitosterol
  230. Bloodย cholesterolย and lipid-loweringย effects of carrageenan on human volunteers.
  231. Bloodย cholesterolย loweringย effect of adenantherapavonina seed extract on atherogenicย dietย induced hyperlipidemia in rats
  232. Blood lipids and stroke: what more can we do besides reducing low-density lipoproteinย cholesterol?
  233. Blood pressure andย cholesterolโ€“loweringย efficacy of a fixed-dose combination with irbesartan and atorvastatin in patients with hypertension and โ€ฆ
  234. Blood pressure and low-density lipoproteinย cholesterolย control status in Chinese hypertensive dyslipidemia patients during lipid-loweringย therapy
  235. Blood pressure and low-density lipoprotein-cholesterolย loweringย for prevention of strokes and cognitive decline: a review of available trial evidence
  236. Blood sugar and totalย cholesterolย loweringย effect of Glycine soja (Sieb and Zucc.), Mucuna pruriens (DC) and Dolichos biflorus (Linn.) seedย diets in normalย fastingย โ€ฆ
  237. Blood-pressure andย cholesterolย loweringย in persons without cardiovascular disease
  238. Blood-Pressure andย cholesterolย loweringย in the HOPE-3 Trial.
  239. Blood-pressure andย cholesterolย loweringย in the HOPE-3 Trial.
  240. Body mass index impacts the choice of lipidโ€loweringย treatment with no correlation to bloodย cholesterolโ€“Findings from 52 916 patients in the Dyslipidemia โ€ฆ
  241. Body-weight-loss andย cholesterolโ€“loweringย effects of Cheonggukjang (a fermented soybean paste) given to rats fed a high-fat/high-cholesterolย diet
  242. Brainย cholesterolย x: effect of scheduling on the sterolย loweringย capability of methylphenidate (Ritalin).
  243. Breast cancer; role of tamoxifen as selective estrogen receptor modulator in preventing bone loss, reducing serumย cholesterolย and activity of liver enzymes in patients โ€ฆ
  244. But willย loweringย cholesterolย raise cancer rates?
  245. Caffeine-free hawk tea lowersย cholesterolย by reducing freeย cholesterolย uptake and the production of very-low-density lipoprotein
  246. Calcium supplementation increases circulatingย cholesterolย by reducing its catabolism via GPER and TRPC1-dependent pathway in estrogen deficient women
  247. Can aย cholesterolโ€“loweringย dietย cause gallstones?
  248. Can any agreement be reached onย cholesterolย lowering?
  249. Canย cholesterolโ€“loweringย be harmful?
  250. Cancer among men onย cholesterolโ€“loweringย diets: experience from five clinical trials
  251. Candidateโ€Gene Study of Functional Polymorphisms in SLCO1B1 and CYP3A4/5 and theย cholesterolโ€loweringย Response to Simvastatin
  252. Carboxymethylation of polysaccharide from Morchella angusticepes Peck enhances itsย cholesterolโ€“loweringย activity in rats
  253. Cardiovascular Benefit ofย cholesterolโ€“loweringย Therapy
  254. Cardiovascular benefit ofย cholesterolโ€“loweringย therapy: does improved endothelial vasodilator function matter?
  255. Cardiovascular event rates and trajectories of LDL-cholesterolย levels and lipid-loweringย therapy in patients with atherosclerotic cardiovascular disease: a population โ€ฆ
  256. Cardiovascular mortality after intensive LDL-cholesterolย lowering: Does baseline LDL-cholesterolย really matter?
  257. Cardiovascular outcomes associated withย loweringย low-density lipoproteinย cholesterolย in rheumatoid arthritis and matched nonrheumatoid arthritis
  258. Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterolย lowering
  259. Cerivastatin induces carotid artery plaque stabilization independently ofย cholesterolย loweringย in patients with hypercholesterolaemia
  260. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure-andย cholesterolโ€“loweringย effects
  261. Challenges to implementing expanded team models: lessons from a centralised nurse-ledย cholesterolโ€“loweringย programme
  262. Changes inย cholesterolโ€“loweringย medications use over a decade in community-dwelling older adults
  263. Changes in flow-mediated brachial artery vasoactivity withย loweringย of desirableย cholesterolย levels in healthy middle-aged men
  264. Changes in vitamin and mineral intakes and serum concentrations among free-living men onย cholesterolโ€“loweringย diets: theย dietary Alternatives Study
  265. Characterisation of an extract and fractions of Azadirachta indica flower onย cholesterolย loweringย property and intestinal motility
  266. Characterisation of Lactobacillus fermentum SMโ€7 isolated from koumiss, a potential probiotic bacterium withย cholesterolโ€loweringย effects
  267. Characterisation of non human origin probiotic Lactobacillus plantarum withย cholesterolโ€“loweringย property
  268. Characteristics associated with compliance toย cholesterolย loweringย eating patterns
  269. Characteristics ofย cholesterolโ€“loweringย Lactobacillus casei subsp. casei strain GL-03 isolated from cheese
  270. Characteristics of growth and theย cholesterol-reducing ability in meat of native lactic acid bacteria
  271. Characterization and application of a novelย cholesterol-reducing anaerobe, Eubacterium coprostanoligenes ATCC 51222
  272. CHARACTERIZATION OF Aย cholesterol-REDUCING ANAEROBE
  273. Characterization of Eubacterium coprostanoligenes sp. nov., aย cholesterol-reducing anaerobe
  274. Characterization of juice fermented with Lactobacillus plantarum EM and itsย cholesterolโ€loweringย effects on rats fed a highโ€fat and highโ€cholesterolย diet
  275. Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: A potential probiotic bacterium withย cholesterolโ€“loweringย effects
  276. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium withย cholesterolโ€“loweringย effects
  277. Characterization of lowโ€density lipoproteinย cholesterolโ€loweringย efficacy for atorvastatin in a populationโ€based DNA biorepository
  278. Characterization of starter kimchi fermented with Leuconostoc kimchii GJ2 and itsย cholesterolโ€loweringย effects in rats fed a highโ€fat and highโ€cholesterolย diet
  279. Characterization of theย cholesterol-reducing activity in a cell-free supernatant of Lactobacillus acidophilus ATCC 43121
  280. Chemerin Inhibiting ABCAl Expression and Reducingย cholesterolย Efflux in THP-1-derived Macrophage Foam Cells Mediated by NF-ฮบB Pathway
  281. Chemical and microbiological considerations of phytosterols and their relative efficacies in functional foods for theย loweringย of serumย cholesterolย levels in humans: A โ€ฆ
  282. Chemical composition of soybean oil extracted from hypocotyle-enriched soybean raw material and itsย cholesterolย loweringย effects in rats
  283. Chemoenzymatic synthesis of statine side chain building blocks and application in the total synthesis of theย cholesterolโ€“loweringย compound solistatin
  284. Chimeric apolipoproteins as novel plasmaย cholesterolย loweringย agents (1002.2)
  285. Chitosan,ย cholesterolย lowering, and caloric loss
  286. Chlorogenic acid exhibitsย cholesterolย loweringย and fatty liver attenuating properties by upโ€regulating the gene expression of PPARโ€ฮฑ in hypercholesterolemic rats โ€ฆ
  287. Choice of the optimal medium for the growth ofย cholesterol-reducing Lactobacillus casei WB
  288. Cholestanol: a serum marker to guide LDLย cholesterolโ€“loweringย therapy
  289. cholesterolย (Blood lipid)ย loweringย potential of Rosuvastatin chitosan nanoparticles for atherosclerosis: Preclinical study in rabbit model
  290. cholesterolย absorption inhibition: a strategy forย cholesterolโ€“loweringย therapy.
  291. cholesterolย absorption inhibition: filling an unmet need in lipid-loweringย management
  292. cholesterolย and Cognition: Rationale for the ADย cholesterolโ€loweringย Treatment Trial and Sexโ€Related Differences in ฮฒโ€Amyloid Accumulation in the Brains of โ€ฆ
  293. cholesterolย and fatย loweringย with hydrophobic polysaccharide derivatives
  294. cholesterolย and fatย loweringย with hydrophobic polysaccharide derivatives
  295. cholesterolย and strokes:ย cholesterolย loweringย is indicated for strokes due to carotid atheroma
  296. cholesterolย and triglyceridesย loweringย activities of caraway fruits in normal and streptozotocin diabetic rats
  297. cholesterolย and Visceral Fatย loweringย Effects of Combined Lactic Acid Bacteria (Lactobacillus casei WK3, Enterococcus faecium WK5, Bifidobacterium longum WK9 โ€ฆ
  298. cholesterolย depletion by mฮฒcd enhances cell membrane tension and its variations-reducing integrity
  299. cholesterolย Depletion Impairs Vascular Reactivity to Endothelin-1 by Reducing Store-Operated Ca2+ Entry Dependent on TRPC1
  300. cholesterolย depletion uncouples ฮฒ-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle
  301. cholesterolย efflux from bovine sperm: II. Effect of reducing spermย cholesterolย on penetration of zonaโ€free hamster and in vitro matured bovine ova
  302. cholesterolย efflux from bovine sperm. I. Induction of the acrosome reaction with lysophosphatidylcholine after reducing spermย cholesterol
  303. cholesterolย ester transfer protein polymorphism rs5882 is associated with triglyceride-loweringย in response to plant sterol consumption
  304. cholesterolย goal achievement and lipid-loweringย therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia โ€ฆ
  305. cholesterolย induced heart valve inflammation and injury: efficacy ofย cholesterolย loweringย treatment
  306. cholesterolย lowering
  307. cholesterolย loweringย a practical guide to therapy
  308. cholesterolย loweringย action and antioxidant status improving efficacy of noodles made from unmarketable oak mushroom (Lentinus edodes) in highย cholesterolย fed โ€ฆ
  309. cholesterolย loweringย action of HOE 402 in the normolipidemic and hypercholesterolemic golden Syrian hamster
  310. cholesterolย loweringย activity of formulated green caviar (Caulerpa lentillifera J. Agardh., Caulerpaceae) seaweed extract tablet in hypercholesterolemia-induced โ€ฆ
  311. cholesterolย loweringย activity of mango ginger (Curcuma amada Roxb.) in induced hypercholesterolemic rats
  312. cholesterolย loweringย activity of ropy fermented milk
  313. cholesterolย loweringย activity of soyโ€derived glyceollins in golden hamster model
  314. cholesterolย loweringย activity of the aqueous fruit extract of Trichosanthes dioica Roxb. in normal and streptozotocin diabetic rats
  315. cholesterolย loweringย After Heart Transplantation is Associated with a Lower Incidence of Transplant Coronary Artery Disease.
  316. cholesterolย loweringย after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland
  317. cholesterolย loweringย and antioxidant potential of probiotic bacteria isolated from locally fermented milk product kalarei
  318. cholesterolย loweringย and Antioxidative Effect of Pregerminated Brown Rice in Hypercholesterolemic Rats
  319. cholesterolย loweringย and bile acid excretion in the hamster with cholestyramine treatment
  320. cholesterolย loweringย and cerebrospinal fluid neurotransmitters: Increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin โ€ฆ
  321. cholesterolย loweringย and coronary artery disease: mechanisms of risk reduction
  322. cholesterolย loweringย and Coronary Revascularization: Finally a Marriage to Sustain?
  323. cholesterolย loweringย and emotional distress: Current status and future directions.
  324. cholesterolย loweringย and endothelial function
  325. cholesterolย loweringย and ezetimibe
  326. cholesterolย loweringย and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
  327. cholesterolย loweringย and life expectancy: a critical evaluation
  328. cholesterolย loweringย and morbidity and mortality.
  329. cholesterolย loweringย and mortality: the importance of considering initial level of risk.
  330. cholesterolย loweringย and mortality: time for a new paradigm?
  331. cholesterolย loweringย and prevention of CHD
  332. cholesterolย loweringย and Prevention of Stroke: An Overview
  333. cholesterolย loweringย and secondary prevention of CHDโ€“the evidence of benefit is unequivocal
  334. cholesterolย loweringย and the reduction of CHD incidence and total mortality: results from a meta-analysis of randomized trials
  335. cholesterolย loweringย and the reduction of coronary heart disease risk
  336. cholesterolย loweringย and the risk of coronary heart disease
  337. cholesterolย loweringย and the risk of stroke
  338. cholesterolย loweringย and the risk of stroke-Reply
  339. cholesterolย loweringย and the use of healthcare resources: results of the Scandinavian Simvastatin Survival Study
  340. cholesterolย loweringย and the vessel wall: new insights and future perspectives
  341. cholesterolย loweringย and vascular protective effects of ethanolic extract of dried fruit of Crataegus pinnatifida, hawthorn (Shan Zha), inย diet-induced โ€ฆ
  342. cholesterolย loweringย as a treatment for established coronary heart disease.
  343. cholesterolย loweringย Atherosclerosis Study (CLAS)
  344. cholesterolย loweringย Atherosclerosis Study (CLAS)
  345. cholesterolย loweringย attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia
  346. cholesterolย loweringย benefits of soy and linseed enriched foods
  347. cholesterolย loweringย by a-linolenic acid
  348. cholesterolย loweringย by atorvastatin parallels rapid changes in intima-media thickness and diamter of carotid arteries
  349. cholesterolย loweringย by Citrus
  350. cholesterolย loweringย byย diet: what can be achieved?
  351. cholesterolย loweringย by Pediococcus acidilactici LAB4 and Lactobacillus plantarum LAB12 in adult zebrafish is associated with improved memory and involves an โ€ฆ
  352. cholesterolย loweringย Capability of some Lactobacillus Strains and its Effect on Mice Fed a Highย cholesterolย diet
  353. cholesterolย loweringย Capacity of Lactic Acid Bacteria Isolated from Fermented Tapai
  354. cholesterolย loweringย diets and coronary heart disease: Advice should now be to increase intake of vegetable oils and fish
  355. cholesterolย loweringย diets and coronary heart disease:ย dietย alone substantially reducesย cholesterolย in hypercholesterolaemia
  356. cholesterolย loweringย diets and coronary heart disease.ย dietary advice should focus on promoting antioxidants and the right sort of fats.
  357. cholesterolย loweringย does have a role in secondary prevention.
  358. cholesterolย loweringย effect in the gall bladder of dogs by a standardized infusion of Herniaria hirsuta L.
  359. cholesterolย loweringย effect in the gall bladder of dogs by Herniaria hirsuta
  360. cholesterolย loweringย effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia
  361. cholesterolย loweringย effect of Aporosa lindleyana in male Wistar rats.
  362. cholesterolย loweringย effect of cashew leaf (Anacardium occidentale) extract on egg yolk induced hypercholesterolaemic rabbits
  363. cholesterolย loweringย EFFECT OF CHITOSAN NANOPARTICLES USING PARIJOTO FRUITS EXTRACT
  364. cholesterolย loweringย effect of Citrus paradisi (Grape fruit) peel extract in hypercholestrolemic patients in an urban community: A randomized control trial.
  365. cholesterolย loweringย effect of Cnidoscolous aconitifolius leave extracts in egg yolk induced hypercholesterolemia in rabbit
  366. cholesterolย loweringย Effect of Colchicine.
  367. cholesterolย loweringย effect ofย dietary weight loss and orlistat treatmentโ€“efficacy and limitations
  368. cholesterolย loweringย effect ofย dietary yeast and yeast fractions
  369. cholesterolย loweringย effect of Enterococcus faecium ID9201 isolated from breast milk-fed Korean infant
  370. cholesterolย loweringย Effect of Ethanol Extracts of Salted and Fermented Small Shrimp in Rats Administered a High Fatย diet
  371. cholesterolย loweringย effect of guava leaves (Psidium guajava) extract on egg yolk induced hypercholestero-laemic rabbits
  372. cholesterolย loweringย effect of jackbean (Canavalia ensiformis) seed protein.
  373. cholesterolย loweringย effect of lactic acid bacteria isolated from the human intestine.
  374. cholesterolย loweringย effect of Lactobacillus plantarum isolated from human feces
  375. cholesterolย loweringย effect of metformin in combined hyperlipidemia: placebo controlled double blind trial
  376. cholesterolย loweringย effect of neomycin and N-methylated neomycin in germfree chicks.
  377. cholesterolย loweringย effect of plant stanol ester yoghurt drinks with added camelina oil
  378. cholesterolย loweringย effect of SG-GN3, the extract of salted and fermented small shrimps, Acetes japonicus, in Triton WR-1339 or highย cholesterolโ€“dietย induced โ€ฆ
  379. cholesterolย loweringย Effect of Simvastatin in Patients with Normal and Impaired Renal Function
  380. cholesterolย loweringย effect of spirulina.
  381. cholesterolย loweringย effect of subchronic inhalation particulate matter 10 coal dust on rats
  382. cholesterolย loweringย effect of sulfur-containing amino acids added to a soybean proteinย dietย in rats
  383. cholesterolย loweringย effect of Tamarind (Tamarindus indica)
  384. cholesterolย loweringย effect of the methanol insoluble materials from the quinoa seed pericarp
  385. cholesterolย loweringย effect of the recombinant ฮฑโ€™E peptide from 7S soy globulin inย cholesterolโ€fed rats upon chronic treatment
  386. cholesterolย loweringย effects of a choleretic phloracetophenone in hypercholesterolemic hamsters
  387. cholesterolย loweringย effects of acacia nilotica subalata in normal and type 2 diabetic male rats
  388. cholesterolย loweringย Effects of Milk with Added Phytosterols
  389. cholesterolย loweringย effects of milk with added plant sterols
  390. cholesterolย loweringย effects of mono-lactose-appended ฮฒ-cyclodextrin in Niemannโ€“Pick type C disease-like HepG2 cells
  391. cholesterolย loweringย effects of nuts compared with a Canola oil enriched cereal of similar fat composition
  392. cholesterolย loweringย effects of red koji
  393. cholesterolย loweringย effects of rhubarb stalk fiber in hypercholesterolemic men.
  394. cholesterolย loweringย effects of simvastatin in patients with non-insulin dependent diabetes mellitus
  395. cholesterolย loweringย efficacy of plant stanol ester in a new type of product matrix, a chewableย dietary supplement
  396. cholesterolย loweringย efficacy of plant sterols: mechanisms of action.
  397. cholesterolย loweringย Efficacy of Simvastatin at Doses of 80 and 160 mg/d in a new low systemic exposure formulation
  398. cholesterolย loweringย for all: a closer look
  399. cholesterolย loweringย for secondary prevention of coronary artery disease: Assessment of screening and treatment practices in Hamilton
  400. cholesterolย loweringย for the prevention of stroke
  401. cholesterolย loweringย guidelines: from whence we came and where we are now
  402. cholesterolย loweringย Herbal Program
  403. cholesterolย loweringย improves endothelial function
  404. cholesterolย loweringย in 2015: still answering questions about how and in whom
  405. cholesterolย loweringย in atherosclerosis
  406. cholesterolย loweringย in Cancer Prevention and Therapy
  407. cholesterolย loweringย in intermediate-risk persons without cardiovascular disease
  408. cholesterolย loweringย in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E.
  409. cholesterolย loweringย in older patients
  410. cholesterolย loweringย in patients with CHD and metabolic syndrome
  411. cholesterolย loweringย in pigs through enhanced bacterial bile salt hydrolase activity
  412. cholesterolย loweringย in the elderly population
  413. cholesterolย loweringย in the elderly: results of theย cholesterolย Reduction in Seniors Program (CRISP) pilot study
  414. cholesterolย loweringย in the management of coronary artery disease: the clinical implications of recent trials
  415. cholesterolย loweringย in the management of coronary heart disease
  416. cholesterolย loweringย in the older population: time for reassessment?
  417. cholesterolย loweringย in the Patient with Coronary Heart Disease: Physician Monograph
  418. cholesterolย loweringย margarine is effective
  419. cholesterolย loweringย margarine launched in United Kingdom
  420. cholesterolย loweringย margarine launched in United Kingdom
  421. cholesterolย loweringย margarine may not be useful in healthy fat modifiedย diet
  422. cholesterolย loweringย mechanism of soybean protein hydrolysate
  423. cholesterolย loweringย modulates T cell function in vivo and in vitro
  424. cholesterolย loweringย Potential of Allium Sativum Essential Oil in Type 2 Diabetic Patients
  425. cholesterolย loweringย potential of Lactobacillus brevis
  426. cholesterolย loweringย POTENTIAL OF SEABUCKTHORN
  427. cholesterolย loweringย potentials of a blend of standardized methanol extracts of moringa oleifera leaves and fruits in albino wistar rats
  428. cholesterolย loweringย property of garlic (Allium sativum) on patients with hypercholesterolemia
  429. cholesterolย loweringย property of lactobacillus plantarum isolated from cow milk
  430. cholesterolย loweringย reduces the incidence of and may improve event-free survival after coronary revascularization
  431. cholesterolย loweringย therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large โ€ฆ
  432. cholesterolย loweringย therapy after myocardial infarction. Consequences of the CARE study
  433. cholesterolย loweringย therapy inhibits the lowโ€flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjects
  434. cholesterolย loweringย therapy: treat to target or reduce the global risk? The unresolved problem of residual risk
  435. cholesterolย loweringย treatment and mortality.
  436. cholesterolย loweringย treatment restores blood global DNA methylation in chronic kidney disease (CKD) patients
  437. cholesterolย loweringย trials in coronary heart disease: frequency of citation and outcome.
  438. cholesterolย loweringย trials: advice for the British physician
  439. cholesterolย loweringย Trials: Advice for the British Physician
  440. cholesterolย loweringย with Antacid
  441. cholesterolย loweringย with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications
  442. cholesterolย loweringย with EVOLocumab to prevent cardiac allograft Vasculopathy in Deโ€novo heart transplant recipients: Design of the randomized controlled โ€ฆ
  443. cholesterolย loweringย with high-viscosity hydroxypropylmethylcellulose
  444. cholesterolย loweringย with pravastatin improves resistance artery endothelial function in subjects with normal coronary arteriograms
  445. cholesterolย loweringย with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms
  446. cholesterolย loweringย with simvastatin and ezetimibe inhibitsย cholesterolย crystal formation and associated inflammation
  447. cholesterolย loweringย with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin โ€ฆ
  448. cholesterolย lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal
  449. cholesterolย lowering, fecal bile acid, and sterol changes during neomycin and colchicine
  450. cholesterolย lowering, lowย cholesterol, and mortality
  451. cholesterolย lowering, lowย cholesterol, and noncardiovascular disease.
  452. cholesterolย lowering, Nutrition and Stroke Prevention
  453. cholesterolย lowering: practical approaches
  454. cholesterolย lowering: role in cancer prevention and treatment
  455. cholesterolย lowering: should it continue to be the last thing we do?
  456. cholesterolย lowering: to live longer, start younger?
  457. cholesterolย profile in women with premature menopause after risk reducing salpingo-oophorectomy
  458. cholesterolย reducing agents inhibit assembly of type I parainfluenza viruses
  459. cholesterolย reducing and bile-acid binding properties of taioba (Xanthosoma sagittifolium) leaf in rats fed a high-fatย diet
  460. cholesterolย reducing food certainly is useful
  461. cholesterolย screening andย cholesterolย loweringย treatment.
  462. cholesterolย side chain analogs but not its ether analogs possessย cholesterolโ€“loweringย activity
  463. cholesterolย sulphate affects production of steroid hormones by reducing steroidogenic acute regulatory protein level in adrenocortical cells
  464. cholesterolย target value attainment and lipid-loweringย therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study โ€ฆ
  465. cholesterol-Absorber Status Modifies the LDLย cholesterolโ€“loweringย Effect of a Mediterranean-Typeย dietย in Adults with Moderate Cardiovascular Risk Factors
  466. cholesterol-and apolipoprotein-loweringย effect of plant stanol ester in healthy Japanese men and women.
  467. cholesterolโ€“loweringย Abilities of a Novel Proprietary Preparation (CholesLoโ„ข)-A Randomized, Double-Blind, Placebo-Controlled Study.
  468. cholesterolโ€“loweringย ability of a phytostanol softgel supplement in adults with mild to moderate hypercholesterolemia
  469. cholesterolโ€“loweringย action and antioxidative effects of microbial gum in C57BL/6N mice fed a high fatย diet
  470. cholesterolโ€“loweringย action of a novel nutraceutical combination in uremic rats: Insights into the molecular mechanism in a hepatoma cell line
  471. cholesterolโ€“loweringย action of BNA-based antisense oligonucleotides targeting PCSK9 in atherogenicย diet-induced hypercholesterolemic mice
  472. cholesterolโ€“loweringย action ofย diets rich in polyunsaturated fatty acids
  473. cholesterolโ€“loweringย action of guar gum in the rat: Changes in bile acids and sterols excretion and in enterohepatic cycling of bile acids
  474. cholesterolโ€“loweringย action of plant sterols
  475. cholesterolโ€“loweringย action of psyllium mucilloid in the hamster: sites and possible mechanisms of action
  476. cholesterolโ€“loweringย ACTIVITY AND ANTIOXIDANT PROPERTIES OF SYNBIOTIC PRODUCT ยซNำ˜Rยป
  477. cholesterolโ€“loweringย activity of Artocarpus ovatus Blanco (Moraceae) ethanolic leaf extract in animal models
  478. cholesterolโ€“loweringย activity of lactic acid bacteria and yeast when used as probiotics in laying quail (Coturnix coturnix japonica).
  479. cholesterolโ€“loweringย activity of lactic acid bacteria probiotic strains in vivo
  480. cholesterolโ€“loweringย activity of Lactobacillus gasseri: in vitro and in vivo results.
  481. cholesterolโ€“loweringย activity of Lactobacillus plantarum HLX37 in vitro and in vivo
  482. cholesterolโ€“loweringย activity of linear-and gel-type sodium polyacrylate asย dietary fiber models
  483. cholesterolโ€“loweringย activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:ย cholesterolย acyltransferase in rats
  484. cholesterolโ€“loweringย Activity of Persea americana Mill.
  485. cholesterolโ€“loweringย activity of sesamin is associated with down-regulation on genes of sterol transporters involved inย cholesterolย absorption
  486. cholesterolโ€“loweringย activity of soy-derived glyceollins in the golden Syrian hamster model
  487. cholesterolโ€“loweringย activity of tartary buckwheat protein
  488. cholesterolโ€“loweringย activity of the aqueous extract of Spergularia purpurea in normal and recent-onset diabetic rats
  489. cholesterolโ€“loweringย activity of the major polyphenols in grape seed
  490. cholesterolโ€“loweringย activity of various undigested fractions of soybean protein in rats
  491. cholesterolโ€“loweringย agents: PCSK9 inhibitors today and tomorrow
  492. cholesterolโ€“loweringย and anti-obesity effects of Polymnia sonchifolia Poepp. & Endl. powder in rats fed a high fat-highย cholesterolย diet
  493. cholesterolโ€“loweringย and antioxidant status-improving efficacy of germinated giant embryonic rice (Oryza sativa L.) in highย cholesterol-fed rats
  494. cholesterolโ€“loweringย and blood pressure effects of immune milk
  495. cholesterolโ€“loweringย and gallstone-preventing action of chitosans with different degrees of deacetylation in hamsters fedย cholesterol-richย diets
  496. cholesterolโ€“loweringย and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients
  497. cholesterolโ€“loweringย and hepatoprotective effect of fruit juice extract of Azadirachta indica on Plasmodium berghei infected mice
  498. cholesterolโ€“loweringย and High-Density Lipoprotein-Raising Properties of Lecithinated Soy Proteins in Type II Hyperlipidemic Patients
  499. cholesterolโ€“loweringย and lipid oxidation reduction potentials of traditional seasonings in Salchichon dry-fermented sausages
  500. cholesterolโ€“loweringย and liver-protective effects of cooked and germinated mung beans (Vigna radiata L.)
  501. cholesterolโ€“loweringย and vascular reactivity in relation to coronary heart disease.
  502. cholesterolโ€“loweringย benefits of a whole grain oat ready-to-eat cereal
  503. cholesterolโ€“loweringย benefits of oat-containing cereal in Hispanic Americans
  504. cholesterolโ€“loweringย bile acid-binding agents: novel lipophilic polyamines
  505. cholesterolโ€“loweringย blockbuster candidates speed into Phase III trials
  506. cholesterolโ€“loweringย by rice bran and rice bran oil unsaponifiable matter in hamsters
  507. cholesterolโ€“loweringย Clinical Trials: Where Do We Go From Here?
  508. cholesterolโ€“loweringย Decreased mTOR Complex 2 Signaling and Enhanced Antitumor Immunity
  509. cholesterolโ€“loweringย diets Change Vitamin and Mineral Intakes
  510. cholesterolโ€“loweringย diets may increase the food costs for Danish children. A cross-sectional study of food costs for Danish children with and without familial โ€ฆ
  511. cholesterolโ€“loweringย diets: a review of the evidence
  512. cholesterolโ€“loweringย effect of a low-fatย dietย containing lean beef is reversed by the addition of beef fat
  513. cholesterolโ€“loweringย effect of a new fermented milk product in healthy 44-year old Danish men
  514. cholesterolโ€“loweringย effect of a theaflavin-enriched green tea extract: a randomized controlled trial
  515. cholesterolโ€“loweringย effect of agemaki, a kind of shellfish, in mice
  516. cholesterolโ€“loweringย effect of allicin on hypercholesterolemic ICR mice
  517. cholesterolโ€“loweringย effect of Aralia elata (Miq.) Seem via the activation of SREBP-2 and the LDL receptor
  518. cholesterolโ€“loweringย effect of astringent persimmon fruits (Diospyros kaki Thunb.) extracts
  519. cholesterolโ€“loweringย effect of barley bran flour and oil
  520. cholesterolโ€“loweringย effect of beta glucan extracted from Saccharomyces cerevisiae in rats
  521. cholesterolโ€“loweringย Effect of Beta Glucan Extracted from Saccharomyces cerevisiae in Rats.
  522. cholesterolโ€“loweringย effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice
  523. cholesterolโ€“loweringย effect of black tea polyphenols, theaflavins, theasinensin A and thearubigins, in rats fed high fatย diet
  524. cholesterolโ€“loweringย effect of calcium alginate in rats
  525. cholesterolโ€“loweringย effect of Clostridium butyricum inย cholesterol-fed rats
  526. cholesterolโ€“loweringย effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients
  527. cholesterolโ€“loweringย effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia
  528. cholesterolโ€“loweringย effect of continuous enteral nutrition in man
  529. cholesterolโ€“loweringย effect ofย dietย with added sweet potato (Ipomea batatas) vines in rabbits
  530. cholesterolโ€“loweringย effect ofย dietary Lupinus angustifolius proteins in adult rats through regulation of genes involved inย cholesterolย homeostasis
  531. cholesterolโ€“loweringย effect of extruded amaranth (Amaranthus caudatus L.) in hypercholesterolemic rabbits
  532. cholesterolโ€“loweringย effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats
  533. cholesterolโ€“loweringย effect of food bars containing guar gum in healthy women and men
  534. cholesterolโ€“loweringย effect of garlic
  535. cholesterolโ€“loweringย effect of garlic extracts and organosulfur compounds: human and animal studies
  536. cholesterolโ€“loweringย effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids
  537. cholesterolโ€“loweringย effect of kori-tofu protein and its high-molecular-weight fraction content
  538. cholesterolโ€“loweringย effect of lactic acid bacteria in mice with hyperlipidemia
  539. cholesterolโ€“loweringย effect of Lactobacillus plantarum NCU116 in a hyperlipidaemic rat model
  540. cholesterolโ€“loweringย effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model
  541. cholesterolโ€“loweringย effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
  542. cholesterolโ€“loweringย effect of N-(ฮฑ-methylbenzyl) linoleamide (melinamide) inย cholesterol-fed diabetic rats
  543. cholesterolโ€“loweringย effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia
  544. cholesterolโ€“loweringย effect of non-viscous solubleย dietary fiber NUTRIOSE (R) 6 in moderately hypercholesterolemic hamsters
  545. cholesterolโ€“loweringย effect of oat
  546. cholesterolโ€“loweringย Effect of Octaarginine-appended ฮฒ-Cyclodextrin in Npc1-trap-CHO Cells
  547. cholesterolโ€“loweringย effect of organosulphur compounds from garlic: a possible mechanism of action.
  548. cholesterolโ€“loweringย effect of phytosterol-containing lactic-fermented milk powder in hamsters
  549. cholesterolโ€“loweringย effect of plant sterols
  550. cholesterolโ€“loweringย effect of platycodin D in hypercholesterolemic ICR mice
  551. cholesterolโ€“loweringย effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-caseinย diet
  552. cholesterolโ€“loweringย effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects
  553. cholesterolโ€“loweringย effect of rice bran protein containing bile acid-binding proteins
  554. cholesterolโ€“loweringย effect of rice protein by enhancing fecal excretion of lipids in rats
  555. cholesterolโ€“loweringย effect of rolled oats
  556. cholesterolโ€“loweringย effect of skim milk from immunized cows in hypercholesterolemic patients
  557. cholesterolโ€“loweringย effect of soy protein in normocholesterolemic and hypercholesterolemic men
  558. cholesterolโ€“loweringย effect of soyabean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion
  559. cholesterolโ€“loweringย effect of soybean oligopeptides
  560. cholesterolโ€“loweringย effect of soybean protein isolate in chicks is partly lost by microbial protease digestion
  561. cholesterolโ€“loweringย effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects
  562. cholesterolโ€“loweringย effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial
  563. cholesterolโ€“loweringย effect of sulfaguanidine in mice and rats
  564. cholesterolโ€“loweringย effect of taurine and its mechanism in high-cholesterolย Hep G2 cells
  565. cholesterolโ€“loweringย effect of the food for heart nutrition education program
  566. cholesterolโ€“loweringย effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats
  567. cholesterolโ€“loweringย effect of the regulatory peptide Pro-Gly-Pro-Leu
  568. cholesterolโ€“loweringย effect of whole lupin (Lupinus albus) seed and its protein isolate
  569. cholesterolโ€“loweringย effect of ฮฒ-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when ฮฒ-glucan is incorporated into bread and cookies
  570. cholesterolโ€“loweringย effects and potential mechanisms of chitooligosaccharide capsules in hyperlipidemic rats
  571. cholesterolโ€“loweringย effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice
  572. cholesterolโ€“loweringย effects and utilization of protein, lipid, fiber and energy in rats fed unprocessed and baked oat bran
  573. cholesterolโ€“loweringย Effects in Rat Liver Fed Barley and Barley Fraction withย cholesterol
  574. cholesterolโ€“loweringย effects of a 10 mg daily dose of lovastatin in patients with initial totalย cholesterolย levels 200 to 240 mg/dl (5.18 to 6.21 mmol/liter)
  575. cholesterolโ€“loweringย effects of a new isolated soy protein with high levels of nondenaturated protein in hypercholesterolemic patients
  576. cholesterolโ€“loweringย effects of a proprietary Chinese red-yeast-riceย dietary supplement
  577. cholesterolโ€“loweringย effects of a putative probiotic strain Lactobacillus plantarum EM isolated from kimchi
  578. cholesterolโ€“loweringย effects of Bacillus coagulans B37 and Bacillus pumilus B9 strains in a rat animal model.
  579. cholesterolโ€“loweringย effects of barleyย dietary fibre in humans: scientific support for a generic health claim
  580. cholesterolโ€“loweringย effects of bovine serum immunoglobulin in participants with mild hypercholesterolemia
  581. cholesterolโ€“loweringย effects of certain grains and of oat fractions in the chick.
  582. cholesterolโ€“loweringย effects ofย dietary blue lupin (Lupinus angustifolius L.) in intact and ileorectal anastomosed pigs
  583. cholesterolโ€“loweringย effects ofย dietary citrus juices and their flavonoids. Studies in rats, mice and rabbits
  584. cholesterolโ€“loweringย effects ofย dietary fiber
  585. cholesterolโ€“loweringย effects ofย dietary fiber: a meta-analysis
  586. cholesterolโ€“loweringย effects ofย dietary lupin (Lupinus albus var Multolupa) in chickenย diets
  587. cholesterolโ€“loweringย effects ofย dietary pomegranate extract and inulin in mice fed an obesogenicย diet
  588. cholesterolโ€“loweringย effects of dl-N-(ฮฑ-methylbenzyl)-linoleamide and its optically active isomers inย cholesterolfed animals
  589. cholesterolโ€“loweringย Effects of Extract from Garcinia daedalanthera in Hyperlipidemic rats
  590. cholesterolโ€“loweringย effects of guar gum: changes in bile acid pools and intestinal reabsorption
  591. cholesterolโ€“loweringย effects of high-protein soya milk
  592. cholesterolโ€“loweringย effects of isolated soybean protein hydrolyzate with bound phospholipids in rats
  593. cholesterolโ€“loweringย Effects of Lactobacilli and Bifidobacteria Probiotics in vitro and in vivo
  594. cholesterolโ€“loweringย effects of Lactobacillus brevis isolated from turnip โ€œtsuda kabuโ€
  595. cholesterolโ€“loweringย effects of Lactobacillus species
  596. cholesterolโ€“loweringย effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats
  597. cholesterolโ€“loweringย effects of modified animal fats in postmenopausal women.
  598. cholesterolโ€“loweringย effects of N-methylated neomycin and basic antibiotics
  599. cholesterolโ€“loweringย effects of NTE-122, a novel acyl-CoA:ย cholesterolย acyltransferase (ACAT) inhibitor, onย cholesterolย diet-fed rats and rabbits
  600. cholesterolโ€“loweringย effects of oat ฮฒ-glucan
  601. cholesterolโ€“loweringย effects of oat ฮฒ-glucan: a meta-analysis of randomized controlled trials
  602. cholesterolโ€“loweringย effects of piceatannol, a stilbene from wine, using untargeted metabolomics
  603. cholesterolโ€“loweringย effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods
  604. cholesterolโ€“loweringย effects of plant sterol esters differ in milk, yoghurt, bread and cereal
  605. cholesterolโ€“loweringย effects of plant sterols in one serve of wholegrain wheat breakfast cereal biscuitsโ€”A randomised crossover clinical trial
  606. cholesterolโ€“loweringย effects of plant steryl and stanyl laurate by oral administration in mice
  607. cholesterolโ€“loweringย effects of policosanol in rabbits.
  608. cholesterolโ€“loweringย effects of probiotics and prebiotics: a review of in vivo and in vitro findings
  609. cholesterolโ€“loweringย effects of probioticsโ€“a review
  610. cholesterolโ€“loweringย effects of psyllium hydrophilic mucilloid for hypercholesterolemic men
  611. cholesterolโ€“loweringย effects of psyllium hydrophilic mucilloid: adjunct therapy to a prudentย dietย for patients with mild to moderate hypercholesterolemia
  612. cholesterolโ€“loweringย effects of psyllium intake adjunctive toย dietย therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials
  613. cholesterolโ€“loweringย effects of psyllium seed associated with urea metabolism
  614. cholesterolโ€“loweringย effects of psyllium-enriched cereal as an adjunct to a prudentย dietย in the treatment of mild to moderate hypercholesterolemia
  615. cholesterolโ€“loweringย effects of ready-to-eat cereal containing psyllium
  616. cholesterolโ€“loweringย effects of rice bran and rice bran oil fractions in hypercholesterolemic hamsters
  617. cholesterolโ€“loweringย effects of soluble-fiber cereals as part of a prudentย dietย for patients with mild to moderate hypercholesterolemia
  618. cholesterolโ€“loweringย effects of soybean, potato and rice proteins depend on their low methionine contents in rats fed aย cholesterol-free purifiedย diet
  619. cholesterolโ€“loweringย effects of unripe black raspberry water extract
  620. cholesterolโ€“loweringย effects ohypercholesterolemiain patients with mild to moderate hypercholesterolemia
  621. cholesterolโ€“loweringย efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic โ€ฆ
  622. cholesterolโ€“loweringย efficacy of a sitostanol-containing phytosterol mixture with a prudentย dietย in hyperlipidemic men
  623. cholesterolโ€“loweringย efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults
  624. cholesterolโ€“loweringย efficacy of plant sterol-enriched flavored milk, yogurt, fruit bar, and soya milk in mild hypercholesterolemic Indian subjects
  625. cholesterolโ€“loweringย efficacy of plant sterols in low-fat yogurt consumed as a snack or with a meal
  626. cholesterolโ€“loweringย efficacy of plant sterols/stanols provided in capsule and tablet formats: results of a systematic review and meta-analysis
  627. cholesterolโ€“loweringย efficacy of unrefined bran oil from the pigmented black rice (Oryza sativa L cv. Suwon 415) in hypercholesterolemic rats
  628. cholesterolโ€“loweringย food additives: lipase-catalysed preparation of phytosterol and phytostanol esters
  629. cholesterolโ€“loweringย foods and reduction in serumย cholesterolย levels
  630. cholesterolโ€“loweringย foods and reduction in serumย cholesterolย levelsโ€”reply
  631. cholesterolโ€“loweringย gene therapy counteracts the development of non-ischemic cardiomyopathy in mice
  632. cholesterolโ€“loweringย Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice
  633. cholesterolโ€“loweringย gene therapy prevents HFpEF in obese type 2 diabetic mice
  634. cholesterolโ€“loweringย in hamsters fed rice bran at various levels, defatted rice bran and rice bran oil
  635. cholesterolโ€“loweringย in infancy?
  636. cholesterolโ€“loweringย in man
  637. cholesterolโ€“loweringย Independent Effects of Pravastatin on the Artery Wall of Atherosclerotic Primates.
  638. cholesterolโ€“loweringย independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in โ€ฆ
  639. cholesterolโ€“loweringย injectables: more harm than good
  640. cholesterolโ€“loweringย intervention and coronary artery disease after cardiac transplantation
  641. cholesterolโ€“loweringย Intervention Program: effect of the step Iย dietย in community office practices
  642. cholesterolโ€“loweringย interventions and stroke: insights from a meta-analysis of randomized controlled trials
  643. cholesterolโ€“loweringย interventions and stroke: Insights from IMPROVE-IT
  644. cholesterolโ€“loweringย MECHANISMS OF PHYTOCHEMICALS: A REVIEW.
  645. cholesterolโ€“loweringย medications reduce the risk of age-related maculopathy progression
  646. cholesterolโ€“loweringย nature of unsaturated fat in rats may be due to its inability to increase hepatic iron
  647. cholesterolโ€“loweringย nutraceuticals affecting vascular function and cardiovascular disease risk
  648. cholesterolโ€“loweringย nutraceuticals and functional foods
  649. cholesterolโ€“loweringย of Pantethine is Due to the Hydrolysis Product Cysteamine
  650. cholesterolโ€“loweringย pattern affects the progression of atherosclerosis in apolipoprotein E deficient mice
  651. cholesterolโ€“loweringย phytosterols: factors affecting their use and efficacy
  652. cholesterolโ€“loweringย potential in human subjects of fat from pigs fed rapeseed oil
  653. cholesterolโ€“loweringย Potential of Probiotic Yogurts Containing Lactobacillus acidophilus and Streptococcus Thermophiles on Mild Hypercholesterolemic Male โ€ฆ
  654. cholesterolโ€“loweringย potentials of lactic acid bacteria based on bile-salt hydrolase activity and effect of potent strains onย cholesterolย metabolism in vitro and in โ€ฆ
  655. cholesterolโ€“loweringย potentials of Lactobacillus strain overexpression of bile salt hydrolase on highย cholesterolย diet-induced hypercholesterolemic mice
  656. cholesterolโ€“loweringย probiotics as potential biotherapeutics for metabolic diseases
  657. cholesterolโ€“loweringย probiotics: in vitro selection and in vivo testing of bifidobacteria
  658. cholesterolโ€“loweringย probiotics: in vitro selection and in vivo testing of bifidobacteria
  659. cholesterolโ€“loweringย properties and safety of chitosan
  660. cholesterolโ€“loweringย properties of amaranth flakes, crude and refined oils in hamsters
  661. cholesterolโ€“loweringย properties of amaranth grain and oil in hamsters
  662. cholesterolโ€“loweringย PROPERTIES OF DEFATTED KENAF SEED MEAL AND ITS PHENOLICS-SAPONINS-RICH EXTRACT IN A RAT MODEL
  663. cholesterolโ€“loweringย properties of different pectin types in mildly hyper-cholesterolemic men and women
  664. cholesterolโ€“loweringย properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs
  665. cholesterolโ€“loweringย properties of lupin peptides: molecular and functional investigations at Hepg2 cell line
  666. cholesterolโ€“loweringย properties of oat ฮฒ-glucan and the promotion of cardiovascular health: did Health Canada make the right call?
  667. cholesterolโ€“loweringย properties of oats: Effects of processing and the role of oat components
  668. cholesterolโ€“loweringย properties of plant sterols esterified with beef tallow fatty acids in hamsters
  669. cholesterolโ€“loweringย proteins and peptides.
  670. cholesterolโ€“loweringย therapy
  671. cholesterolโ€“loweringย therapy
  672. cholesterolโ€“loweringย therapy after heart transplantation: a 12-month randomized trial.
  673. cholesterolโ€“loweringย therapy and cell membranes. Stable plaque at the expense of unstable membranes?
  674. cholesterolโ€“loweringย therapy evokes time-limited changes in serotonergic transmission
  675. cholesterolโ€“loweringย therapy for primary prevention: still much we donโ€™t know
  676. cholesterolโ€“loweringย therapy for smokers and non-smokers: a life-table analysis
  677. cholesterolโ€“loweringย therapy for the treatment of nonalcoholic fatty liver disease: an update
  678. cholesterolโ€“loweringย therapy in secondary prevention: Remaining issues
  679. cholesterolโ€“loweringย therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study โ€ฆ
  680. cholesterolโ€“loweringย Therapy Interventions
  681. cholesterolโ€“loweringย therapy may retard the progression of diabetic nephropathy
  682. cholesterolโ€“loweringย therapy with pravastatin in heart-transplant patients taking cyclosporine A
  683. cholesterolโ€“loweringย therapy with pravastatin in older patients (aged 65 to 75) in the lipid study
  684. cholesterolโ€“loweringย therapy; a recommendation from the Health Council
  685. cholesterolโ€“loweringย Therapy: Evaluation of Clinical Trial Evidence
  686. cholesterolโ€“loweringย Therapy: Is Therereallya Controversy?
  687. cholesterolโ€“loweringย therapy: new data on tolerability and noncompliance
  688. cholesterolโ€“loweringย therapy: Old evidence, new guidelinesโ€“Which one to follow? A critical appraisal
  689. cholesterolโ€“loweringย treatment in chronic kidney disease: Multistage pairwise and network meta-analyses
  690. cholesterolโ€“loweringย treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased โ€ฆ
  691. cholesterolโ€“loweringย treatment with PCSK9-inhibitors
  692. cholesterol-metabolizing cytochromes P450: implications forย cholesterolย lowering
  693. cholesterol-Reducing Activity in a Cell-Free Supernatant of Lactobacillus reuteri
  694. cholesterol-reducing agents for treatment of aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis of randomized controlled trials
  695. cholesterol-reducing bacterium from human feces.
  696. cholesterol-reducing effect of ergosterol is modulated via inhibition ofย cholesterolย absorption and promotion ofย cholesterolย excretion
  697. cholesterol-reducing flavonoids found in citrus peels
  698. cholesterol-reducing Lactic Acid Bacteria Screening and Research [J]
  699. cholesterol-Reducing of Lactobacillus Plantarum
  700. cholesterolโ€loweringย effect of an acylโ€coenzyme A:ย cholesterolย acyltransferase inhibitor, FR145237, in hypercholesterolemic rabbits fed a highโ€cholesterolย dietย and a โ€ฆ
  701. cholesterolโ€loweringย effect of dextroโ€thyroxine in patients with hypercholesterolemia and coronary diseasel
  702. cholesterolโ€loweringย effect of plant sterols
  703. cholesterolโ€loweringย effect of ursodeoxycholic acid in patients with primary biliary cirrhosis
  704. cholesterolโ€loweringย effect of YMโ€16638 in cynomolgus monkeys
  705. cholesterolโ€loweringย Effects and Mechanisms in View of Bile Acid Pathway of Resveratrol and Resveratrol Glucuronides
  706. cholesterolโ€loweringย effects of E nterococcus
  707. cholesterolโ€loweringย effects of Northern wild rice in LDL receptor knockout mice
  708. cholesterolโ€loweringย effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetesโ€“CORALL study
  709. cholesterolโ€loweringย properties of whole cowpea seed and its protein isolate in hamsters
  710. cholesterolโ€loweringย strategies reduce vascular LRP1 overexpression induced by hypercholesterolaemia
  711. cholesterolโ€loweringย therapy with pravastatin in patients with averageย cholesterolย levels and established ischaemic heart disease: is it costโ€effective?
  712. cholesterolโ€reducing agents for aneurysmal subarachnoid haemorrhage
  713. cholesterolโ€“GalNAc dual conjugation strategy for reducing renal distribution of antisense oligonucleotides
  714. cholesterolโ€“loweringย effect of oat flour supplementationon lipid profile of mild hyperlipidemic male subjects
  715. cholesterol,ย cholesterolย lowering, and endothelial function
  716. cholesterol, copper and Aฮฒ in controls, MCI, AD and the ADย cholesterolโ€“loweringย treatment trial (ADCLT)
  717. cholesterol, triglycerides and ldlย loweringย effects of generic products of simvastatin and hdl effect as compared to original brand of simvastatin in hypercholesterolemic โ€ฆ
  718. cholesterol: Its low density lipoproteins and natural approaches in lipidย loweringย therapy
  719. cholesterol/HDL-c ratioย loweringย effect of green tea in rats exposed to depot medroxiprogesterone acetate
  720. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDLย cholesterolย and of the lipoprotein response to a lipid-loweringย dietย in type 1 diabetes
  721. Choosing hamsters but not rats as a model for studying plasmaย cholesterolโ€loweringย activity of functional foods
  722. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing theย cholesterolย efflux-inducing ability of โ€ฆ
  723. Clinical and cost-effectiveness of an intervention for reducingย cholesterolย and cardiovascular risk for people with severe mental illness in English primary care โ€ฆ
  724. Clinical application of bergamot (Citrus bergamia) for reducing highย cholesterolย and cardiovascular disease markers
  725. Clinical benefits and cost-effectiveness ofย loweringย serumย cholesterolย levels: the case of simvastatin and cholestyramine in the Netherlands
  726. Clinical benefits ofย cholesterolย loweringย treatments. Meta-analysis of randomized therapeutic trials
  727. Clinical reality ofย loweringย total and LDLย cholesterol
  728. Clinical trial ofย plantstanol-ester inducedย cholesterolโ€“loweringย in NIDDM-patients
  729. Clinical trials ofย cholesterolย loweringย intervention for cardiovascular prevention in elderly
  730. Co-administration ofย cholesterolโ€“loweringย probiotics and anthraquinone from Cassia obtusifolia L. ameliorate non-alcoholic fatty liver
  731. Co-administration of ezetimibe enhances proteinuria-loweringย effects of pitavastatin in chronic kidney disease patients partly via aย cholesterol-independent manner
  732. Cognition afterย loweringย LDL-cholesterolย with evolocumab
  733. Colesevelam hydrochloride: a non-absorbed, polymericย cholesterolโ€“loweringย agent
  734. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant forย loweringย LDL-cholesterol
  735. Combined effect of vegetable protein (soy) and soluble fiber added to a standardย cholesterolโ€“loweringย diet
  736. Combinedย loweringย effects of rosuvastatin and L. acidophilus onย cholesterolย levels in rat
  737. Combiningย cholesterolโ€“loweringย strategies with imaging data: a visible benefit?
  738. Comment on:โ€ A comparison of the LDL-cholesterolย loweringย efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of โ€ฆ
  739. Commentary to part two: Doesย loweringย cholesterolย cause increases in depression, suicide, and accidents?
  740. Common genetic variation in the ABCB1 gene is associated with theย cholesterolโ€“loweringย effect of simvastatin in males
  741. Compactin (ML-236B) and related compounds as potentialย cholesterolโ€“loweringย agents that inhibit HMG-CoA reductase
  742. Comparativeย cholesterolย loweringย properties of vegetable oils: beyond fatty acids
  743. Comparativeย cholesterolโ€“loweringย activity of citrus and tomato pectin
  744. Comparativeย cholesterolโ€“loweringย effects of barley ฮฒ-glucan and barley oil in golden Syrian hamsters
  745. Comparative Effectiveness of Atorvastatin (Low Vs High Dose) inย loweringย Low-Density Lipoproteinย cholesterolย in Intermediate Risk Cardiovascular Patients
  746. Comparative of in vitro antioxidant andย cholesterolโ€”loweringย activities of fermented goat & cow milk
  747. Comparative studies on the serumย cholesterolย loweringย action of whey protein and soybean protein in rats
  748. Comparative Study on Acute Toxicity, Antioxidant andย cholesterolย loweringย Activities of Po-Sa (Leaves And Stem)
  749. Comparison between the plasmaย cholesterolโ€“loweringย effects of glycine and taurine in rats fed on highย cholesterolย diets
  750. Comparison of Antioxidant andย cholesterolโ€“loweringย Activity of Mulberry (Morus alba L.)
  751. Comparison ofย cholesterolโ€“loweringย effect of ฮฒ-glucan in cereals and bread
  752. Comparison ofย cholesterolโ€“loweringย efficacy and anti-atherogenic properties of hydrogenated versus non-hydrogenated (Phytrolโ„ข) tall oil-derived phytosterols in apo โ€ฆ
  753. Comparison ofย cholesterolโ€“loweringย regimens.
  754. Comparison of docosahexaenoic acid with eicosapentaenoic acid on theย loweringย effect of endogenous plasmaย cholesterolย in adult mice
  755. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoproteinย cholesterolย levels
  756. Comparison of hesperetin and its metabolites forย cholesterolโ€“loweringย and antioxidative efficacy in hypercholesterolemic hamsters
  757. Comparison of LDL-cholesterolย analytical performance using direct homogeneous enzymatic assay and Friedwald formular for cost reducing apply to the annual โ€ฆ
  758. Comparison of monounsaturated fatty acids and carbohydrates forย loweringย plasmaย cholesterol
  759. Comparison of monounsaturated fatty acids and carbohydrates for reducing raised levels of plasmaย cholesterolย in man
  760. COMPARISON OF ROSUVASTATIN WITH ATORVASTATIN INย loweringย LOW DENSITY LIPOPROTEINย cholesterolย AMONG DYSLIPIDEMIC PATIENTS
  761. Comparison of theย cholesterolโ€“loweringย effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits
  762. Comparison of theย cholesterolโ€“loweringย Effects between Loquat Leaf and Fruit Extract in Rats Fed a High-cholesterolย diet
  763. Comparison of the effectiveness of individual versus group counseling on reducing low density lipoproteinย cholesterolย levels.
  764. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines inย loweringย serumย cholesterolย concentrations in hypercholesterolaemic โ€ฆ
  765. Comparison of theย loweringย effect on bloodย cholesterolย of clofibrate and simvastatin
  766. Comparison of therapeutic effectย loweringย low density lipoproteinย cholesterolย in Uygur and Kazak na-tionality patients with coronary heart disease from Xinj iang
  767. Comparison of threeย cholesterolโ€“loweringย diets in normolipidemic men
  768. comparison of variousย cholesterolย loweringย diets in young healthy volunteers: effects on serum lipoproteins and on other risk indicators for cardiovascular diseases
  769. Complementaryย cholesterolโ€“loweringย response of a phytosterol/ฮฑ-lipoic acid combination in obese zucker rats
  770. Complementary low-density lipoprotein-cholesterolย loweringย and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background โ€ฆ
  771. Complete genome sequence of Lactobacillus plantarum EM, a putative probiotic strain with theย cholesterolโ€“loweringย effect and antimicrobial activity
  772. Components characterization of total tetraploid jiaogulan (Gynostemma pentaphyllum) saponin and itsย cholesterolโ€“loweringย properties
  773. Concept and protocol to isolateย cholesterol-reducing bacteria from carnivores
  774. Concordance ofย dietย with the recommendedย cholesterolย loweringย dietย in patients with coronary heart disease
  775. Configuring users ofย cholesterolย loweringย foods: A review of biomedical discourse
  776. CONSISTENT LOW-DENSITY LIPOPROTEINย cholesterolย loweringย EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK โ€ฆ
  777. Consumer attitudes and understanding ofย cholesterolโ€“loweringย claims on food: randomize mock-package experiments with plant sterol and oat fibre claims
  778. Consumption of aย dietary portfolio ofย cholesterolย loweringย foods improves blood lipids without affecting concentrations of fat soluble compounds
  779. Consumption of restructured meat products with added walnuts has aย cholesterolโ€“loweringย effect in subjects at high cardiovascular risk: a randomised, crossover โ€ฆ
  780. Continuous dose-response relationship of the LDL-cholesterolโ€“loweringย effect of phytosterol intake
  781. Control Measures and Mechanisms for Reducing Eggย cholesterolย Content [J]
  782. Control measures and mechanisms for reducing eggย cholesterolย content.
  783. Control of plasmaย cholesterolโ€“loweringย action of probucol with various lipid carrier systems
  784. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensiveย cholesterolย loweringย with low-density lipoprotein-apheresis: 1-year โ€ฆ
  785. Coronary heart disease risk factors and LDLย cholesterolโ€“loweringย efficacy of fibrates and simvastatin
  786. Coronary risk assessment methods andย cholesterolย lowering
  787. Correction to Lancet Psychiatry 2018; 5: 145โ€“54. Clinical and cost-effectiveness of an intervention for reducingย cholesterolย and cardiovascular risk for people with โ€ฆ
  788. Correction: activation of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducingย cholesterolย efflux from human โ€ฆ
  789. Correlates of LDL-cholesterolย goal attainment in patients under lipidย loweringย therapy
  790. Correlation of Serum Lipoproteins with Total Serumย cholesterolย Values before and during Treatment withย cholesterolโ€“loweringย Agents
  791. Correlation of the plasmaย cholesterolโ€“loweringย effect ofย dietary glycine with the alteration of hepatic phospholipid composition in rats
  792. Cost and health implications ofย cholesterolย lowering.
  793. Cost effectiveness ofย cholesterolย Appraising medical researchย loweringย articles
  794. Cost effectiveness ofย cholesterolโ€“loweringย therapy in The Netherlands: simvastatin versus cholestyramine
  795. Cost effectiveness of incremental programmes forย loweringย serumย cholesterolย concentration: is individual intervention worth while?
  796. Cost effectiveness ofย loweringย cholesterol
  797. Cost effectiveness ofย loweringย cholesterol. Cost consequence analysis may be more useful to decision makers.
  798. Cost effectiveness ofย loweringย cholesterol. Costs in general practice.
  799. Cost effectiveness ofย loweringย cholesterol. Full treatment of the costs and benefits is needed.
  800. Cost-effectiveness analysis ofย cholesterolโ€“loweringย therapies in Spain
  801. Cost-effectiveness analysis of low density lipoproteinย cholesterolโ€“loweringย therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen โ€ฆ
  802. Cost-effectiveness ofย cholesterolย lowering: results from the Scandinavian Simvastatin Survival Study (4S)
  803. Cost-effectiveness ofย cholesterolโ€“loweringย therapies according to selected patient characteristics
  804. Cost-effectiveness ofย cholesterolโ€“loweringย therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger โ€ฆ
  805. Cost-effectiveness ofย loweringย of bloodย cholesterolย using simvastatin and cholestyramine
  806. Creative approaches toย cholesterolย loweringย used in theย dietary Intervention Study in Children
  807. Critical review of 2016 ACC guidelines on therapies forย cholesterolย loweringย with reference to laboratory testing
  808. Curcumin potentiatesย cholesterolโ€“loweringย effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial
  809. Current strategies for atherosclerosis andย loweringย cholesterol
  810. Cutaneous microvascular responses are improved afterย cholesterolโ€“loweringย in patients with peripheral vascular disease and hypercholesterolaemia
  811. Cyclodextrin (CD) complexes ofย cholesterolโ€“their potential use in reducingย dietaryย cholesterolย intake
  812. Cyclosporine A Impairs the Macrophage Reverseย cholesterolย Transport in Mice by Reducing
  813. Cyclosporine A impairs the macrophage reverseย cholesterolย transport in mice by reducing sterol fecal excretion
  814. CYP7A1 polymorphism influences the LDLย cholesterolโ€loweringย response to atorvastatin
  815. CYP7A1-rs3808607 and APOE isoform associate with LDLย cholesterolย loweringย after plant sterol consumption in a randomized clinical trial
  816. D-Allulose Alters Serumย cholesterolย Levels Partly Via Reducing Serum Pcsk9 Levels In Hamsters.
  817. D-glucaric acid content of various fruits and vegetables andย cholesterolโ€“loweringย effects ofย dietary D-glucarate in the rat
  818. Dadih (L. acidophilus), contained aย cholesterolย reducing food
  819. Deaths from injury, violence, and suicide in secondary prevention trials ofย cholesterolย lowering
  820. Decisions regardingย cholesterolโ€“loweringย therapy in the elderly: the experience in a lipid clinic and a review of the literature
  821. Declaring war on undertreatment: rationale for an aggressive approach toย loweringย cholesterol
  822. Declining Totalย cholesterolย Levels and Increasing Lipidย loweringย Therapy Use at Presentation in Patients With Acute Coronary Syndrome
  823. Deficiency in Hepatic MTTP Reverses Gallstone Susceptibility in L-Fabp Knockout Mice by Reducing Canalicularย cholesterolย Secretion
  824. Defining the role of bempedoic acid inย loweringย low-density lipoproteinย cholesterol
  825. Depression andย cholesterolโ€“loweringย chemotherapy: Potential influence of smoking cessation, depression history, andย dietary change
  826. Depression and failure ofย cholesterolย loweringย after acute myocardial infarction
  827. Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducingย cholesterol)-6-HDL and LDL Treatment โ€ฆ
  828. Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducingย cholesterol)โ€”a randomized trial comparing the โ€ฆ
  829. Design, synthesis, andย cholesterolโ€“loweringย efficacy for prodrugs of berberrubine
  830. Determinants of Responsiveness of LDL-cholesterolย loweringย to Lifestyle Modification in Hypercholesterolemic Patients.
  831. Determining Antibacterial andย cholesterolย loweringย Effect of Lactic Acid Bacteria Isolated from Dairy Products in East Azerbaijan
  832. Determining the probiotic potential ofย cholesterol-reducing Lactobacillus and Weissella strains isolated from gherkins (fermented cucumber) and south Indian โ€ฆ
  833. Development and initial evaluation of a culturally sensitiveย cholesterolโ€loweringย dietย program for Mexican and African American patients with systemic lupus โ€ฆ
  834. Development and production ofย cholesterolโ€“loweringย Monascus-nata complex
  835. Development and testing of theย cholesterolโ€“loweringย dietย self-efficacy scale
  836. Development of types of psyllium-enriched bread as part of aย cholesterolย loweringย diet.
  837. Development Technology of Functional Food ofย cholesterolย loweringย Yogurt
  838. Dextran sulphate: use as an anticoagulant, and action inย loweringย serumย cholesterol
  839. Dextro-thyroxine as aย cholesterolโ€“loweringย agent in patients with angina pectoris
  840. Dextrothyroxine forย loweringย serumย cholesterol: Analysis of data on 6066 patients
  841. dietย and probucol inย loweringย cholesterolย concentrations: Additive effects on plasmaย cholesterolย concentrations in patients with familial type II hyperlipoproteinemia
  842. dietย enrichment with calcium and magnesium enhances theย cholesterolโ€“loweringย effect of plant sterols in obese Zucker rats.
  843. dietย modification inย loweringย plasmaย cholesterolย levels: a randomised trial of three types of intervention
  844. dietย therapy of hypercholesterolemia. Can theย dietย of persons who already follow aย cholesterolโ€“loweringย dietย be further improved by guidelines given by a clinical โ€ฆ
  845. dietary advice forย loweringย plasmaย cholesterol.
  846. dietary Aloe vera componentsโ€™ effects onย cholesterolย loweringย and estrogenic responses in juvenile goldfish, Carassius auratus
  847. dietaryย cholesterolย and the Optimalย dietย for Reducing Risk of Atherosclerosis
  848. dietaryย cholesterolย and the optimalย dietย for reducing risk of atherosclerosis.
  849. dietary D-allulose altersย cholesterolย metabolism in Golden Syrian hamsters partly by reducing serum PCSK9 levels
  850. dietary effects of seaweed Sargassum ilicifolium on reducingย cholesterolย level of white leg shrimp (Litopenaeus vannamei)
  851. dietary fiber for reducing bloodย cholesterol
  852. dietary fibers, prebiotics, and exopolysaccharides produced by lactic acid bacteria: potential health benefits with special regard toย cholesterolโ€“loweringย effects
  853. dietary flaxseed independently lowers circulatingย cholesterolย and lowers it beyond the effects ofย cholesterolโ€“loweringย medications alone in patients with peripheral โ€ฆ
  854. dietary high-polyphenols extra-virgin olive oil is effective in reducingย cholesterolย content in eggs
  855. dietary phytosterols asย cholesterolโ€“loweringย agents in humans
  856. dietary restriction slightly affects glucose homeostasis and delays plasmaย cholesterolย removal in rabbits withย dietary lipidย lowering
  857. dietary wheat bran oil is equally as effective as rice bran oil in reducing plasmaย cholesterol
  858. dietary ฮฑ-linolenic acid is as effective as oleic acid and linoleic acid inย loweringย bloodย cholesterolย in normolipidemic men
  859. dietary ฮฒโ€sitosterol is more potent in reducing plasmaย cholesterolย than sesamin in hypercholesterolemia hamsters
  860. diets for reducing the concentration of fat (cholesterolย concentration) in the blood.
  861. Difference between calculated and direct-measured low-density lipoproteinย cholesterolย in subjects with diabetes mellitus or taking lipid-loweringย medications
  862. Differences in Action of Atorvastatin and Ezetimibe inย loweringย Low-Density Lipoproteinย cholesterolย and Effect on Endothelial Functionโ€“Randomized Controlled Trial โ€ฆ
  863. Differences in synthesis and absorption ofย cholesterolย of two effective lipid-loweringย therapies
  864. Differential effects ofย dietary eicosapentaenoic and docosahexaenoic fatty acids onย loweringย of tri-glyceride andย cholesterolย levels in the serum of rats on โ€ฆ
  865. Differential response ofย cholesterolย and particle measures of atherogenic lipoproteins to LDL-loweringย therapy: implications for clinical practice
  866. Differential sensitivity to acuteย cholesterolย loweringย of activation mediated via the highโ€affinity IgE receptor and Thyโ€1 glycoprotein
  867. Differentiating the effects of raising low levels of high-density lipoproteinย cholesterolย versusย loweringย normal triglycerides: further insights from the Veterans Affairs โ€ฆ
  868. Digital gene-expression profiling analysis of theย cholesterolโ€“loweringย effects of alfalfa saponin extract on laying hens
  869. Dillenia indica fruit extract has Glucose andย cholesterolย loweringย effects
  870. Dimethyl sulfoxide as aย cholesterolโ€“loweringย agent in cultured fibroblasts exposed to low density lipoproteins
  871. Dipeptidyl-peptidase IV (DPP4) inhibitorsโ€™ย cholesterolย loweringย effect: a systematic review
  872. Disadvantages of Current LDL-cholesterolย loweringย and the Role of PCSK9 Inhibitors.
  873. Discontinuation rates ofย cholesterolโ€“loweringย medications: implications for primary care.
  874. Discussion of Evaluation ofย cholesterolโ€“loweringย and antioxidant properties of sugar cane policosanols in hamsters and humans
  875. Disparate effects of a triglycerideย loweringย dietย and of bezafibrate on the HDL system: a study in patients with hypertriglyceridaemia and low HDLโ€cholesterolย levels
  876. Diverse conditions contribute to theย cholesterolโ€“loweringย ability of different Lactobacillus plantarum strains
  877. DMP 504, a novel hydrogel bile acid sequestrant: III. Safety, tolerability, andย cholesterolโ€loweringย in healthy hypercholesterolemic subjects
  878. Doย cholesterolโ€loweringย agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.
  879. Doesย cholesterolย loweringย Increase Nonโ€”Illness-Related Mortality?-Reply
  880. Doesย cholesterolย loweringย prevent stroke?
  881. Doesย loweringย cholesterolย cause cancer?
  882. Doesย loweringย ofย cholesterolย levels influence functional properties of large arteries?
  883. Doesย loweringย serumย cholesterolย levels lower coronary heart disease risk?
  884. Does reducing blood pressure andย cholesterolย provide any HOPE for preventing cognitive decline and dementia?
  885. Does reducingย cholesterolย improve CAD survival?
  886. Dose response to soluble fiber from psyllium inย cholesterolย loweringย in the hamster
  887. Dose-dependentย cholesterolโ€“loweringย effect of a mayonnaise-type product with a main component of diacylglycerol-containing plant sterol esters
  888. Dose-dependentย cholesterolโ€“loweringย effects of D-003 on normocholesterolemic rabbits
  889. Dose-dependent LDL-cholesterolย loweringย effect by plant stanol ester consumption: clinical evidence
  890. Double-Blind Randomized Placebo Controlled Trial Demonstrating Serumย cholesterolย loweringย Efficacy of a Smoothie Drink with Added Plant Stanol Esters in โ€ฆ
  891. DYNAMICS OF TOTALย cholesterolย LEVELS AND ITS EFFECT ON MORTALITY IN PEOPLE OVER AGE 65 NOT RECEIVING LIPID-loweringย THERAPY
  892. e39 Indications forย loweringย LDLย cholesterolย in rheumatoid arthritis: an unrecognised problem
  893. Editorial [Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-cholesterolย (LDL-C)ย loweringย Enough?]
  894. Effect and mechanism ofย cholesterolโ€“loweringย by kluyveromyces from tibetan kefir
  895. Effect LDL-cholesterolย loweringย effect of hydroxytyrosol (HTEssenceยฎ): A randomized double-blind, placebo-controlled parallel study
  896. Effect of 2 different reducingย diets on the concentration of HDLย cholesterolย in obese adolescents
  897. Effect of aย cholesterolย loweringย compound on hippocampal synaptogenesis
  898. Effect of aย cholesterolโ€“loweringย dietย during pregnancy on maternal and fetal Doppler velocimetry: the CARRDIP study
  899. Effect of aย cholesterolโ€“loweringย dietย on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial
  900. Effect of a culturally sensitiveย cholesterolย loweringย dietย program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic โ€ฆ
  901. Effect of aย dietary portfolio ofย cholesterolโ€“loweringย foods given at 2 levels of intensity ofย dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial
  902. Effect of a lipid-loweringย agent or a high-cholesterolย dietย on focal glomerulosclerosis in hyperlipidemic rats.
  903. Effect of a prudent reducingย dietย on the serumย cholesterolย of overweight middle-aged men.
  904. Effect of a serumย cholesterolโ€“loweringย dietย on composition of depot fat in man.
  905. Effect of antiโ€oxidant treatment andย cholesterolย loweringย on resting arterial tone, metabolic vasodilation and endothelial function in the human forearm: a randomized โ€ฆ
  906. Effect of antibiotics asย cholesterolโ€“loweringย agents
  907. Effect of apolipoprotein E phenotype onย diet-inducedย loweringย of plasma low density lipoproteinย cholesterol.
  908. Effect of biological and analytical variation inย cholesterolย measurement on the cost-effectiveness ofย cholesterolโ€“loweringย therapy
  909. Effect of blending and lipase catalyzed interesterification reaction on theย cholesterolย loweringย properties of palm oil with rice bran oil in rats
  910. Effect of broccoli sprouts onย cholesterolโ€“loweringย and anti-obesity effects in rats fed high fatย diet
  911. Effect ofย cholesterolย loweringย agent (Lipolax) on some physiological parameters in some infertile obese PCOS Egyptian women undergoing ICSI
  912. Effect ofย cholesterolย loweringย multiplex lactic acid bacteria on lipid metabolism in a hamster model
  913. Effect ofย cholesterolย loweringย on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia
  914. Effect ofย cholesterolย loweringย treatment on plasma markers of endothelial dysfunction in chronic kidney disease
  915. Effect ofย cholesterolย loweringย treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms
  916. Effect ofย cholesterolย reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese โ€ฆ
  917. Effect ofย cholesterolโ€“loweringย agents
  918. Effect ofย cholesterolโ€“loweringย dietย on mortality from coronary heart disease and other causes.
  919. Effect ofย cholesterolโ€“loweringย dietย on mortality from coronary heart-disease and other causes: a twelve-year clinical trial in men and women
  920. Effect ofย cholesterolโ€“loweringย dietย on production of adrenal cortical hormones in man
  921. Effect ofย cholesterolโ€“loweringย diets on indices of depression and hostility
  922. Effect ofย cholesterolโ€“loweringย medications on progression of mild atherosclerotic lesions of the carotid arteries and on the risk of stroke
  923. Effect ofย cholesterolโ€“loweringย starter cultures in smoked sausages on the formation of bioactive peptides and lipid profile in triton-induced hyperlipidemic rats
  924. Effect ofย cholesterolโ€“loweringย therapy on coronary endothelial vasomotor function in patients with coronary artery disease
  925. Effect ofย cholesterolโ€“loweringย therapy on endothelial function
  926. Effect ofย cholesterolโ€“loweringย treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond
  927. Effect ofย cholesterol-reducing lactobacillus onย cholesterolย of chicken.
  928. Effect of combinationย cholesterolโ€“loweringย therapy and triglyceride-loweringย therapy on medical costs in patients with type 2 diabetes mellitus
  929. Effect of combined antihypertensive andย cholesterolย loweringย treatment on the arterial elasticity in middle-old-aged hypertension patients
  930. Effect of combining psyllium fiber with simvastatin inย loweringย cholesterol
  931. Effect of cream pasteurization, microfiltration and enzymatic proteolysis on in vitroย cholesterolโ€“loweringย activity of buttermilk solids
  932. Effect of crilvastatin, a newย cholesterolย loweringย agent, on unesterified LDLโ€cholesterolย metabolism into bile salts by rat isolated hepatocytes
  933. Effect ofย dietary carbohydrate onย cholesterolย loweringย action of blackgram fiber
  934. Effect of different herbs and spices onย cholesterolย loweringย in broiler: An overview
  935. Effect of dried mushroom, Lentinus edodes (Berk.) Sing., onย cholesterolย metabolism in rats. 2. Fractionation of theย cholesterol-reducing fraction. 1.
  936. EFFECT OF EAR ACUPUNCTURE ON REDUCING WEIGHT AND LEVELS OF THE SERUM TOTALย cholesterolย AND TRIGLYCERIDE
  937. Effect of enzymatic hydrolysis onย cholesterolโ€“loweringย activity of oat ฮฒ-glucan
  938. Effect of ethanol extract of Coccinia grandis Lin leaf on glucose andย cholesterolย loweringย activity
  939. Effect of feeding of aย cholesterol-reducing bacterium, Eubacterium coprostanoligenes, to germ-free mice
  940. EFFECT OF FEEDING ON SOMEย dietARY FIBERS FOR REDUCING BLOODย cholesterol
  941. Effect of Goat Milk Yogurt towards Reducing Uric Acid,ย cholesterol, and Blood Glucose Level
  942. Effect of HMGCR Variant Alleles on Lowโ€Density Lipoproteinย cholesterolโ€”loweringย Response to Atorvastatin in Healthy Korean Subjects
  943. Effect of Honey Eurya Spp. in Jiangxi on the Immunity andย cholesterolโ€“loweringย Function of Animals
  944. Effect of intensive LDLย cholesterolย loweringย with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia
  945. Effect of long term, nonย cholesterolย loweringย dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats
  946. Effect of long-termย cholesterolโ€“loweringย treatment with HMG-CoA reductase inhibitor (simvastatin) on myocardial perfusion evaluated by thallium-201 single photon โ€ฆ
  947. Effect of Lotus Leaf Alkaloid on Kunming Miceย cholesterolโ€“loweringย and Reducing Weight
  948. Effect of Lotus Leaf Alkaloid on Reducing Weight of Kunming Miceย cholesterolโ€“lowering
  949. Effect of low dose atorvastatin versusย diet-inducedย cholesterolย loweringย on atherosclerotic lesion progression and inflammation in apolipoprotein E* 3โ€“Leiden โ€ฆ
  950. Effect of Low-density Lipoproteinย cholesterolย loweringย With Alirocumab on Stroke in ODYSSEY OUTCOMES
  951. Effect of lowโ€density lipoproteinย cholesterolย loweringย by ezetimibe/simvastatin on outcome incidence: Overview, metaโ€analyses, and metaโ€regression analyses of โ€ฆ
  952. Effect ofย loweringย LDLย cholesterolย substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets โ€ฆ
  953. Effect ofย loweringย serumย cholesterolย on the composition of surfactant in adult rat lung
  954. Effect of mushrooms onย cholesterolย metabolism in rats. 4. Separation of the plasmaย cholesterolย reducing substances from mushroom. 2.
  955. Effect of mushrooms onย cholesterolย metabolism in rats. 5. Separation of the plasmaย cholesterol-reducing substances from mushroom.
  956. Effect of nonpharmacologic intervention onย loweringย plasmaย cholesterolย levels
  957. Effect of oat and tartary buckwheatโ€“based food onย cholesterolโ€“loweringย and gut microbiota in hypercholesterolemic hamsters
  958. Effect of perilla oil on reducing triglyceride andย cholesterolย level in serum of hyperlipidemia model rats
  959. Effect of pharmacist interventions on reducing low-density lipoproteinย cholesterolย (LDL-C) levels: A systematic review and meta-analysis
  960. Effect of pharmacologic lipidย loweringย on healthโ€related quality of life in older persons: results from theย cholesterolย Reduction in Seniors Program (CRISP) Pilot Study
  961. Effect of phytosterols on reducing low-density lipoproteinย cholesterolย in dogs
  962. Effect of plant sterols in combination with otherย cholesterolโ€“loweringย foods
  963. Effect Of Pomegranate (Punica granatum L.) Fraction In Reducing Total Bloodย cholesterolย Levels and Triglyceride in Mice (Mus muscullus L.)
  964. Effect of prebiotics on bacteriocin production andย cholesterolย loweringย activity of Pediococcus acidilactici LAB 5
  965. Effect of solubleย dietary fiber from rice bran on reducingย cholesterolย content and rheological property of mayonnaise
  966. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial ofย cholesterolย lowering
  967. Effect of time of administration onย cholesterolโ€“loweringย by psyllium: a randomized cross-over study in normocholesterolemic or slightly hypercholesterolemic โ€ฆ
  968. Effect of ฮฒ-glucan molecular weight and viscosity on the mechanism ofย cholesterolย loweringย in humans
  969. Effect on hematologic risk factors for coronary heart disease of aย cholesterolย reducingย diet
  970. Effect on non-vascular outcomes ofย loweringย LDLย cholesterolย in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
  971. Effective in vivoย cholesterolย and triglyceridesย loweringย activities of hydroethanolic extract of Launaea taraxacifolia leaves
  972. Effectiveย loweringย ofย cholesterolย With Portfolioย dietย in a Highly Trained Young Man
  973. Effectiveย loweringย of plasma, LDL, and esterifiedย cholesterolย in LDL receptorโ€“knockout mice by adenovirus-mediated gene delivery of apoB mRNA editing enzyme โ€ฆ
  974. Effectiveness of a low saturated fat, lowย cholesterol, weight-reducingย dietย for the control of hypertriglycer-idemia
  975. Effectiveness of a nutritional education program inย loweringย bloodย cholesterolย levels in a public health center
  976. Effectiveness of adherence to lipidย loweringย therapy on LDL-cholesterolย in patients with very high cardiovascular risk: a real-world evidence study in primary care
  977. Effectiveness of an alimentary educational program inย loweringย childrenโ€™sย cholesterolย levels in primary school
  978. Effectiveness of atorvastatin for reducing low-density lipoproteinย cholesterolย to Nationalย cholesterolย Education Program treatment goals.
  979. Effectiveness of Boiled Water of Breadfruit Leaf (Artocarpus Altilis) on Reducingย cholesterolย Levels in The Blood of Mice (Mus Musculus)
  980. Effectiveness of chitosan as aย dietary supplement inย loweringย cholesterolย in murine models: A meta-analysis
  981. EFFECTIVENESS OFย cholesterolย FEEDBACK IN REDUCING BLOODย cholesterolย LEVELS
  982. Effectiveness of customary use of phytosterol/-stanol enriched margarines on bloodย cholesterolย lowering
  983. Effectiveness ofย dietetic counselling inย loweringย plasmaย cholesterolย of children affected by hypercholesterolemia
  984. Effectiveness of low-dose lovastatin inย loweringย serumย cholesterol: Experience with 56 patients
  985. Effectiveness of probucol in reducing plasma low-density lipoproteinย cholesterolย oxidation in hypercholesterolemia
  986. Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoproteinย cholesterolย goals in a usual care setting
  987. Effects of aย dietary portfolio ofย cholesterolโ€“loweringย foods vs lovastatin on serum lipids and C-reactive protein
  988. Effects of a highย cholesterol-reducing Lactobacillus acidophilus strain and Staphyloccus xylose on the physico-chemical quality and harmful biogenic amines of โ€ฆ
  989. Effects of aggressiveย cholesterolย loweringย and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery โ€ฆ
  990. Effects of anti-oxidative andย cholesterolย loweringย capacities of selected edible-medicinalย mushrooms towards amelioration of alzheimerโ€™s disease/Mohammad Azizur โ€ฆ
  991. Effects of antrodia camphorata mycelia extract containing antroquinonol onย loweringย low-density lipoproteinย cholesterol: a randomized double-blind study
  992. Effects ofย cholesterolย loweringย on the progression of coronary atherosclerosis in women: a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
  993. Effects ofย cholesterolโ€“loweringย diets on the risk for cancer and other non-cardiovascular diseases.
  994. Effects ofย cholesterolโ€“loweringย probiotics on the metabolism of bile acid in a rat model of non-alcoholic fatty liver disease and the possible mechanism
  995. Effects ofย cholesterolโ€“loweringย treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in type 2 โ€ฆ
  996. Effects ofย cholesterolโ€“loweringย treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic โ€ฆ
  997. Effects ofย cholesterolโ€“loweringย with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
  998. Effects of diacylglycerol containing phytosterol on reducing bloodย cholesterolย level
  999. Effects of different intensive lipid-loweringย regimens onย cholesterolย metabolism makers and their ratios in patients after percutaneous coronary intervention [J]
  1000. Effects of feedingย cholesterolย raising andย cholesterolย loweringย diets on albino rats.
  1001. Effects of Fiber Consumption inย loweringย cholesterolย Level
  1002. Effects of gender, apolipoprotein E phenotype andย cholesterolโ€loweringย by plant stanol esters in children: The STRIP study
  1003. Effects of including soy protein in a bloodย cholesterolโ€“loweringย dietย on markers of cardiac risk in men and in postmenopausal women with and without hormone โ€ฆ
  1004. Effects of internet-based tailored advice on the use ofย cholesterolโ€“loweringย interventions: a randomized controlled trial
  1005. Effects of lactic acid bacteria isolated from fermented mustard onย loweringย cholesterol
  1006. Effects of Lactobacillus paragasseri Y20 onย cholesterolโ€“lowering, intestinal microbiota and liver metabolism in rats with hypercholesterolaemia
  1007. Effects of long termย cholesterolย loweringย on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).
  1008. Effects of Lovastatin on progression of coronary artery disease and restenosis after PTCA: Theย cholesterolย loweringย atherosclerosis PTCA trial (CLAPT)
  1009. Effects ofย loweringย average or below-averageย cholesterol
  1010. Effects ofย loweringย average or below-averageย cholesterolย levels on the progression of carotid atherosclerosis: results of the LIPID atherosclerosis substudy
  1011. Effects ofย loweringย elevated LDLย cholesterolย on the cardiovascular risk of lipoprotein (a)
  1012. Effects ofย loweringย LDLย cholesterolย on progression of kidney disease
  1013. Effects of natural antioxidants in reducing lipid andย cholesterolย oxidation in irradiated chicken breast meat.
  1014. Effects of plant sterols and stanols beyond low-density lipoproteinย cholesterolย lowering
  1015. Effects of prebiotic carbohydrates on the growth promotion andย cholesterolโ€“loweringย abilities of compound probiotics in vitro
  1016. Effects of prospective, randomizedย cholesterolโ€“loweringย dietary intervention and apolipoprotein E phenotype on serum lipoprotein (a) concentrations of infants aged 7 โ€ฆ
  1017. Effects of simvastatin and ezetimibe inย loweringย low-density lipoproteinย cholesterolย in subjects with type 1 and type 2 diabetes mellitus
  1018. Effects of soybean-germ oil on reducing serumย cholesterolย level
  1019. Effects of soybean-germ oil on reducing serumย cholesterolย levels in a double-blind controlled trial in healthy humans
  1020. Effects of theย cholesterolโ€loweringย compound methylโ€ฮฒโ€cyclodextrin in models of ฮฑโ€synucleinopathy
  1021. Effects of Therapeuticย loweringย of Non-High Density Lipoproteinย cholesterolย on Cardiovascular Outcomes Among Women versus Men: A Meta-Regression Analysis
  1022. Effects on 11-year mortality and morbidity ofย loweringย LDLย cholesterolย with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised โ€ฆ
  1023. Efficacy and safety ofย cholesterolโ€“loweringย treatment
  1024. Efficacy and safety of different doses of alirocumab in reducing low-density lipoproteinย cholesterolย levels: a network meta-analysis
  1025. Efficacy and safety of different doses of evolocumab in reducing low-density lipoproteinย cholesterolย levels: A meta-analysis
  1026. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterolโ€“loweringย therapy for the treatment of patients with hypercholesterolemia โ€ฆ
  1027. Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoproteinย cholesterolย Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary โ€ฆ
  1028. Efficacy and safety of furtherย loweringย of low-density lipoproteinย cholesterolย in patients starting with very low levels: a meta-analysis
  1029. Efficacy and safety ofย loweringย dietary intake of fat andย cholesterolย in children with elevated low-density lipoproteinย cholesterol: theย dietary Intervention Study in โ€ฆ
  1030. Efficacy and safety ofย loweringย dietary intake of fat andย cholesterolย in children with elevated low-density lipoproteinย cholesterol: Theย dietary Intervention Study in โ€ฆ
  1031. Efficacy and safety ofย loweringย dietary intake of total fat, saturated fat, andย cholesterolย in children with elevated LDLย cholesterol: theย dietary Intervention Study in โ€ฆ
  1032. Efficacy and safety ofย loweringย LDLย cholesterolย in older patients: a systematic review and meta-analysis of randomised controlled trials
  1033. Efficacy and safety of more intensiveย loweringย of LDLย cholesterol
  1034. Efficacy and safety of more intensiveย loweringย of LDLย cholesterolโ€“Authorsโ€™ reply
  1035. Efficacy and safety of more intensiveย loweringย of LDLย cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
  1036. Efficacy and safety of more intensiveย loweringย of LDLย cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
  1037. Efficacy and safety of rosuvastatin vs. atorvastatin inย loweringย LDLย cholesterol
  1038. Efficacy of chenodeoxycholic acid and ursodeoxycholic acid forย loweringย cholesterolย saturation index of gallbladder in patients with a sphincterotomy
  1039. Efficacy ofย cholesterolโ€“loweringย treatment in Japanese elderly patients with coronary artery disease and normalย cholesterolย level using 3-hydroxy-3-methylglutaryl โ€ฆ
  1040. Efficacy of combination of ezetimibe and simvastatin versus atorvastatin in reducing low density lipoprotein-cholesterolย in male patients of hypercholesterolemia, at โ€ฆ
  1041. Efficacy of ezetimibe for reducing serum lowโ€density lipoproteinย cholesterolย levels resistant to lifestyle intervention in patients with nonโ€alcoholic fatty liver disease
  1042. Efficacy of garlic supplementation inย loweringย serumย cholesterolย levels
  1043. Efficacy of Individualizedย dietary Advice forย loweringย cholesterol
  1044. Efficacy of Individualizedย dietary Advice forย loweringย cholesterol-Reply
  1045. Efficacy of low-dose simvastatin inย cholesterolโ€“loweringย treatment in elderly
  1046. Efficacy ofย loweringย Low-density Lipoproteinย cholesterolย in Elderly Subjects: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  1047. Efficacy of moderate-intensity physical activity inย loweringย non-high-density lipoproteinย cholesterolย in stage 2 essential hypertensive patients
  1048. Efficacy of Myrmecodia Platytyrae (MyP) Water Extract in Reducingย cholesterolย Level in Hypercholesterolemia Induced Sprague Dawley Rat
  1049. Efficacy of Psyllium in Reducing Serumย cholesterolย Levels in Hypercholesterolemic Patients on High or Low-Fatย diets
  1050. Efficacy of psyllium in reducing serumย cholesterolย levels in hypercholesterolemic patients on high-or low-fatย diets
  1051. Efficacy of simvastatin forย loweringย cholesterolย in non-insulin dependent diabetic patients with hypercholesterolemia
  1052. Efficacy of yogurt drink with added plant stanol esters (Benecolยฎ, Colanta) in reducing total and LDLย cholesterolย in subjects with moderate โ€ฆ
  1053. EGCG reducing the susceptibility toย cholesterolย gallstone formation through the regulation of inflammation
  1054. Egg yolkย cholesterolย loweringย effects of garlic and tea
  1055. Egg yolkย cholesterolย loweringย effects of garlic and tea
  1056. Eicosapentaenoic acid membrane incorporation impairsย cholesterolย efflux fromย cholesterol-loaded human macrophages by reducing the cholesteryl ester mobilization โ€ฆ
  1057. Eicosapentaenoic acid reduced the progression of the coronary atherosclerosis in the patients with optimal LDLย cholesterolย loweringย therapy
  1058. Elevatedย cholesterolย Inhibits The Surface Tension Reducing Activity Of Human Pulmonary Surfactant
  1059. Emerging lipidย loweringย agents targeting LDLย cholesterol
  1060. Encapsulation of Lactic Acid Bacteria Isolated from Tapai and the Effects onย cholesterolย loweringย Ability and Survivability in Simulated Gastric Conditions
  1061. Enhancedย cholesterolโ€and triglycerideโ€loweringย effect of West African green tea
  1062. Enhanced low density lipoprotein-cholesterolย loweringย efforts by consuming plant stanols as part of a low saturated fatย diet
  1063. Enhanced plasmaย cholesterolย loweringย effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and โ€ฆ
  1064. Enhancement of antioxidant activity in O/W emulsion andย cholesterol-reducing capacity of epigallocatechin by derivatization with representative phytosterols
  1065. Enhancement of Galloylation efficacy of Stigmasterol and ฮฒ-Sitosterol followed by evaluation ofย cholesterol-reducing activity
  1066. Enoyl-ACP reductase gene mRNA expression analysis in differentย cholesterolโ€“loweringย ability of Lactobacillus plantarum
  1067. Enrichment of vitamin B12 and B6 andย loweringย cholesterolย levels of eggs by lactic acid bacteria
  1068. Environmental estrogens: effects onย cholesterolย loweringย and bone in the ovariectomized rat
  1069. EPA and DHA Have Differential Effects onย cholesterolย Ester Transfer Protein and Lipoprotein Lipase Activities Following Plasma Triglyceridesย lowering
  1070. Escape phenomenon occurs byย loweringย cholesterolย with a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor in patients with familial โ€ฆ
  1071. Estimating the benefits ofย cholesterolย lowering: are risk factors for coronary heart disease multiplicative?
  1072. Estimation ofย cholesterolย by the Liebennann Burchaid reaction. Significance of theย loweringย of the ratio of ester to totalย cholesterolย in some pathological bloods.
  1073. Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:ย cholesterolย acyltransferase 2 (ACAT2) in monkeys
  1074. Ethanolamine plasmalogens prevent the oxidation ofย cholesterolย by reducing the oxidizability ofย cholesterolย in phospholipid bilayers
  1075. Ethyl acetate extract of crabapple fruit is theย cholesterolโ€“loweringย fraction
  1076. Eulipidemic effects of berberine administered alone or in combination with other naturalย cholesterolโ€“loweringย agents
  1077. Evaluating the efficacy of the Nationalย cholesterolย Education Program adult treatment guidelines:ย cholesterolย loweringย intervention program
  1078. Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoproteinย cholesterolโ€“loweringย effect?
  1079. Evaluation and Application of Differentย cholesterolโ€“loweringย Lactic Acid Bacteria as Potential Meat Starters
  1080. Evaluation and application of differentย cholesterolโ€“loweringย lactic acid bacteria as potential meat starters
  1081. Evaluation of bile salt hydrolases,ย cholesterolโ€“loweringย capabilities, and probiotic potential of Enterococcus faecium isolated from rhizosphere
  1082. Evaluation of Brewerโ€™s spent grain as a plasma lipidย loweringย agent in rats fedย cholesterolย enrichedย diets
  1083. Evaluation ofย cholesterolย loweringย property and antibacterial activity of two potential lactic acid bacteria isolated from the intestine of snakehead fish (Channa โ€ฆ
  1084. Evaluation ofย cholesterolย loweringย property of selected herbs in ghee (heat clarified milk fat)
  1085. Evaluation ofย cholesterolย loweringย treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands
  1086. Evaluation ofย cholesterolโ€“loweringย activity of a galenic, comparable to aย dietary supplement, containing monacolin k and policosanol in subjects with mild to moderate โ€ฆ
  1087. Evaluation ofย cholesterolโ€“loweringย activity of standardized extract of Mangifera indica in albino Wistar rats
  1088. Evaluation of hesperetin 7-O-lauryl ether as lipid-loweringย agent in high-cholesterol-fed rats
  1089. Evaluation of lipid andย cholesterolโ€“loweringย effect of bioflavonoids from bergamot extract
  1090. Evaluation of Lipid-loweringย Therapy andย cholesterolย Goal Attainment in Finland
  1091. Evaluation of proprotein convertase Subtilisin/Kexin Type 9: focus on potential clinical and therapeutic implications for lowโ€density lipoproteinย cholesterolย lowering
  1092. Evaluation of theย cholesterolโ€“loweringย effectiveness of pantethine in women in perimenopausal age
  1093. Evaluation of the clinical efficacy and potential mechanism of theย cholesterolย loweringย effect of soy protein
  1094. Evaluation of the in vitroย cholesterolโ€loweringย activity of the probiotic strain Bacillus coagulansMTCC 5856
  1095. Evaluation of the shortenedย cholesterolโ€“loweringย dietย self-efficacy scale
  1096. Evidence for aย cholesterolโ€“loweringย gene in a French-Canadian kindred with familial hypercholesterolemia
  1097. Evidence forย cholesterolโ€“loweringย activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation
  1098. Evidence for feedback regulation followingย cholesterolย loweringย therapy in a prostate cancer xenograft model
  1099. Evidence for more intensiveย cholesterolย lowering
  1100. Evidence supportingย cholesterolโ€“loweringย therapy for postmenopausal women with heart disease-Reply
  1101. Evolocumab (Repathaยฎ): a human monoclonal antibody against PCSK9 protein as potentย cholesterolโ€“loweringย therapy
  1102. Evolocumab: Second-in-class agent forย loweringย cholesterol
  1103. EVOLVD:ย cholesterolย loweringย with EVOLocumab to prevent cardiac allograft vasculopathy in de-novo heart transplant recipients: rationale and design of a โ€ฆ
  1104. Experimental Study of Enhanced External Counterpulsation (EECP) on Reducing Atherosclerostic Vascular Disease in Highย cholesterol-Fed Pigs
  1105. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoproteinย cholesterolย lowering
  1106. Exploration of dual-function evaluation model of health food for auxiliary glycemia-loweringย and auxiliaryย cholesterolโ€“lowering.
  1107. Extent of undertreatment and overtreatment withย cholesterolโ€“loweringย therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular โ€ฆ
  1108. Extraction process andย cholesterolโ€“loweringย property ofย dietary fiber from cassava pulp
  1109. Extrusion and boiling improve rat body weight gain and plasmaย cholesterolย loweringย ability of peas and chickpeas
  1110. Ezetimibe and plaque regression:ย cholesterolย loweringย or pleiotropic effects?
  1111. Ezetimibe in diabetes: more thanย cholesterolย lowering?
  1112. Ezetimibe monotherapy forย cholesterolย loweringย in 2,722 people: systematic review and metaโ€analysis of randomized controlled trials
  1113. Ezetimibe: a novelย cholesterolโ€“loweringย agent that highlights novel physiologic pathways
  1114. Ezetimibe: a novel option forย loweringย cholesterol
  1115. Ezetimibe:ย cholesterolย loweringย and beyond
  1116. Facing the challenge ofย loweringย blood pressure andย cholesterolย in the same patient: report of a Symposium at the European Society of Hypertension
  1117. Factor VII coagulant activity andย cholesterolย changes in premenopausal women consuming a long-termย cholesterolโ€“loweringย diet.
  1118. Factor VIIc (FVII) response toย cholesterolโ€“loweringย diets covaries with changes in totalย cholesterolย (TC) and triglycerides (TG)
  1119. Failure ofย cholesterolโ€“loweringย by psyllium
  1120. Family cooperation and effectiveness in aย cholesterolโ€“loweringย diet.
  1121. Familyย dietย pattern forย loweringย the serumย cholesterolย level
  1122. Fargesin alleviates atherosclerosis by promoting reverseย cholesterolย transport and reducing inflammatory response
  1123. Fat type in phytosterol products influence theirย cholesterolโ€“loweringย potential: A systematic review and meta-analysis of RCTs
  1124. Fats for the food industry: implications forย cholesterolโ€“lowering
  1125. Fatty acid composition of cholesteryl esters inย cholesterol-fed rabbits treated with lipid-loweringย agent (ethyl 2-(p-chlorophenoxy) isobutyrate)
  1126. FATTY ACID COMPOSITION OF CHOLESTERYL ESTERS INย cholesterol-FED RABBITS TREATED WITHLIPID-loweringย AGENT (ETHYL 2-(p โ€ฆ
  1127. Fatty acid modification of yolk lipids andย cholesterolโ€“loweringย eggs.
  1128. Fatty acid moieties have little effect onย cholesterolโ€loweringย potency of plant sterol esters
  1129. Fenofibrate increases HDL-cholesterolย by reducing cholesteryl ester transfer protein expression
  1130. FENOFIBRATE INCREASES HDL-cholesterolย BY REDUCING CHOLESTERYL ESTER TRANSFER PROTEIN EXPRESSION
  1131. Fenofibrate reduces atherogenesis in ApoE* 3Leiden mice: evidence for multiple antiatherogenic effects besidesย loweringย plasmaย cholesterol
  1132. Fermentable carbohydrates exert a more potentย cholesterolโ€“loweringย effect than cholestyramine
  1133. Fermentation of resistant rice starch produces propionate reducing serum and hepaticย cholesterolย in rats
  1134. Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions ofย cholesterol-fed rabbits in the absence of lipidย lowering
  1135. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) ofย cholesterolย lowering
  1136. Food combinations forย cholesterolย lowering
  1137. Food processing reduces size of soluble cereal ฮฒ-glucan polymers without loss ofย cholesterol-reducing properties
  1138. Formal preparation of semisynthetic analogues of theย cholesterolโ€“loweringย agent mevinolin
  1139. Formulation and Evaluation of Lactic Acid Bacteria Fermented Brassica juncea (Mustard Greens) Pickle withย cholesterolย loweringย Property
  1140. Frequency of citation and outcome ofย cholesterolย loweringย trials: Authorโ€™s reply
  1141. Frequency of citation and outcome ofย cholesterolย loweringย trials.
  1142. Frequency of citation and outcome ofย cholesterolย loweringย trials.
  1143. Frequency of citation and outcome ofย cholesterolย loweringย trials.
  1144. Frequentย cholesterolย feedback as an aid inย loweringย cholesterolย levels
  1145. FRI0528 HIGH INTENSIVE THERAPEUTICย loweringย OF SYSTEMICย cholesterolย DOES NOT AMELIORATE OA DEVELOPMENT IN KNEE JOINTS OF โ€ฆ
  1146. Functional food, uncertainty and consumersโ€™ choices: A lab experiment with enriched yoghurts forย loweringย cholesterol
  1147. Functional foods to increase the efficacy ofย dietย inย loweringย serumย cholesterol
  1148. Functional foods:ย cholesterolโ€“loweringย benefits of plant sterols
  1149. Functional foods:ย cholesterolโ€“loweringย benefits of plant sterols
  1150. Functional Foods:ย cholesterolโ€“loweringย benefits of plant sterolsโ€”reply by Thurnham
  1151. Functional probiotic assessment and in vivoย cholesterolโ€“loweringย efficacy of Weissella sp. associated with arid lands living-hosts
  1152. Functional Probiotic Characterization and In Vivoย cholesterolโ€“loweringย Activity of Lactobacillus helveticus Isolated from Fermented Cow Milk S
  1153. Functions and Fermentation Characteristics of Highย cholesterol-Reducing Lactic Acid Bacteria
  1154. Further LDLย cholesterolย loweringย through targeting PCSK9 for coronary artery disease
  1155. Further studies on theย cholesterolโ€“loweringย effect of apple in human. Biochemical mechanims involved
  1156. Future approaches to reducing low-density lipoproteinย cholesterol
  1157. Garlic powder as blood serum and egg yolkย cholesterolย loweringย agent
  1158. GCGโ€rich tea catechins are effective inย loweringย cholesterolย and triglyceride concentrations in hyperlipidemic rats
  1159. Gemfibrozilโ€”the effect on biliaryย cholesterolย saturation of a new lipid-loweringย agent and its comparison with clofibrate
  1160. Genetic variation at the SLCO1B1 gene locus and low density lipoproteinย cholesterolย loweringย response to pravastatin in the elderly
  1161. Genetic variation of pln loci among probiotic Lactobacillus plantarum group strains with antioxidant andย cholesterolโ€“loweringย ability
  1162. Genetically-enhanced LPL mediated lipolysis, LDLย cholesterolย loweringย alleles and risk of coronary disease and type 2 diabetes
  1163. Genetically-predicted life-longย loweringย of low-density lipoproteinย cholesterolย is associated with decreased frailty: A Mendelian randomization study in UK โ€ฆ
  1164. Genome Shuffling of Mangrove Endophytic Aspergillus luchuensis MERV10 for Improving theย cholesterolโ€“loweringย Agent Lovastatin under Solid State Fermentation
  1165. Getting the Message to Physicians about the Effectiveness of Registeredย dietitians inย loweringย Bloodย cholesterolย Levels
  1166. Ginkgo biloba extract (Egb 761) inhibits ฮฒ-amyloid production byย loweringย freeย cholesterolย levels
  1167. Giveย dietย a chance inย loweringย cholesterolย levels
  1168. Given thatย loweringย raisedย cholesterolย concentrations isa good thing for middle aged people with coronary heart disease, what is the upper age limit for such an โ€ฆ
  1169. Glucose and Low-Density Lipoproteinย cholesterolย loweringย in Elderly Patients with Type 2 Diabetes
  1170. Goals forย cholesterolย lowering
  1171. Greater Dissociation of Apolipoprotein B and LDLย cholesterolย Targets in Diabetes Versus Nondiabetes Patients Receiving Lipid-loweringย Therapy
  1172. Growth ofย cholesterol-reducing Eubacterium onย cholesterol-brain agar.
  1173. Growth-depressing andย cholesterolโ€“loweringย effects of Quillaja and tea saponins in chicks as influenced byย dietย composition
  1174. Guest Editorial: Bloodย cholesterolย loweringย in Elderly Patients
  1175. GUGULIPID: A Naturalย cholesterolโ€“loweringย Agent
  1176. GW24-e1865 Association betweenย cholesterolย synthesis/absorption markers and effects ofย cholesterolย loweringย by atorvastatin among patients with high risk of โ€ฆ
  1177. GW24-e2397 Rosuvastatin could modulate insulin signalling and inhibit atherosclerosis beyond its plasmaย cholesterolโ€“loweringย effect in insulin-resistant mice
  1178. Hazards of reducingย cholesterol.
  1179. Health Canadaโ€™s proposal to accept a health claim about soy products andย cholesterolย lowering
  1180. HEALTH-ECONOMIC BENEFITS OF LOW-DENSITY LIPOPROTEINย cholesterolย loweringย IN HIGH RISK PATIENTS: A DISCRETE-EVENT SIMULATION โ€ฆ
  1181. Healthy drinks made from okra and green tea extract for reducing bloodย cholesterol
  1182. Heat Shock Protein 27 Immune Complex Upregulates LDLR Expression Thereby Reducing Plasmaย cholesterolย and Atherogenesis
  1183. Heat Shock Protein 27 versus Estrogen Therapy for Post-Menopausal Atherosclerosis: Rethinking Mechanisms ofย cholesterolย lowering
  1184. Heat-epimerized tea catechins have the sameย cholesterolโ€“loweringย activity as green tea catechins inย cholesterol-fed rats
  1185. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducingย cholesterolย levels in LDL receptor-deficient mice
  1186. Hepatic lipidomics analysis reveals the antiobesity andย cholesterolโ€“loweringย effects of tangeretin in high-fatย diet-fed rats
  1187. Heterogeneous pools ofย cholesterolย side-chain cleavage activity in adrenal mitochondria from ACTH-treated rats: differential responses to different reducing โ€ฆ
  1188. Highย dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additionalย cholesterolย lowering
  1189. High Performance Liquid Chromatographyโ€“An Effective Tool for Quality Control of Naturalย cholesterolโ€“loweringย Agents
  1190. High Performance thin layer chromatographic quantification of keyย cholesterolย reducing compound (โˆ’ sitosterol) from leaf, bark, fruit and root of Terminalia arjuna, T โ€ฆ
  1191. High Serum Totalย cholesterol: An Indicator for Monitoringย cholesterolย loweringย Efforts: US Adults, 2005-2006
  1192. High-intensive therapeuticย loweringย of systemicย cholesterolย does not ameliorate osteoarthritis development in knee joints of humanized dyslipidemic mice
  1193. High-molecular-weight hydroxypropylmethylcellulose: aย cholesterolโ€“loweringย agent
  1194. Highโ€risk patients benefit fromย loweringย of LDLโ€cholesterol
  1195. Higher Non-High Density Lipoproteinย cholesterolย Thresholds Are More Predictive of Need for Lipid-loweringย Pharmacotherapy in Children
  1196. Hippocampal volume change in the Alzheimer diseaseย cholesterolโ€“loweringย Treatment trial.
  1197. Histamine andย cholesterolย loweringย abilities of lactic acid bacteria isolated from artisanal Pico cheese
  1198. History and development of plant sterol and stanol esters forย cholesterolโ€“loweringย purposes
  1199. HMG CoA reductase inhibitors lower LDLย cholesterolย without reducing Lp (a) levels.
  1200. HMG-CoA reductase inhibitor augments the serum totalย cholesterolโ€“loweringย effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic โ€ฆ
  1201. HMG-CoA reductase inhibitor, fluvastatin, hasย cholesterolโ€“loweringย independent โ€œdirectโ€ effects on atherosclerotic vessels in highย cholesterolย diet-fed rabbits
  1202. HMG-CoA Reductase inhibitory activity of Gnetum gnemon seed extract and identification of potential inhibitors forย loweringย cholesterolย level
  1203. HOE 402 lowers serumย cholesterolย levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and โ€ฆ
  1204. How does fenofibrate exert itsย cholesterolโ€“loweringย effect?(authorโ€™s transl)
  1205. How isย cholesterolย loweringย therapy implemented among patients with coronary heart disease in Iceland?
  1206. How much in vitroย cholesterolย reducing activity of Lactobacilli predicts their in vivoย cholesterolย function?
  1207. How much information do patients prefer when discussingย cholesterolย loweringย medications? Results from an internet based nationally representative survey
  1208. HSP27 immunization attenuates atherogenesis by markedly reducing plasma PCSK9 andย cholesterolย levels
  1209. Hydrogenated fatsโ€™ role inย cholesterolโ€“loweringย diets.
  1210. Hydrolysis of phytosterol esters in the intestine is required for theirย cholesterolย loweringย effects
  1211. Hydrophobically modified celluloses as novelย cholesterolโ€“loweringย polymers
  1212. HYDROPHOBICALLY MODIFIED CHITOSAN AS BIO-BASED MATERIAL FORย loweringย cholesterolย LEVEL
  1213. Hydrophobically modified poly (Allylamine) hydrogels containing internal quaternary ammonium groups asย cholesterolย loweringย agents: synthesis, characterization โ€ฆ
  1214. Hydroxychloroquine reduces low-density lipoproteinย cholesterolย levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-loweringย effect
  1215. Hypercholesterolaemia of prolongedย fastingย andย cholesterolย loweringย of re-feeding in lean human subjects
  1216. Hypocholesterolemic Action of Fermented Brown Rice Supplement inย cholesterolโ€Fed Rats:ย cholesterolโ€loweringย Action of Fermented Brown Rice
  1217. Identical LDL-cholesterolย loweringย but non-identical effects on NF-ฮบB activity: High dose simvastatin vs combination therapy with ezetimibe
  1218. Identification of aย cholesterolย reducing lactic acid bacteria and its tolerance in in vitro gastroenteric environment [J]
  1219. Identification of a novelย cholesterolโ€“loweringย dipeptide, phenylalanine-proline (FP), and its down-regulation of intestinal ABCA1 in hypercholesterolemic rats โ€ฆ
  1220. Identification of gallbladder mucin-bilirubin complex in humanย cholesterolย gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact โ€ฆ
  1221. Identification of Lactobacillus strains from breast-fed infant and investigation of theirย cholesterol-reducing effects
  1222. identification of lunasin as the active component in soy protein responsible for reducing LDLย cholesterolย and risk of cardiovascular disease
  1223. Identification of two herbal compounds with potentialย cholesterolโ€“loweringย activity
  1224. Identification, Physico-chemical Characteristics of Strain Gan-1 and its Effect ofย cholesterolย Reducing in Vitro
  1225. Identifying patients for aggressiveย cholesterolย lowering: the risk curve concept
  1226. Ileorectostomy or cecectomy but not colectomy abolishes the plasmaย cholesterolโ€“loweringย effect ofย dietary beet fiber in rats
  1227. Impact of blood pressureย lowering,ย cholesterolย loweringย and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the โ€ฆ
  1228. Impact ofย cholesterolย loweringย treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress โ€ฆ
  1229. Impact ofย cholesterolโ€“loweringย educational program on total bloodย cholesterolย levels of fifth-grade children.
  1230. Impact of computer-generated personalized goals onย cholesterolย lowering
  1231. Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoproteinย cholesterolย levels in patients with primary โ€ฆ
  1232. Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoproteinย cholesterolย levels in patients with primary โ€ฆ
  1233. Impact of fermented milk on human health:ย cholesterolโ€loweringย and immunomodulatory properties of fermented milk
  1234. Impact of intensive LDLย cholesterolย loweringย on coronary artery atherosclerosis progression: a serial CT angiography study
  1235. Impact of Lipid Monitoring on Treatment Intensification ofย cholesterolย loweringย Therapies (from the Veterans Affairs Healthcare System)
  1236. Impact of lipid-loweringย therapy on mortality according to the baseline non-HDLย cholesterolย level: a meta-analysis
  1237. Impact ofย loweringย Low-Density Lipoproteinย cholesterolย with Contemporary Lipid-loweringย Medicines on Cognitive Function: A Systematic Review and Meta โ€ฆ
  1238. Impact of nutritional counseling in reducing serumย cholesterolย in public health service patients
  1239. Impact of Residual Risks After Achievement of Appropriate Low-Density Lipoproteinย cholesterolย loweringย Management in Secondary Prevention of Japanese โ€ฆ
  1240. Impact of the 2013ย cholesterolย guideline on patterns of lipid-loweringย treatment in patients with atherosclerotic cardiovascular disease or diabetes after 1 year
  1241. Impact of the pattern of basalย cholesterolย synthesis and absorption on the LDLย cholesterolย loweringย efficacy of atorvastatin in Chinese population
  1242. Implementation of bloodย cholesterolโ€“loweringย diets using nutrition labels
  1243. Implementation ofย cholesterolโ€“loweringย Therapy to Reduce Cardiovascular Risk in Persons Living with HIV
  1244. Implementing phytosterols into medical practice as aย cholesterolโ€“loweringย strategy: overview of efficacy, effectiveness, and safety
  1245. Implications of the obesity epidemic for lipid-loweringย therapy: non-HDLย cholesterolย should replace LDLย cholesterolย as the primary therapeutic target
  1246. Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensiveย cholesterolย loweringย therapy
  1247. Improvement in coronary flow reserve determined by positron emission tomography after 6 months ofย cholesterolโ€“loweringย therapy in patients with early stages of โ€ฆ
  1248. Improvement in erectile function in a rat model of highย cholesterolย dietโ€induced atherosclerosis by atorvastatin in a manner that is independent of its lipidโ€loweringย โ€ฆ
  1249. Improvement of atherosclerosis and stiffness of the thoracic descending aorta withย cholesterolโ€“loweringย therapies in familial hypercholesterolemia
  1250. Improvement of coronary prognosis by reducing LDL-cholesterol
  1251. Improvement of erythrocyte deformability byย cholesterolโ€“loweringย therapy with pravastatin in hypercholesterolemic patients
  1252. Improvement to the surface tension reducing capability of human pulmonary surfactant with elevated levels ofย cholesterolย via addition of surfactant protein A
  1253. Improvements in hostility and depression in relation toย dietary change andย cholesterolย lowering: the Family Heart Study
  1254. Improving adherence to aย cholesterolโ€“loweringย diet: a behavioral intervention study
  1255. Improving adherence toย cholesterolย loweringย medications among minority populations in Florida: a randomized trial
  1256. Inย cholesterolย lowering, moderation kills
  1257. In Silico and Wet Lab Studies Reveal theย cholesterolย loweringย 5 Efficacy of Lauric Acid a Medium Chain Fat of Coconut Oil
  1258. In silico and wet lab studies reveal theย cholesterolย loweringย efficacy of lauric acid, a medium chain fat of coconut oil
  1259. In vestigating the lowest t hreshold of vascular b en efits from LDLย cholesterolย loweringย with a PC S K9 mAb i nhibi t or (alirocumab) in health y volunteersโ€“a โ€ฆ
  1260. In vitro activity of fluvastatin, aย cholesterolโ€“loweringย agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.
  1261. In vitro and in vivoย cholesterolย loweringย ability of Lactobacillus pentosus KF923750
  1262. In vitro assessment of pediococci-and lactobacilli-inducedย cholesterolโ€“loweringย effect using digitally enhanced high-performance thin-layer chromatography and โ€ฆ
  1263. In vitro characterization of lactic acid bacteria from Indonesian kefir grains as probiotics withย cholesterolโ€“loweringย effect
  1264. In vitroย cholesterolโ€“loweringย activity of Lactobacillus plantarum and Lactobacillus paracasei strains isolated from the Italian Castelmagno PDO cheese
  1265. In Vitroย cholesterolโ€“loweringย Mechanisms of Selected Lactobacillus and Bifidobacterium Species and Effects of Physical Treatment
  1266. In vitroย cholesterolโ€loweringย properties of Lactobacillus plantarum AN6 isolated from ajiโ€narezushi
  1267. In vitro evaluation of theย cholesterol-reducing ability of a potential probiotic Bacillus spp
  1268. In vitro hypoglycemic andย cholesterolย loweringย effects ofย dietary fiber prepared from cocoa (Theobroma cacao L.) shells
  1269. In vitro hypoglycemic,ย cholesterolโ€“loweringย and fermentation capacities of fiber-rich orange pomace as affected by extrusion
  1270. In vitro screening of lactic acid bacteria forย cholesterolโ€“loweringย activity and the underlying mechanism.
  1271. In vitro study of bile salt hydrolase (BSH) activity of BSH isogenic Lactobacillus plantarum 80 strains and estimation ofย cholesterolย loweringย through enhanced BSH โ€ฆ
  1272. In vivo antioxidant, organ protective, ameliorative andย cholesterolย loweringย potential of ethanolic and methanolic extracts of โ€œAta-Ofaโ€ polyherbal tea (A โ€ฆ
  1273. In vivo safety assessment of Lactobacillus fermentum strains, evaluation of theirย cholesterolโ€loweringย ability and intestinal microbial modulation
  1274. In with the Good and out with the Bad: The Role of SR-BI inย loweringย Bloodย cholesterolย Levels
  1275. Incorporation of Almonds in aย cholesterolโ€loweringย dietย Improves nonโ€ABCA1โ€mediatedย cholesterolย Efflux in Normal Weight Adults
  1276. Increased ether lipid cytotoxicity by reducing membraneย cholesterolย content
  1277. Increased prevalence of cholelithiasis in men ingesting a serum-cholesterolโ€“loweringย diet
  1278. Increasing physician involvement inย cholesterolโ€“loweringย practices: the role of knowledge, attitudes and perceptions
  1279. Increasing physician involvement inย cholesterolโ€loweringย practices
  1280. Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin duringย cholesterolย loweringย with โ€ฆ
  1281. Increasing serum half-life and extendingย cholesterolย loweringย in vivo by engineering antibody with pH-sensitive binding to PCSK9
  1282. INCREASING STORAGE CAPABILITY ANDย cholesterolย REDUCING IN FERMENTED CAMEL MEAT BY LACTOBACILLUS CASEI
  1283. Indications forย loweringย LDLย cholesterolย in rheumatoid arthritis: an unrecognized problem.
  1284. Individual responses to aย cholesterolโ€“loweringย dietย in 50 men with moderate hypercholesterolemia
  1285. Individual responsiveness to aย cholesterolโ€“loweringย dietย in postmenopausal women with moderate hypercholesterolemia
  1286. Individual Responsiveness to aย cholesterolโ€“loweringย dietย in Postmenopausal Women with Moderate Hypercholesterolemia.
  1287. Influence of aย cholesterolโ€“loweringย strain Lactobacillus plantarum LP3 isolated from traditional fermented yak milk on gut bacterial microbiota and metabolome of rats โ€ฆ
  1288. Influence of aqueous extracts from Salvadora persica L.(Chewing sticks) onย loweringย cholesterolย in diabeticsโ€™ male rats
  1289. Influence of body mass index and serum lipids on theย cholesterolโ€“loweringย effects of almonds in free-living individuals
  1290. Influence ofย cholesterolย loweringย on plasma membrane lipids and cationic transport systems.
  1291. Influence ofย cholesterolย loweringย therapy and antioxidant supplementation on coronary artery bypass graft (CABG) occlusion 2 years after surgery
  1292. Influence ofย cholesterolย on survival after stroke. Beneficial effects ofย cholesterolย loweringย on atherosclerosis may not lessen with age.
  1293. Influence ofย cholesterolย screening and nutritional counseling in reducingย cholesterolย levels in children
  1294. Influence ofย cholesterolโ€“loweringย on plasma membrane lipids and function.
  1295. Influence of CYP2C9 polymorphisms on the pharmacokinetics andย cholesterolโ€loweringย activity of (โˆ’)โ€3s,5rโ€fluvastatin and (+)โ€3r,5sโ€fluvastatin in healthy โ€ฆ
  1296. Influence of feeding ฮฒ-cyclodextrin on reducing the content ofย cholesterolย in pork
  1297. Influence of LDL-cholesterolย loweringย on cardiovascular outcomes in patients with diabetes mellitus undergoing coronary revascularization
  1298. Influence of magnesium and calcium on the serumย cholesterolย levelย loweringย (II)
  1299. Influence of magnesium and calcium on the serumย cholesterolย levelย loweringย (III)-Influence of Korea ginseng
  1300. Influence of polymorphisms andย cholesterolโ€“loweringย treatment on SCARB1 mRNA expression
  1301. Influence of reducing fat on leptin andย cholesterolย in adolescent girl students [J]
  1302. Influence of stigmastanol and stigmastanyl-phosphorylcholine, two plasmaย cholesterolย loweringย substances, on synthetic phospholipid membranes. A 2H-and 31P โ€ฆ
  1303. Influence of the SLCO1B1*1b and *5 haplotypes on pravastatinโ€™sย cholesterolย loweringย capabilities and basal sterol serum levels
  1304. Inhibition of intestinalย cholesterolย absorption might explainย cholesterolโ€loweringย effect of telmisartan
  1305. Inhibition of macrophage proliferation dominates plaque regression in response toย cholesterolย lowering
  1306. Inhibition of melanin synthesis in zebrafish by low-temperature maintenance andย loweringย of serumย cholesterol
  1307. Inhibitors of Acyl-CoA:cholesterolย O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. CI-1011:โ€‰An Acyl Sulfamate with Uniqueย cholesterolโ€“loweringย โ€ฆ
  1308. Inhibitory effects of tangeretin and trans-ethyl caffeate on the HMG-CoA reductase activity: Potential agents for reducingย cholesterolย levels
  1309. Insights from recent meta-analysis: role of high-density lipoproteinย cholesterolย in reducing cardiovascular events and rates of atherosclerotic disease progression
  1310. Insulin-sensitizing andย cholesterolโ€“loweringย effects of chromium (D-Phenylalanine) 3
  1311. Intake occasion affects the serumย cholesterolย loweringย of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects
  1312. Intenseย cholesterolย loweringย therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes
  1313. Intensity of lipid-loweringย therapy and low-density lipoproteinย cholesterolย goal attainment among the elderly before and after the 2004 Nationalย cholesterolย Education โ€ฆ
  1314. Intensiveย cholesterolย lowering: no longer a myth
  1315. Intensiveย cholesterolโ€“loweringย therapy improves large artery elasticity in acute myocardial infarction patients
  1316. Intensive LDLย cholesterolโ€“loweringย treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of โ€ฆ
  1317. Intensive LDL-cholesterolย loweringย and inhibition of inflammation to further reduce cardiovascular risk?
  1318. Intensive LDL-cholesterolย loweringย therapy and neurocognitive function
  1319. Intensiveย loweringย of LDLย cholesterolย with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
  1320. Intensiveย loweringย of low-density lipoproteinย cholesterolย levels for primary prevention of coronary artery disease
  1321. Intensivelyย loweringย both low-density lipoproteinย cholesterolย and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients
  1322. Interaction of theย cholesterolย reducing agent simvastatin with zwitterionic DPPC and charged DPPG phospholipid membranes
  1323. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDLย cholesterolโ€“loweringย response to atorvastatin
  1324. Interactions ofย cholesterolย reducing agent simvastatin with charged phospholipid model membranes
  1325. Interactions ofย cholesterolย reducing agent simvastatin with phospholipid model membranes
  1326. Interindividual variability in theย cholesterolโ€“loweringย effect of supplementation with plant sterols or stanols
  1327. Interrelation ofย cholesterolโ€lowering, antioxidant activity and DNA damage protection to the different solvent extracts of mulberry (Morus alba L.)
  1328. Intestinal CREBH overexpression prevents high-cholesterolย diet-induced hypercholesterolemia by reducing Npc1l1 expression
  1329. Intestine-specific DGAT1 deficiency improves atherosclerosis in apolipoprotein E knockout mice by reducing systemicย cholesterolย burden
  1330. Intima-media thickness afterย cholesterolย loweringย in familial hypercholesterolemia. A three-year ultrasound study of common carotid and femoral arteries
  1331. Intracellularย cholesterolย loweringย as Novel Target for Antiโ€Atherosclerotic Therapy
  1332. Inverse relationship between high-density lipoproteinย cholesterolย raising and high-sensitivity C-reactive protein reduction in older patients treated with lipid-loweringย โ€ฆ
  1333. Investigating the effect of operational factors on reducing creamย cholesterolย by beta-cyclodextrin using response surface method
  1334. Investigation of a probiotic yeast as aย cholesterolย loweringย agent on rats fed on a highย cholesterolย enrichedย diet
  1335. Investigation of a Probiotic Yeast as aย cholesterolย loweringย Agent on Rats Fed on a Highย cholesterolย Enrichedย diet
  1336. Investigation of theย cholesterolโ€“loweringย action of insoluble fibre derived from the peel of Citrus sinensis L. cv. Liucheng
  1337. Investigation of the role of amla in modulatingย cholesterolย metabolism, and understanding its mechanism of action in reducing Alzheimerโ€™s risk
  1338. Investigation on the lipid-andย cholesterolโ€“loweringย abilities of biocellulose
  1339. Involvement of post-digestionโ€™hydrophobiaโ€™peptides in plasmaย cholesterolโ€“loweringย effect ofย dietary plant proteins
  1340. Iron and zinc status of women and men who followedย cholesterolโ€“loweringย diets
  1341. Isย cholesterolย loweringย an alternative to revascularization in some patients with coronary artery disease?
  1342. Isย cholesterolย loweringย following UVA blood irradiation an effect of citrate?
  1343. Is direct method of low density lipoproteinย cholesterolย measurement appropriate for targeting lipidย loweringย therapy?
  1344. Is fat globule membrane essential forย cholesterolโ€“loweringย effect of milk?
  1345. Is intensiveย cholesterolย loweringย detrimental in multiple sclerosis?
  1346. Is intensive LDL-cholesterolย loweringย beneficial and safe?
  1347. Isย loweringย bloodย cholesterolย levels safe?
  1348. Is moderate drinking as effective asย cholesterolย loweringย in reducing mortality in high-risk coronary patients?
  1349. Is red yeast rice safe and effective forย loweringย serumย cholesterol?
  1350. Is reducing low-density lipoproteinย cholesterolย all that matters?
  1351. Is soy protein effective in reducingย cholesterolย and improving bone health?
  1352. Is the Australian National Heart Foundation programme effective in reducingย cholesterolย levels among general practice patients?
  1353. Is there a correlation between LDL-cholesterolย loweringย and angiographically (QCA) determined coronary progression?
  1354. Isoflavones enhance the plasmaย cholesterolโ€“loweringย activity of 7S protein in hypercholesterolemic hamsters
  1355. Isolation and Biological Characteristics ofย cholesterolโ€“loweringย LAB from Fermented Food
  1356. Isolation and Characteristics ofย cholesterolโ€“loweringย L. casei subsp. casei Strain GL-03 Isolated from Cheese
  1357. Isolation and characterization ofย cholesterolโ€“loweringย lactic acid bacteria from kimchi
  1358. Isolation and characterization of new strains ofย cholesterol-reducing bacteria from baboons.
  1359. Isolation and characterization of uniqueย cholesterol-reducing anaerobes
  1360. Isolation and identification ofย cholesterolย loweringย probiotic bacteria from palm wine (Raffia mambillensis)
  1361. Isolation and Identification ofย cholesterolย loweringย Probiotic Yeast from Palm Raffia (Raffia mambillensis) Wine
  1362. Isolation and identification ofย cholesterol-reducing lactic acid bacteria from indigenously fermented pickles and dried-sausage
  1363. Isolation and Identification ofย cholesterol-Reducing Lactic Acid Bacteria from Pig
  1364. Isolation and identification ofย cholesterol-reducing lactic acid bacteria from Tibet kefir
  1365. Isolation and identification ofย cholesterol-reducing Lactic acid bacteria.
  1366. Isolation and identification of lactic acid bacteria and the study ofย cholesterol-reducing effect from panda excrement
  1367. Isolation and identification of lactic acid bacteria from fermented vegetables juice and the investigation ofย cholesterol-reducing capability.
  1368. Isolation and selection of potential probiotic lactic acid bacteria from cassava pulp forย cholesterolย loweringย property
  1369. Isolation ofย cholesterolโ€“loweringย Enterococcus faecium JB HML-11 from Human Colostrums
  1370. Isolation ofย cholesterolโ€“loweringย lactic acid bacteria from human intestine for probiotic use
  1371. Isolation of lactic acid bacteria withย cholesterolโ€“loweringย activity from digestive tracts of Indonesian native chickens
  1372. Isolation of plasmaย cholesterolโ€“loweringย components from ningyotake (Polyporus confluens) mushroom
  1373. Isolation of potential probiotic Lactobacillus oris HMI68 from motherโ€™s milk withย cholesterol-reducing property
  1374. Isolation, Identification andย cholesterolโ€“loweringย Characteristics of Lactic Acid Bacteria MR25
  1375. J-104,123, a novel and orally-active inhibitor of squalene synthase: Stereoselective synthesis andย cholesterolย loweringย effects in dogs
  1376. JAMA: Effect of aย dietary portfolio ofย cholesterolโ€“loweringย foods given at 2 levels of intensity ofย dietary advice on serum lipids in hyperlipidemia: a randomized โ€ฆ
  1377. Key points for maximum effectiveness and safety forย cholesterolโ€loweringย properties of plant sterols and use in the treatment of metabolic syndrome
  1378. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoproteinย cholesterolย loweringย response to pravastatin, and heart disease risk reduction in the โ€ฆ
  1379. Lack ofย cholesterolโ€“loweringย efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons
  1380. Lack of effect ofย loweringย LDLย cholesterolย on cancer: meta-analysis of
  1381. Lack of efficacy of low-dose sitostanol therapy as an adjunct to aย cholesterolโ€“loweringย dietย in men with moderate hypercholesterolemia
  1382. Lack of serumย cholesterolโ€“loweringย effect of skimmed milk and butter milk under controlled conditions
  1383. Lactic acid bacteria withย cholesterolโ€“loweringย properties for dairy applications: In vitro and in situ activity
  1384. Lactobacillus attenuates progression of nonalcoholic fatty liver disease byย loweringย cholesterolย and steatosis
  1385. Lactobacillus fermentum NCIMB 5221 and NCIMB 2797 asย cholesterolโ€“loweringย probiotic biotherapeutics: in vitro analysis
  1386. Lactobacillus fermentum strains from human breast milk with probiotic properties andย cholesterolโ€“loweringย effects
  1387. Lactobacillus plantarum strains as potential probiotic cultures withย cholesterolโ€“loweringย activity
  1388. Lactobacillus reuteri attenuates cardiac injury withoutย loweringย cholesterolย in low-density lipoprotein receptor-deficient mice fed standard chow
  1389. Lactostatin (IIAEK) and CSPHP: newย cholesterolโ€“loweringย peptides derived from food proteins.
  1390. Lathosterol in plasma measuresย cholesterolย synthesis and identifies the efficiency ofย dietary phytosterols in reducing the plasmaย cholesterolย concentration
  1391. Lathosterol toย cholesterolย ratio in serum predictsย cholesterolย loweringย response to plant sterol therapy in a dual center, randomized, singleโ€blind placebo controlled โ€ฆ
  1392. Lathosterol-to-cholesterolย ratio in serum predictsย cholesterolโ€“loweringย response to plant sterol consumption in a dual-center, randomized, single-blind placebo โ€ฆ
  1393. LDLย cholesterolย loweringย by bile acid malabsorption during inhibited synthesis and absorption ofย cholesterolย in hypercholesterolemic coronary subjects.
  1394. LDLย cholesterolย loweringย in type 2 diabetes: what is the optimum approach?
  1395. LDLย cholesterolย loweringย therapy: no target value but personalised treatment
  1396. LDLย cholesterolย loweringย with Evolocumab and Outcomes in Patients with Peripheral Artery Disease: Insights from the FOURIER Trial
  1397. LDLย cholesterolย reduction by lipidย loweringย therapy after acute myocardial infarction is not significantly influenced by baseline systemic inflammation
  1398. LDLย cholesterolโ€“loweringย effects of grape extract used as aย dietary supplement on healthy volunteers
  1399. LDLย cholesterolโ€“loweringย therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
  1400. LDL kolesterolรผ dรผsรผrmenin รถtesi/Beyondย loweringย LDLย cholesterol
  1401. LDL-cholesterolย goal attainment under persistent lipid-loweringย therapy in northeast China: subgroup analysis of the dyslipidemia international study of China โ€ฆ
  1402. LDL-cholesterolย loweringย activity of a blend of rice bran oil and safflower oil (8: 2) in patients with hyperlipidaemia: a proof of concept, double blind, controlled โ€ฆ
  1403. LDL-cholesterolย loweringย Among Young Adults Who Experience a First Myocardial Infarction
  1404. LDL-cholesterolย loweringย and atherosclerosis-clinical benefit and possible mechanisms: an update
  1405. LDL-cholesterolย loweringย and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the โ€ฆ
  1406. LDL-cholesterolย loweringย and renal outcomes
  1407. LDL-cholesterolย loweringย effect of a generic product of simvastatin compared to simvastatin (Zocorโ„ข) in Thai hypercholesterolemic subjectsโ€“a randomized โ€ฆ
  1408. LDL-cholesterolย loweringย effect of a newย dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate โ€ฆ
  1409. LDL-cholesterolย loweringย for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-cholesterolย Levels of 190 mg/dL or โ€ฆ
  1410. LDL-cholesterolย loweringย in chronic kidney disease stage V dialysis patients with hyperphosphataemia: a comparison of colestilan (COL) and sevelamer (SEV)
  1411. LDL-cholesterolย loweringย Increased Mortality in Mice with Inherited Cardiomyopathy
  1412. LDL-cholesterolย loweringย increases plasma apelin in isolated hypercholesterolemia
  1413. LDL-cholesterolย loweringย of plant sterols and stanolsโ€”Which factors influence their efficacy?
  1414. LDL-cholesterolย loweringย or HDL-cholesterolย raising for cardiovascular prevention: A lesson fromย cholesterolย turnover studies and others
  1415. LDL-cholesterolย loweringย strategies and population health-time to move to a cumulative exposure model.
  1416. Ldl-cholesterolย loweringย Treatment Changes Hematopoietic Stem Cell Behavior In Familial Hypercholesterolemia Patients
  1417. LDL-cholesterolย loweringย with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
  1418. LDL-cholesterolย lowering, transcapillary leakage of albumin and acetylcholine-mediated vasodilatation in atherosclerotic patients
  1419. LDL-cholesterolโ€“loweringย effect of aย dietary supplement with plant extracts in subjects with moderate hypercholesterolemia
  1420. LDL-cholesterolโ€“loweringย effect of a mixed green vegetable and fruit beverage containing broccoli and cabbage in hypercholesterolemic subjects
  1421. LDL-cholesterolโ€“loweringย effect of monacolin K from red yeast rice extractโ€“results of a randomized, placebo-controlled intervention study
  1422. LDL-cholesterolโ€“loweringย effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies
  1423. LDL-cholesterolโ€“loweringย therapy
  1424. Ldl-receptor genotype dependent response toย cholesterolโ€“loweringย therapy in patients with heterozygous familial hypercholesterolemia
  1425. Lean meat as part of aย cholesterolโ€“loweringย diet
  1426. Leptin receptor polymorphism is associated with serum lipid levels and impairment ofย cholesterolย loweringย effect by simvastatin in Japanese men
  1427. Lessons fromย cholesterolโ€“loweringย trials
  1428. Letter by Alkhalil Regarding Article,โ€œLow-Density Lipoproteinย cholesterolย loweringย With Evolocumab and Outcomes in Patients With Peripheral Artery Disease โ€ฆ
  1429. Letter by Calabrรฒ et al Regarding Article,โ€œLow-Density Lipoproteinย cholesterolย loweringย With Evolocumab and Outcomes in Patients With Peripheral Artery Disease โ€ฆ
  1430. Leuconostoc mesenteroides MKSR isolated from kimchi possesses ฮฑ-glucosidase inhibitory activity, antioxidant activity, andย cholesterolโ€“loweringย effects
  1431. Leukocyte ABCA1 impedes progression of established atherosclerotic lesions afterย dietaryย cholesterolย loweringย in LDLr-/-mice
  1432. Limitations ofย cholesterolย loweringย with PCSK9 inhibitors
  1433. Lipase inhibition andย cholesterolโ€“loweringย activities of laccase-catalyzed catechin polymers
  1434. Lipase-catalyzed synthesis of canola phytosterols oleate esters asย cholesterolย loweringย agents
  1435. Lipase-catalyzed synthesis of conjugated linoleyl ฮฒ-sitosterol and itsย cholesterolโ€“loweringย properties in mice
  1436. Lipid andย cholesterolย loweringย effect of green vs black tea-how much, how frequent: A literature review
  1437. Lipid binding from aqueous solution by lipid conjugated hydroxypropyl methylcellulose (HPMC): a novel food additive for reducingย cholesterolย and fat intestinal โ€ฆ
  1438. Lipidย loweringย and anti-atherosclerotic properties of Tinospora crispa aqueous extract on high-cholesterolย diet-induced hyperlipidemic rabbits
  1439. Lipidย loweringย and Antioxidant Activities of Methanolic Extract of Ficus hispida Linn. Fruits inย cholesterolย Fed Rats
  1440. Lipidย loweringย and antioxidant effects of Amomum subulatum seeds (Family Zingiberaceae) inย cholesterolย fed rabbits
  1441. Lipidย loweringย and Antioxidant Effects of C. Verum on Liver inย cholesterolย fed Rabbits
  1442. Lipidย loweringย effect of S-methyl cysteine sulfoxide from Allium cepa Linn in highย cholesterolย dietย fed rats
  1443. Lipidย loweringย effects of hydroalcoholic extract of Anethum graveolens L. and dill tablet in highย cholesterolย fed hamsters
  1444. Lipidย loweringย in patients with coronary artery disease: low density lipoproteinย cholesterolย and beyond
  1445. Lipidย loweringย Therapies Andย cholesterolย Levels After St-Segment Elevation Myocardial Infarction: Single Center Experience Of Secondary Prevention
  1446. Lipid Monitoring and Treatment Intensification ofย cholesterolย loweringย Therapies-Insight From the Veterans Affairs Healthcare System
  1447. Lipid-loweringย activity of Cow urine ark in guinea pigs fed with a highย cholesterolย diet
  1448. Lipid-loweringย and antioxidant effects of an ethyl acetate extract of fenugreek seeds in high-cholesterol-fed rats
  1449. Lipid-loweringย and antioxidant effects of hydroxytyrosol and its triacetylated derivative recovered from olive tree leaves inย cholesterol-fed rats
  1450. Lipid-loweringย and antioxidative activities of 3, 4-di (OH)-cinnamate and 3, 4-di (OH)-hydrocinnamate inย cholesterol-fed rats
  1451. Lipid-loweringย and antioxidative activities of aqueous extracts of Ocimum sanctum L. leaves in rats fed with a high-cholesterolย diet
  1452. Lipid-loweringย effect of bergamot polyphenolic fraction: role of pancreaticย cholesterolย ester hydrolase.
  1453. Lipid-loweringย effects of Coriolus versicolor extract in poloxamer 407-induced hypercholesterolaemic rats and highย cholesterol-fed rats
  1454. Lipid-loweringย effects of methanolic extract of Vernonia amygdalina leaves in rats fed on highย cholesterolย diet
  1455. Lipid-loweringย efficacy of hesperetin metabolites in high-cholesterolย fed rats
  1456. Lipid-loweringย intensification and low-density lipoproteinย cholesterolย achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event โ€ฆ
  1457. Lipid-loweringย therapies and achievement of LDL-cholesterolย targets
  1458. Lipid-loweringย Therapy and Low-Density Lipoproteinย cholesterolย (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China
  1459. Lipid-loweringย therapy and low-density lipoproteinย cholesterolย goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
  1460. Lipid-loweringย therapy and low-density lipoproteinย cholesterolย goal attainment after acute coronary syndrome: a Danish population-based cohort study
  1461. LIPID-loweringย THERAPY PATTERNS AND LOW-DENSITY LIPOPROTEIN-cholesterolย MANAGEMENT AMONG PATIENTS WITH ACUTE MYOCARDIAL โ€ฆ
  1462. lipid-loweringย therapy: effect onย cholesterolย efflux from the cells
  1463. Lipid-loweringย treatment and low-density lipoproteinย cholesterolย target achievement in patients with type 2 diabetes and acute coronary syndrome
  1464. Lipid-loweringย treatment to the end? A review of observational studies and RCTs onย cholesterolย and mortality in 80+-year olds
  1465. Lipidโ€loweringย effect of eriocitrin, the main flavonoid in lemon fruit, in rats on a highโ€fat and highโ€cholesterolย diet
  1466. LIPIDโ€loweringย EFFECTS OF ARONIA MELANOCARPA FRUIT JUICE IN RATS FEDย cholesterolโ€CONTAININGย dietS
  1467. Lipidโ€loweringย therapy use and achievement ofย cholesterolย targets in an Australian diabetes clinic
  1468. Lipids and cerebrovascular disease-New therapeutic options inย loweringย LDL-cholesterol
  1469. Lipids andย cholesterolโ€loweringย Activity of Red Cabbage Microgreens
  1470. Lipophilic 1, 1-bisphosphonates are potent squalene synthase inhibitors and orally activeย cholesterolย loweringย agents in vivo.
  1471. Lipoprotein (a)-and low-density lipoproteinโ€“derivedย cholesterolย in nephrotic syndrome: Impact on lipid-loweringย therapy?
  1472. Liver lipid metabolism and effect ofย cholesterolโ€“loweringย agents in the hyperlipidemia induced in rats by implantation of the pituitary-derived MtT-F4 tumor
  1473. Long termย cholesterolย loweringย therapy does not interfere with clinical response to anti CD20 therapy in patients with rheumatoid arthritis
  1474. Long-term bloodย cholesterolโ€“loweringย effects of aย dietary fiber supplement
  1475. Long-termย cholesterolโ€“loweringย effects of 4 fat-restrictedย diets in hypercholesterolemic and combined hyperlipidemic men: theย dietary Alternatives Study
  1476. Long-termย cholesterolโ€“loweringย effects of psyllium as an adjunct toย dietย therapy in the treatment of hypercholesterolemia
  1477. Long-term effects of a plant-basedย dietary portfolio ofย cholesterolโ€“loweringย foods on blood pressure
  1478. Long-term effects ofย cholesterolย loweringย and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary โ€ฆ
  1479. Long-term effects on clinical outcomes of aggressiveย loweringย of low-density lipoproteinย cholesterolย levels and low-dose anticoagulation in the post coronary artery โ€ฆ
  1480. Long-term hemostatic effects ofย cholesterolโ€“loweringย therapy with atorvastatin
  1481. Long-term low-density lipoproteinย cholesterolโ€“loweringย efficacy, persistence, and safety of evolocumab in treatment of hypercholesterolemia: results up to 4 years from โ€ฆ
  1482. Long-termย loweringย of plasmaย cholesterolย levels in LDL-receptor-deficient WHHL rabbits by gene therapy
  1483. Long-Term Safety and Effectiveness ofย cholesterolย loweringย with Pravastatin Treatment Over 11 Years: The Lipid Study Extension
  1484. Long-term safety and efficacy of aย cholesterolโ€“loweringย dietย in children with elevated low-density lipoproteinย cholesterol: seven-year results of theย dietary Intervention โ€ฆ
  1485. Longโ€termย cholesterolโ€loweringย effect of colestipol resin in humans
  1486. Lovastatin efficacy in reducing low-density lipoproteinย cholesterolย levels on high-vs low-fatย diets
  1487. Lovastatin forย loweringย cholesterolย levels in non-insulin-dependent diabetes mellitus
  1488. Lovastatin: a newย cholesterolโ€“loweringย agent.
  1489. Lovastatin: A newย cholesterolโ€loweringย agent
  1490. Lovastatin: an HMG-CoA reductase inhibitor forย loweringย cholesterol.
  1491. Low Density Lipoproteinย cholesterolย (LDL-C)ย loweringย in a Population Represented in a Meta-Analysis of Major Randomized Trials is Associated with a Positive โ€ฆ
  1492. Low density lipoproteinย cholesterolย lowering: Are the treatment guidelines still appropriate?
  1493. Low Density Lipoproteinย cholesterolโ€“loweringย Strategies and Population Health: Time to Move to a Cumulative Exposure Model
  1494. Low density lipoprotein-cholesterolย loweringย activity of a blend of rice bran oil and safflower oil (7: 3) in Indian patients with hyperlipidemia: a randomized โ€ฆ
  1495. Low density lipoprotein-cholesterolย loweringย mechanism and blood lipid profile managing effect of phytosterol in healthy normal and hypercholesterolemia: a meta โ€ฆ
  1496. LOW LDL-cholesterolย TARGET VALUE ATTAINMENT AT THE TIME OF ACUTE CORONARY SYNDROME (ACS) AND EVEN 4 MONTHS AFTER THE ACUTE โ€ฆ
  1497. Low Levels of Low-Density Lipoproteinย cholesterolย and Endothelial Function in Subjects without Lipid-loweringย Therapy
  1498. Low rates of both lipid-loweringย therapy use and achievement of low-density lipoproteinย cholesterolย targets in individuals at high-risk for cardiovascular โ€ฆ
  1499. Low-Density Lipoproteinย cholesterolย and High-Sensitivity C-Reactive Proteinย loweringย With
  1500. Low-density lipoproteinย cholesterolย goal attainment among post myocardial infarction patients on lipidย loweringย therapy at Siriraj Outpatient Clinic
  1501. Low-density lipoproteinย cholesterolย loweringย efficacy of evolocumab may reduce need for apheresis in heterozygous familial hypercholesterolaemia patients โ€ฆ
  1502. Low-density lipoproteinย cholesterolย loweringย for the prevention of cardiovascular outcomes in patients with ischemic stroke
  1503. Low-density lipoproteinย cholesterolย loweringย in the prevention of CHD: how low should we go?
  1504. Low-density lipoproteinย cholesterolย loweringย therapies: what is on the horizon?
  1505. Low-density lipoproteinย cholesterolย loweringย therapy and established atherosclerosis
  1506. Low-density lipoproteinย cholesterolย loweringย therapy for the secondary prevention of atherosclerotic cardiovascular disease
  1507. Low-density lipoproteinย cholesterolย loweringย treatment: the current approach
  1508. Low-Density Lipoproteinย cholesterolย loweringย With Evolocumab and Outcomes in Patients With Peripheral Artery Disease
  1509. Low-density lipoproteinย cholesterolย loweringย with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further โ€ฆ
  1510. Low-density lipoproteinย cholesterolย outcomes post-non-PCSK9i lipid-loweringย therapies in atherosclerotic cardiovascular disease and probable heterozygous โ€ฆ
  1511. Low-density lipoproteinย cholesterolย target value attainment based on 2019 ESC/EAS guidelines and lipid-loweringย therapy titration for patients with acute coronary โ€ฆ
  1512. Low-density lipoproteinย cholesterolโ€“loweringย effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients โ€ฆ
  1513. Low-density lipoprotein receptor genotype-dependent response toย cholesterolย loweringย by combined pravastatin and cholestyramine in familial hypercholesterolemia
  1514. Low-Density Lipoprotein-cholesterolย loweringย in Real-World Patients Treated With Evolocumab
  1515. Low-density lipoprotein-cholesterolย loweringย strategies for prevention of atherosclerotic cardiovascular disease: focus on siRNA treatment targeting PCSK9 โ€ฆ
  1516. Low-density lipoprotein-dependent and-independent effects ofย cholesterolโ€“loweringย therapies on C-reactive protein: a meta-analysis
  1517. Low-dose simvastatin is a well-tolerated and efficaciousย cholesterolโ€“loweringย agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized โ€ฆ
  1518. Lowโ€density lipoproteinโ€cholesterolย loweringย in individuals at intermediate cardiovascular risk: Percent reduction or target level?
  1519. loweringย โ€œdesirableโ€ย cholesterolย levels improves flow-mediated vasoactivity in healthy, middle-aged men
  1520. loweringย bloodย cholesterol
  1521. loweringย bloodย cholesterolย to reduce coronary heart disease risk
  1522. loweringย bloodย cholesterol: recent developments of significance to community health nurses.
  1523. loweringย blood totalย cholesterol: a meta-analysis and policy statement
  1524. loweringย cellularย cholesterolย inhibits signal transduction via glycosyl phosphatidyl-inositol (GPI)-anchored proteins
  1525. loweringย cholesterol
  1526. loweringย cholesterolย 1998.ย cholesterolย synthesis inhibitors compared
  1527. loweringย cholesterolย and death due to accidents, suicides: unresolved issues
  1528. loweringย cholesterolย and Death due to Accidents, Suicides: Unresolved Issues-Reply
  1529. loweringย cholesterolย andย loweringย costs
  1530. loweringย cholesterolย andย loweringย costs-Reply
  1531. loweringย cholesterolย and the incidence of coronary heart disease
  1532. loweringย cholesterolย concentrations and mortality
  1533. loweringย cholesterolย concentrations and mortality
  1534. loweringย cholesterolย concentrations and mortality
  1535. loweringย cholesterolย concentrations and mortality
  1536. loweringย cholesterolย concentrations and mortality
  1537. loweringย cholesterolย concentrations and mortality
  1538. loweringย cholesterolย concentrations and mortality
  1539. loweringย cholesterolย concentrations and mortality
  1540. loweringย cholesterolย concentrations and mortality: a quantitative review of primary prevention trials.
  1541. loweringย cholesterolย concentrations and mortality: Authorsโ€™ reply
  1542. loweringย cholesterolย does pay off
  1543. loweringย cholesterolย for prevention of coronary heart diseaseโ€”problems and perspectives
  1544. loweringย cholesterolย in chronic kidney disease: is it safe and effective?
  1545. loweringย cholesterolย in high risk individuals and populations
  1546. loweringย cholesterolย in old age.
  1547. loweringย cholesterolย in quail eggs using some extracts
  1548. loweringย cholesterolย Levels in Children and Adolescents: A Role for the Occupational Health Nurse
  1549. loweringย cholesterolย naturally
  1550. loweringย cholesterolย The Secondary Prevention of Coronary Heart Disease
  1551. loweringย cholesterolย with Anticholestโ€“a high fiber guar-apple pectin drink
  1552. loweringย cholesterolย withย dietย and Lovastatin
  1553. loweringย cholesterolย with granulocyte-macrophage colony-stimulating factor
  1554. loweringย cholesterolย With Granulocyte-Macrophage Colony-Stimulating Factor
  1555. loweringย cholesterolย with Lovastatin: The wrong approach
  1556. loweringย cholesterolย with PCSK9 inhibitors
  1557. loweringย cholesterol, 1988. Rationale, mechanisms, and means.
  1558. loweringย cholesterol: a review on the role of plant sterols
  1559. loweringย cholesterol: effects on trauma death, cancer death and total mortality
  1560. loweringย cholesterol: how low is low enough?
  1561. loweringย effect of an isoflavone-rich fermented soybean extract on the serumย cholesterolย concentrations in female rats, with or without ovariectomy, but not in male โ€ฆ
  1562. loweringย effect ofย dietary milk-whey protein v. casein on plasma and liverย cholesterolย concentrations in rats
  1563. loweringย effect ofย dietary milk-whey protein versus casein on plasma and liverย cholesterolย concentrations in rats
  1564. loweringย Highย cholesterol
  1565. loweringย High Plasmaย cholesterolย levels is not dangerous
  1566. loweringย High Plasmaย cholesterolย Levels Is Not Dangerous-Reply
  1567. loweringย increasedย cholesterolโ€“prolonging life?
  1568. loweringย LDLย cholesterolย in adults: a prospective, community-based practice initiative
  1569. loweringย LDLย cholesterolย is good, but how and in whom
  1570. loweringย LDLย cholesterolย reduces atherosclerotic risk in patients with chronic kidney disease
  1571. loweringย LDLย cholesterolย reduces cardiovascular risk independently of presence of inflammation
  1572. loweringย LDLย cholesterolย with margarine containing plant stanol/sterol esters: is it still relevant in 2011?
  1573. loweringย LDLย cholesterol, but not raising LDL receptor activity, by ezetimibe
  1574. loweringย LDLย cholesterol, but not Raising LDL Receptor Activity, by Ezetimibe
  1575. loweringย LDLย cholesterol: questions from recent meta-analyses and subset analyses of clinical trial data issues from the Interdisciplinary Council on Reducing the โ€ฆ
  1576. loweringย LDL-cholesterolย IS PROTECTIVE FOR THE FRAILTY INDEX: A MENDELIAN RANDOMIZATION STUDY IN THE UK BIOBANK
  1577. loweringย LDL-cholesterol: the lower the better?
  1578. loweringย LDLโ€cholesterolย and CV Benefits: Is There a Limit to How Low LDLโ€C Needs to be for Optimal Health Benefits?
  1579. loweringย line tension with highย cholesterolย content induces a transition from macroscopic to nanoscopic phase domains in model biomembranes
  1580. loweringย low density lipoproteinย cholesterolย with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in โ€ฆ
  1581. loweringย low-density lipoproteinย cholesterolย by PCSK9 inhibition in patients with diabetes on insulin therapy: is it efficacious and safe?
  1582. loweringย Low-Density Lipoproteinย cholesterolย Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a โ€ฆ
  1583. loweringย low-density lipoproteinย cholesterolย levels in patients with type 2 diabetes mellitus
  1584. loweringย of blood pressure, plasma renin substrate,ย cholesterolย and triglyceride by portacaval anastomosis in rats fed on a 60% sucrose/5% lardย diet
  1585. loweringย ofย cholesterolย absorption and blood levels by ileal exclusion: experimental basis and preliminary clinical report
  1586. loweringย ofย cholesterolย bioaccessibility and serum concentrations by saponins: in vitro and in vivo studies
  1587. loweringย ofย cholesterolย levels and the risk of stroke
  1588. loweringย ofย cholesterolย levels through adding pectins and soybean proteins to a reducingย dietย (authorโ€™s transl)
  1589. loweringย of HDLย cholesterolย in post-menopausal women by tibolone is not associated with changes inย cholesterolย efflux capacity or paraoxonase activity
  1590. loweringย of HDL2-cholesterolย and lipoprotein A-1 particle levels by increasing the ratio of polyunsaturated to saturated fatty acids
  1591. loweringย of high density lipoproteinย cholesterolย levels: case report
  1592. loweringย of human serumย cholesterolย by an oral hydrophilic colloid.
  1593. loweringย of LDLย cholesterol
  1594. loweringย of LDLย cholesterol
  1595. loweringย of LDLย cholesterolย rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes
  1596. loweringย of LDL-cholesterolย improves endothelial function by increased nitric oxide synthase activity
  1597. loweringย of plasmaย cholesterolย and enhanced sterol excretion with the consumption of polyunsaturated ruminant fats
  1598. loweringย of plasmaย cholesterolย in herbivores and omnivores by low molecular weight dextran
  1599. loweringย of plasmaย cholesterolย levels in animals by lovastatin and simvastatin
  1600. loweringย of plasmaย cholesterolย levels in free-living adolescent males; use of natural and synthetic polyunsaturated foods to provide balanced fatย diets
  1601. loweringย of plasma LDLย cholesterolย in hamsters by the tomato glycoalkaloid tomatine
  1602. loweringย of Serumย cholesterolย and Triglyceride by Para-Aminosalicylic Acid in Hyperlipoproteinemia: Studies in Patients with Types II-A and II-B
  1603. loweringย of serumย cholesterolย and triglyceride levels by balancing amino acid intake in the white rat
  1604. loweringย of serumย cholesterolย and triglycerides and modulation of divalent cations byย dietary phytate.
  1605. loweringย of serumย cholesterolย by Lactobacillus sporogenes
  1606. loweringย of serumย cholesterolย by Temoe Lawak Singer, a Curcuma mixture.
  1607. loweringย of serumย cholesterolย by the administration of a plant sterol
  1608. loweringย of serumย cholesterolย by ultraviolet irradiation.
  1609. loweringย of serumย cholesterolย in hypercholesterolemic humans by tocotrienols (palmvitee)
  1610. loweringย of serum totalย cholesterolย to high density lipoproteinย cholesterolย ratios in hypercholesterolaemic patients by Abana: possible cardioprotective action
  1611. loweringย of serum-cholesterolย level in rats by intraperitoneal cod-liver oil.
  1612. loweringย patientsโ€™ย cholesterol
  1613. loweringย patientsโ€™ย cholesterol. Excluding patients from trials increases uncertainty.
  1614. loweringย patientsโ€™ย cholesterol. Extrapolating results of trial of simvastatin gives room for doubt.
  1615. loweringย patientsโ€™ย cholesterol. Few eligible patients currently receive treatment.
  1616. loweringย plasmaย cholesterolย byย diet
  1617. loweringย plasmaย cholesterolย by raising LDL receptors
  1618. loweringย plasmaย cholesterolย by raising LDL receptorsโ€”revisited
  1619. loweringย plasmaย cholesterolย levels halts progression of aortic valve disease in mice
  1620. loweringย risk withoutย loweringย cholesterol: Implications for nationalย cholesterolย policy
  1621. loweringย SERUMย cholesterolย AND REGRESSION OF EXPERIMENTAL ATHEROSCLEROTIC PLAQUES INDUED BY ALFALFA SAPONINS [J]
  1622. loweringย serumย cholesterolย level by feeding a 40% ethanol-eluted fraction from HP-20 resin treated with hot water extract of adzuki beans (Vigna angularis) to rats fed โ€ฆ
  1623. loweringย SERUMย cholesterolย LEVELS BYย dietARY MODIFICATION A CHANGE IN FOOD HABITS, NOT A SPECIALย diet
  1624. loweringย serumย cholesterol: it is time to proceed
  1625. loweringย Targeted Atherogenic Lipoproteinย cholesterolย Goals for Patients at โ€œExtremeโ€ ASCVD Risk
  1626. loweringย theย cholesterolย content of MA104 cells inhibits receptor-mediated transport of folate.
  1627. loweringย the cost ofย loweringย theย cholesterol
  1628. loweringย the repeat unplanned revascularization rate after coronary stenting by focusing on the long-term stable control of low-density lipoproteinย cholesterol
  1629. loweringย the triglyceride/high-density lipoproteinย cholesterolย and its association with the beneficial impact of pioglitazone on coronary atherosclerosis in the โ€ฆ
  1630. loweringย the triglyceride/high-density lipoproteinย cholesterolย ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in โ€ฆ
  1631. Lupin protein exertsย cholesterolโ€“loweringย effects targeting PCSK9: From clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells
  1632. Major benefits fromย cholesterolโ€“loweringย in patients with diabetes.
  1633. Managing comorbidities throughย cholesterolโ€“loweringย agents
  1634. Manufacture of Cheddar cheese using probiotic Lactobacillus plantarum K25 and itsย cholesterolโ€“loweringย effects in a mice model
  1635. Marked aortic valve stenosis progression after receiving long-term aggressiveย cholesterolโ€“loweringย therapy using low-density lipoprotein apheresis in a patient with โ€ฆ
  1636. Markedย loweringย of high-density lipoproteinย cholesterolย levels due to high dose bexarotene therapy
  1637. Marked Regression of Aortic Plaque by Intensiveย cholesterolโ€“loweringย Therapyโ€”A Case ofย cholesterolย Embolism
  1638. Maximal expected benefits fromย loweringย cholesterolย in primary prevention for a high-risk population
  1639. Maximal low density lipoprotein receptor activity and the effect of lipidย loweringย dietย on total serumย cholesterol
  1640. Maximal response to a plasmaย cholesterolโ€“loweringย dietย is achieved within two weeks.
  1641. Mechanism for theย cholesterolโ€“loweringย action of egg white protein in rats
  1642. Mechanism of serumย cholesterolโ€“loweringย action of an anabolic steroid in contrast to a glucorticoid
  1643. Mechanism of the plasmaย cholesterolย loweringย effect of tazasubrate in rats: accelerated plasmaย cholesterolย transport with increased liver lipoprotein receptor activity
  1644. Mechanisms of calcium intake inย loweringย serumย cholesterolย levels
  1645. Mechanisms ofย cholesterolย and saturated fatty acidย loweringย by Quillaja saponaria extract, studied by in vitro digestion model
  1646. MECHANISMS OFย cholesterolโ€“loweringย EFFECT OF BARLEY ฮฒ-GLUAN
  1647. Mechanisms ofย cholesterolโ€“loweringย Effects ofย dietary Fiber
  1648. Mechanisms ofย cholesterolโ€“loweringย effects ofย dietary insoluble fibres: relationships with intestinal and hepaticย cholesterolย parameters
  1649. Mechanisms ofย cholesterolโ€“loweringย effects of lactobacilli and bifidobacteria strains as potential probiotics with their bsh gene analysis
  1650. Mechanisms of LDL-cholesterolย loweringย action of psyllium hydrophillic mucilloid in the hamster
  1651. Mechanisms of the triglyceride-andย cholesterolโ€“loweringย effect of fenofibrate in hyperlipidemic type 2 diabetic patients
  1652. Mechanisms underlying theย cholesterolโ€“loweringย properties of solubleย dietary fibre polysaccharides
  1653. medicinalย plantsย withย cholesterolโ€“loweringย effect marketed in the Buenos Aires-La Plata conurbation, Argentina: An Urban Ethnobotany study
  1654. Mediterraneanย dietย supplemented withย cholesterolโ€“loweringย foods and health-related quality of life in adults with HIV infection
  1655. Meeting report.โ€ MIRACLโ€ study ofโ€ Myocardial Ischemia Reduction with Aggressiveย cholesterolย loweringโ€œ
  1656. Men and womenโ€“similar but not identical: insights into LDL-loweringย therapy in women from theย cholesterolย Treatment Trialists Collaboration
  1657. Meta analysis of efficacy and safety of bempedoic acid inย loweringย low density lipoproteinย cholesterol
  1658. Meta-analysis of theย cholesterolโ€“loweringย effects ofย dietary fiber
  1659. Meta-analysis of the relation of body mass Index to cardiovascular outcomes in patients Receiving Intensive low-density Lipoproteinย cholesterolย loweringย therapy
  1660. Meta-analysis, clinical trials, and transferability of research results into practice: the case ofย cholesterolโ€“loweringย interventions in the secondary prevention of coronary โ€ฆ
  1661. Metabolic Basis for theย cholesterolโ€loweringย Action ofย dietary Polyunsaturated Fatty Acids
  1662. Metabolic changes induced in elderly patients with aย cholesterolย loweringย resin, cholestyramine
  1663. Metabolic disposition studies on simvastatin, aย cholesterolโ€“loweringย prodrug.
  1664. Metabolic profile associated with glucose andย cholesterolย loweringย effects of berberine in Spragueโ€“Dawley rats
  1665. Metabolic response of soy pinitol on lipidโ€lowering, antioxidant and hepatoprotective action in hamsters fedโ€high fat and highย cholesterolย diet
  1666. Metabolites of Avena sativa with Bloodย cholesterolย loweringย Properties
  1667. Metformin exhibited anticancer activity byย loweringย cellularย cholesterolย content in breast cancer cells
  1668. Method of administration influences the serumย cholesterolโ€“loweringย effect of psyllium
  1669. Method of reducingย cholesterolย in eggs
  1670. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and aย cholesterolโ€“loweringย agent
  1671. Microbiological and Histopathological studies onย cholesterolย reducing effect of lactobacillus acidophilus
  1672. Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication inย loweringย cholesterol
  1673. Microsomal triglyceride transfer protein inhibition: a novel treatment forย loweringย plasmaย cholesterol
  1674. Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors andย cholesterolย loweringย agents
  1675. Mipomersen, an apolipoprotein B synthesis inhibitor, forย loweringย of LDLย cholesterolย concentrations in patients with homozygous familial hypercholesterolaemia: a โ€ฆ
  1676. Mode of Action ofย cholesterolโ€“loweringย Agents: A Critique of Facts and Theories
  1677. Mode of action of probucol in reducing serumย cholesterolย in mice
  1678. Mode of action of the lipid-loweringย agents, clofibrate and BM 15075, onย cholesterolย biosynthesis in rat liver
  1679. Modeling of the LDLย cholesterolโ€“loweringย effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers.
  1680. Modelling total CHD burden and long-term benefit ofย cholesterolย loweringย in middle aged men with and without a history of cardiovascular disease.
  1681. Modelling total coronary heart disease burden and long-term benefit ofย cholesterolย loweringย in middle aged men with and without a history of cardiovascular disease
  1682. Modern concepts onย cholesterolย loweringย and coronary heart disease
  1683. Modification of coronary artery disease progression byย cholesterolโ€“loweringย therapy: the angiographic studies.
  1684. Modulated expression of genes associated with NO signal transduction contributes to theย cholesterolโ€“loweringย effect of electro-acupuncture
  1685. Modulation of Adhesion Molecules byย cholesterolโ€loweringย Therapy in Mononuclear Cells from Hypercholesterolemic Patients
  1686. Modulation of gene expression inย cholesterolโ€“loweringย effect of electroacupuncture at Fenglong acupoint (ST40): a cDNA microarray study
  1687. Molecular and vibrational dynamics in theย cholesterolโ€“loweringย agent Lovastatin: solid-state NMR, inelastic neutron scattering, and periodic DFT study
  1688. Molecular identification ofย cholesterolโ€“loweringย lactic acid bacteria isolated from cocowater kefir
  1689. Molecular insights into the mechanisms underlying theย cholesterolโ€“loweringย effects of phytosterols
  1690. Molecular mechanisms ofย cholesterolโ€“loweringย peptides derived from food proteins
  1691. Molecular mechanisms underlying theย cholesterolโ€“loweringย effect of Ginkgo biloba extract in hepatocytes: a comparative study with lovastatin
  1692. Monascus fermentation of dioscorea for increasing the production ofย cholesterolโ€“loweringย agentโ€”monacolin K and antiinflammation agentโ€”monascin
  1693. Monounsaturated fatty acids for plasmaย cholesterolโ€“loweringย diets
  1694. More on the Chinese red-yeast-rice supplement and itsย cholesterolโ€“loweringย effect
  1695. More-intensive vs less-intensive LDL-cholesterolย loweringย reduces mortality
  1696. MP37-09ย cholesterolย loweringย THERAPY PRIOR TO PROSTATECTOMY LOWERS PROLIFERATION RATES IN NORMAL GLAND AND LOW-GRADE โ€ฆ
  1697. MRC BHFHeart Protection Study ofย cholesterolโ€“loweringย therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary โ€ฆ
  1698. MRC/BHF Heart Protection Study ofย cholesterolย loweringย with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  1699. MRC/BHF Heart Protection Study ofย cholesterolโ€“loweringย with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
  1700. MRI of rabbit atherosclerosis in response toย dietaryย cholesterolย lowering
  1701. MTP inhibitor decreases plasmaย cholesterolย levels in LDL receptor-deficient WHHL rabbits byย loweringย the VLDL secretion
  1702. Multifariousย cholesterolย loweringย potential of lactic acid bacteria equipped with desired probiotic functional attributes
  1703. Multifunctional fat absorption and bloodย cholesterolย reducing fo
  1704. Mutation Breeding ofย cholesterol-Reducing Lactobacillus acidophilus
  1705. Myocardial Ischemia andย cholesterolย loweringย Therapy
  1706. Myocardial perfusion afterย cholesterolย lowering
  1707. Mystery ofย cholesterolโ€“loweringย peptides, lactostatin and soystatin
  1708. N-cyclohexyl linoleamide: Metabolism andย cholesterolโ€“loweringย effect in rats
  1709. Naringin administration inhibits platelet aggregation and release by reducing bloodย cholesterolย levels and the cytosolic free calcium concentration in โ€ฆ
  1710. Naturalย cholesterolโ€“loweringย products: focus on probiotics
  1711. Naturally derived micelles for rapid in vitro screening of potentialย cholesterolโ€“loweringย bioactives
  1712. Need for large scale randomised evidence aboutย loweringย LDLย cholesterolย in people with diabetes mellitus: MRC/BHF heart protection study and other major trials
  1713. Need to individualiseย cholesterolโ€“loweringย therapy
  1714. Neurogenic regulation of lipid metabolism in the rabbitโ€”A mechanism for theย cholesterolโ€“loweringย effect of acupuncture
  1715. Neuroprotection byย loweringย cholesterol
  1716. Neuroprotection byย loweringย cholesterol: a decrease in membraneย cholesterolย content reduces transporter-mediated glutamate release from brain nerve โ€ฆ
  1717. New Approaches toย cholesterolย lowering: Efficacy and Safety
  1718. Newย cholesterolโ€“loweringย margarines: Are they better?
  1719. New features of the nationalย cholesterolย education program adult treatment panel III lipidโ€loweringย guidelines
  1720. New Guidelines forย loweringย Bloodย cholesterol
  1721. New Insight into Metformin-Inducedย cholesterolย loweringย Effect: Cross-Talk Between Glucose andย cholesterolย Homeostasis via ChREBP-Mediated PCSK9 โ€ฆ
  1722. New insight into theย cholesterolโ€“loweringย effect of phytosterols in rat cardiomyocytes
  1723. New Insights into the Value ofย cholesterolย lowering
  1724. New LDL-cholesterolย loweringย therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes
  1725. New molecular targets forย cholesterolโ€“loweringย therapy
  1726. New targets and emerging therapies for reducing LDLย cholesterol
  1727. New therapies for reducing low-density lipoproteinย cholesterol
  1728. Newerย cholesterolโ€“loweringย agents: What you must know
  1729. Niacin reduces atherosclerosis development in APOE* 3Leiden. CETP mice mainly by reducing nonHDL-cholesterol
  1730. Niacin reduces atherosclerosis development in APOE* 3Leiden. CETP mice mainly by reducing nonHDL-cholesterol
  1731. NIH Consensus Development Conference onย loweringย bloodย cholesterolย to prevent heart disease: implications forย dietitians.
  1732. Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability duringย cholesterolย loweringย in rabbits
  1733. No additionalย cholesterolโ€“loweringย effect observed in the combined treatment of red yeast rice and Lactobacillus casei in hyperlipidemic patients: A double-blind โ€ฆ
  1734. No limit to the benefits of LDL-cholesterolย lowering
  1735. Nonโ€Highโ€Density Lipoproteinย cholesterol: An Alternate Target for Lipidโ€loweringย Therapy
  1736. Nonโ€“High-Density Lipoproteinย cholesterolย and Guidelines forย cholesterolย loweringย in Recent History
  1737. Noncholesterolย sterols andย cholesterolย loweringย by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol
  1738. Nonpharmacological approaches for reducing serum low-density lipoproteinย cholesterol
  1739. Nonpharmacologicalย cholesterolโ€“loweringย approach: Managingย cholesterolย naturally
  1740. Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasmaย cholesterolย loweringย โ€ฆ
  1741. Novel aspects of atherosclerosis: focusing on new target genes and the effect ofย cholesterolโ€“lowering
  1742. Novel method for reducing plasmaย cholesterol: a ligand replacement therapy
  1743. Novel therapeutic agents forย loweringย low density lipoproteinย cholesterol
  1744. Nutraceuticals andย cholesterolโ€“loweringย action
  1745. Nutraceuticals with lipid-loweringย activity: do they have any effect beyondย cholesterolย reduction?
  1746. Nutrient adequacy ofย diets of adults with hypercholesterolemia after aย cholesterolโ€“loweringย intervenion: Long-term assessment
  1747. Nutrient intake andย dietย quality in patients with systemic lupus erythematosus on a culturally sensitiveย cholesterolย loweringย dietary program.
  1748. Nutrition education research project example: An experimental design to test the effectiveness of two nutrition education protocols in reducing serumย cholesterol
  1749. Nutrition with pumpkin (Cucrbita pepo) cake asย loweringย cholesterolย in rats
  1750. Nutritional influences on illness: nutrients forย loweringย cholesterol
  1751. Nutritional value andย cholesterolโ€“loweringย effect of wild lettuce (Launaea taraxacifolia) leaf protein
  1752. Nutritive bambara groundnut powdered drink mix: characterization and in-vivo assessment of theย cholesterolโ€“loweringย effect
  1753. Oat bran as aย cholesterol-reducingย dietary adjunct in a young, healthy population
  1754. Oat ฮฒ-glucan: physico-chemical characteristics in relation to its blood-glucose andย cholesterolโ€“loweringย properties
  1755. Observations on theย cholesterolโ€“loweringย mechanism of nicotinic acid and nicotinyl alcohol tartrate
  1756. Omega-6 polyunsaturated fatty acids: Is a broadย cholesterolโ€“loweringย health claim appropriate?
  1757. One Year Impact of the 2013ย cholesterolย Guidelines on Patterns of Lipidย loweringย Treatment
  1758. Oneโ€yearย cholesterolย loweringย treatment reduces medial temporal lobe atrophy and memory decline in strokeโ€free elderly with atrial fibrillation: evidence from a โ€ฆ
  1759. OP81 Estimating the Potential of Population Level Changes inย cholesterolย and Blood Pressure for Reducing UK Coronary Heart Disease Mortality Rates: A Novel โ€ฆ
  1760. Optimal serumย cholesterolย and efficacy of methods forย loweringย cholesterolemia
  1761. Optimization of Conditions for Production of Lovastatin, Aย cholesterolย loweringย Agent, from a Novel Endophytic Producer Meyerozyma guilliermondii
  1762. Optimization of cryoprotectant of I4ย cholesterolโ€“loweringย plant Lactobacillus bacteria using response surface method
  1763. Optimization of Producing Enriched Yogurt With Phytosterols in Order To Reducingย cholesterolย Content
  1764. Optimization of producing enriched yogurt with phytosterols in order to reducingย cholesterolย content.
  1765. Osteopontin deficiency protects mice fromย cholesterolย gallstone formation by reducing expression of intestinal NPC1L1
  1766. Other therapies for reducing low-density lipoproteinย cholesterol: medications in development
  1767. Overview of 2013 American College of Cardiology/American Heart Associationย cholesterolย guideline for reducing cardiovascular risk
  1768. Overview of clinical trials ofย cholesterolย loweringย in relationship to epidemiologie studies
  1769. Overview of therapeutic approaches forย cholesterolย loweringย and attenuation of thrombosis for prevention of atherothrombosis
  1770. P02. 123. The anti-diabetic andย cholesterolโ€“loweringย effects of common and cassia cinnamon (Cinnamomum verum and C. aromaticum): a randomized controlled trial
  1771. P173Low LDL-cholesterolย goal attainment 4 months after ACS due to lack of adjustment in lipidย loweringย treatment: Results from DYSIS II
  1772. P5387 LDLย cholesterol, apolipoprotein B, lipoprotein (a), apolipoprotein CIII and triglycerideย loweringย by MGL-3196, a thyroid hormone beta selective agonist, in a 12 โ€ฆ
  1773. P642 What is the most important residual risk after achievement of appropriate low-density lipoproteinย cholesterolย loweringย therapy in secondary prevention of โ€ฆ
  1774. P698Highย cholesterolย dietย and angiotensin II induce spontaneous atherothrombotic occlusion of balloon-injured rabbit femoral arteries; effects of lipid-loweringย โ€ฆ
  1775. P828 Low-density lipoproteinย cholesterolย loweringย therapy and target level attainment after a recent myocardial infarction-nationwide cohort study
  1776. Para-aminosalicylate ์˜ ํ˜ˆ์••๋ฐ ํ˜ˆ์ฒญย cholesterolย ์ €ํ•˜์ž‘์šฉ (Original Articles: Blood Pressure and Serumย cholesterolย Reducing Activity of Para-aminosalicylate)
  1777. Particle size reduction effectively enhances theย cholesterolโ€“loweringย activities of carrot insoluble fiber and cellulose
  1778. Partners inย loweringย cholesterol: comparison of a multidisciplinary educational program, monetary incentives, or usual care in the treatment of dyslipidemia identified โ€ฆ
  1779. Pasta withย cholesterolโ€“loweringย effect on human health
  1780. Patient booklet onย loweringย LDLย cholesterolย levels.
  1781. PCSK9 &ย loweringย LDLย cholesterol
  1782. PCSK9 and atherosclerosis: Beyond LDL-cholesterolย lowering
  1783. PCSK9 genetic variants, life-longย loweringย of LDL-cholesterolย and cognition: a large-scale Mendelian randomization study
  1784. PCSK9 inhibition and LDLย cholesterolย lowering: the biology of an attractive therapeutic target and critical review of the latest clinical trials
  1785. PCSK9 inhibition: a new player inย cholesterolโ€“loweringย therapies?
  1786. PCSK9 inhibition: the dawn of a new age inย cholesterolย lowering?
  1787. PCSK9 inhibitors and their role in high-risk patients in reducing LDLย cholesterolย levels: alirocumab
  1788. PCSK9 inhibitors and their role in high-risk patients in reducing LDLย cholesterolย levels: evolocumab
  1789. PCSK9 inhibitors as LDLย cholesterolโ€“loweringย agents: Rationale, concerns and preliminary outcomes
  1790. PCSK9 Inhibitors forย loweringย cholesterol: Ready for Prime Time?
  1791. PCSK9 inhibitors: novel therapeutic strategies forย loweringย LDL-cholesterol
  1792. PCSK9-A New and Potent Approach toย loweringย cholesterol
  1793. PCSK9โ€”an exciting target for reducing LDL-cholesterolย levels
  1794. PCSK9, a novel target forย loweringย LDLย cholesterol: promise and progress
  1795. PCSK9: A Major New Advance inย cholesterolโ€“loweringย Therapy
  1796. PCV2: THE COST-EFFECTIVENESS OFย cholesterolย loweringย TREATMENT IN THE PRIMARY PREVENTION OF CORONARY HEART DISEASE: THE CASE โ€ฆ
  1797. PE-151:ย cholesterolโ€“loweringย Agents Decreased NAS Score without Intrahepatic Fat Improvement in Patients with Non-alcoholic Fatty Liver Disease: Systematic โ€ฆ
  1798. People with hyperlipidaemia who followed aย dietary portfolio ofย cholesterolโ€“loweringย foods achieved a greater reduction in LDLย cholesterolย over 6 months than those โ€ฆ
  1799. Per os colchicine administration inย cholesterolย fed rabbits: Triglyceridesย loweringย effects without affecting atherosclerosis progress
  1800. Per os colchicine administration inย cholesterolย fed rabbits: Triglyceridesย loweringย effects without affecting atherosclerosis progress
  1801. Persistent inflammatory residual risk despite aggressiveย cholesterolโ€“loweringย therapy: further evidence fuelling the dual target concept
  1802. Perspectives inย cholesterolโ€“loweringย therapy: the role of ezetimibe, a new selective inhibitor of intestinalย cholesterolย absorption
  1803. PERSPECTIVES IN LIPIDย loweringย THERAPY. NEW THERAPIES TARGETING LDLโ€“cholesterol
  1804. Perspectives on soy protein as a nonpharmacological approach forย loweringย cholesterol
  1805. Pharmacogenetics and pharmacogenomics ofย cholesterolโ€“loweringย therapy
  1806. Pharmacogenomics and pharmacogenetics ofย cholesterolโ€“loweringย therapy
  1807. Pharmacogenomics ofย cholesterolโ€“loweringย therapy
  1808. Pharmacokinetic/Pharmacodynamic Modelling to Describe theย cholesterolย loweringย Effect of Rosuvastatin in People Living with HIV
  1809. Pharmacokinetics, Safety andย cholesterolย loweringย in Healthy Volunteers Treated with Single and Multiple Doses of Madrigalโ€™s 3196 Liver-directed Thyroid Hormone โ€ฆ
  1810. Pharmacologic options for aggressive low-density lipoproteinย cholesterolย lowering: benefits versus risks
  1811. Pharmacologicalย cholesterolย loweringย reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
  1812. Pharmacological profile of tazasubrate, A newย cholesterolโ€“loweringย agent
  1813. Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyondย loweringย LDLย cholesterol
  1814. Phenome-wide association analysis of LDL-cholesterolย loweringย genetic variants in PCSK9
  1815. Phenome-wide association analysis of LDL-cholesterolย loweringย genetic variants in PCSK9
  1816. Phenome-wide association analysis of LDL-cholesterolย loweringย genetic variants in PCSK9
  1817. Physiological and Biochemical Characters of theย cholesterolโ€“loweringย Lactobacillus Plantarum LpT1 and LpT2
  1818. Phytochemical Analysis andย cholesterolย loweringย Efficiency of Averrhoa Carambola Linn (star Fruit).: An Overview
  1819. Phytochemical analysis of fruit extracts of Baccaurea courtallensis and evaluation ofย cholesterolย loweringย property
  1820. Phytochemical characterization of Averrhoa bilimbi and in vitro analysis ofย cholesterolย loweringย effect on fatty food materials
  1821. Phytochemical profiling of Garcinia gummi-gutta (Malabar tamarind) and in vitro analysis ofย cholesterolย loweringย effect
  1822. Phytosterol compositions of enriched products influence theirย cholesterolโ€“loweringย efficacy: a meta-analysis of randomized controlled trials
  1823. Phytosterols dissolved in diacylglycerol oil reinforce theย cholesterolโ€“loweringย effect of low-dose pravastatin treatment
  1824. Phytosterols: physiologic and metabolic aspects related toย cholesterolโ€“loweringย properties
  1825. Pilot study examining the effect ofย cholesterolย loweringย on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild โ€ฆ
  1826. Plant stanol content remains stable during storage ofย cholesterolโ€“loweringย functional foods
  1827. Plant Stanol Ester Margarine as a Serumย cholesterolย loweringย Agent in Healthy Children on aย dietย Low in Saturated Fat andย cholesterol. The STRIP Project
  1828. Plant Stanol Ester: Review ofย cholesterolโ€loweringย Efficacy and Implications for Coronary Heart Disease Risk Reduction
  1829. Plant sterol and stanolsโ€”comparison and contrasts. Sterols versus stanols inย cholesterolโ€“lowering: is there a difference?
  1830. Plant sterol-enriched spread enhances theย cholesterolโ€“loweringย potential of a fat-reducedย diet
  1831. Plant sterols and stanols asย cholesterolโ€“loweringย ingredients in functional foods
  1832. Plant sterols and stanols asย dietary factors reducing hypercholesterolemia by inhibiting intestinalย cholesterolย absorption
  1833. Plant sterols are efficacious inย loweringย plasma LDL and non-HDLย cholesterolย in hypercholesterolemic type 2 diabetic and nondiabetic persons
  1834. Plant sterols asย cholesterolโ€“loweringย agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance
  1835. Plant sterols: chemical and enzymatic structural modifications and effects on theirย cholesterolโ€“loweringย activity
  1836. Plant sterols/stanols asย cholesterolย loweringย agents: a meta-analysis of randomized controlled trials
  1837. Plaque rupture and thrombosis are reduced byย loweringย cholesterolย levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron โ€ฆ
  1838. Plaque stabilization by intensive LDL-cholesterolย loweringย therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery diseaseโ€”Serial โ€ฆ
  1839. Plasma and hepaticย cholesterolโ€“loweringย effects of tomato pomace, tomato seed oil and defatted tomato seed in hamsters fed with high-fatย diets
  1840. Plasma and Liverย cholesterolย loweringย Substances in Gyrophora Esculenta (Sogi) I. Effects of Gyrophora esculenta (Sogi) on the plasma and liverย cholesterolย in rats
  1841. Plasmaย cholesterolย and lipoproteinย loweringย effect of Anna Pavala Sindhooram
  1842. Plasmaย cholesterolย loweringย action of bile acid binding polymers in experimental animals
  1843. Plasmaย cholesterolย loweringย in an AngIIโ€‘infused atherosclerotic mouse model with moderate hypercholesterolemia
  1844. Plasmaย cholesterolย reducing effect of FR129169, a novel acyl-CoA:ย cholesterolย acyltransferase inhibitor, in the rat
  1845. Plasmaย cholesterolโ€“loweringย activity ofย dietary dihydrocholesterolย in hypercholesterolemia hamsters
  1846. Plasmaย cholesterolโ€“loweringย activity of gingerol-and shogaol-enriched extract is mediated by increasing sterol excretion
  1847. Plasmaย cholesterolโ€“loweringย activity of lard functionalized with mushroom extracts is independent of Niemannโ€“Pick C1-like 1 Protein and ABC sterol transporter โ€ฆ
  1848. Plasmaย cholesterolโ€“loweringย activity of monocyte colony-stimulating factor (M-CSF).
  1849. Plasmaย cholesterolโ€“loweringย activity of piperine is mediated by inhibition onย cholesterolย absorption via down-regulation of intestinal ACAT2 and MTP
  1850. Plasmaย cholesterolโ€“loweringย Activity of Soybean Germ Phytosterols
  1851. Plasmaย cholesterolโ€“loweringย and transient liver dysfunction in mice lacking squalene synthase in the liver
  1852. Plasmaย cholesterolโ€“loweringย effect on rats ofย dietary fiber extracted from immatureย plants
  1853. Plasmaย cholesterolโ€“loweringย Effects of Alpiniae katsumadaii Extract as an Inhibiter of Pancreaticย cholesterolย Esterase Activity
  1854. Plasmaย cholesterolโ€“loweringย Effects of Alpiniae katsumadaii Extract as an Inhibiter of Pancreaticย cholesterolย Esterase Activity
  1855. Plasmaย cholesterolโ€“loweringย effects of soymilk and okara treated by lactic acid fermentation in rats
  1856. Plasmaย cholesterolโ€“loweringย potential of edible-oil blends suitable for commercial use
  1857. Plasmaย cholesterol, lipidย lowering, and risk for cancer
  1858. Plasma LDLย cholesterolย loweringย by plant phytosterols in a hamster model
  1859. Plasma lipoprotein composition inย cholesterolย fed rabbits treated with pirinixil (BR 931), a new lipidย loweringย agent
  1860. Plasmenylethanolamine: growth factor forย cholesterol-reducing Eubacterium.
  1861. Platelet reactivity and arachidonic acid metabolism in type II hyperlipoproteinaemia and its modification byย cholesterolโ€“loweringย agents.
  1862. Pleiotropic effects andย cholesterolโ€“loweringย therapy
  1863. Policies for the prevention of coronary heart disease throughย cholesterolโ€“lowering
  1864. Pollen as aย cholesterolโ€“loweringย Agent
  1865. Polysorbates as novel lipid-modulating candidates for reducing serum totalย cholesterolย and low-density lipoprotein levels in hyperlipidemic C57BL/6J mice and rats
  1866. Polyunsaturated fatty acids result in greaterย cholesterolย loweringย and less triacylglycerol elevation than do monounsaturated fatty acids in a dose-response โ€ฆ
  1867. Postprandial reverseย cholesterolย transport in type 2 diabetic patients: effect of a lipidย loweringย treatment
  1868. Postscripts from the Post Coronary Artery Bypass Graft Trial: the sustained benefit of more aggressiveย cholesterolย loweringย and the enigma of low-dose โ€ฆ
  1869. Potencies of vitamin D analogs, 1ฮฑโ€hydroxyvitamin D3, 1ฮฑโ€hydroxyvitamin D2 and 25โ€hydroxyvitamin D3, inย loweringย cholesterolย in hypercholesterolemic mice in vivo
  1870. POTENCY OMEGA-9 OLEIC ACID IN THE AVOCADO FRUIT MESOCARPย cholesterolย loweringย BLOOD SERUM
  1871. Potentย cholesterolย loweringย Effect by HM12525A, A Novel Long-acting GLP-1/Glucagon Dual Receptor Agonist
  1872. Potentย cholesterolโ€“loweringย effect by human granulocyte-macrophage colony-stimulating factor in rabbits. Possible implications of enhancement of macrophage โ€ฆ
  1873. Potential effect on coronary-heart-disease morbidity ofย loweringย the blood-cholesterol
  1874. Potential effects of antioxidant and serumย cholesterolโ€“loweringย effects of Gynura bicolor water extracts in Syrian Hamster
  1875. Potential fat-loweringย and prebiotic effects of enzymatically treated okara in high-cholesterol-fed Wistar rats
  1876. Potential forย cholesterolย loweringย in secondary prevention of coronary heart disease in Europe: findings from EUROASPIRE study
  1877. Potential role of nonstatinย cholesterolย loweringย agents
  1878. Practical Possibilities forย loweringย Serumย cholesterol: Results of a Double-Blind Study
  1879. Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by itsย cholesterolโ€“loweringย โ€ฆ
  1880. Pravastatin hasย cholesterolโ€“loweringย independent effects on the artery wall of atherosclerotic monkeys
  1881. Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL)ย cholesterolโ€“loweringย effect and LDL receptor activity on skin fibroblasts
  1882. Pravastatin reduces thrombogenicity by mechanisms beyond plasmaย cholesterolย lowering
  1883. Pravastatin sodium activates endothelial nitric oxide synthase independent of itsย cholesterolโ€“loweringย actions
  1884. Pravastatin, a newย cholesterolย synthesis inhibitor forย loweringย increased serumย cholesterol
  1885. Pravastatin: an antithrombotic effect independent of theย cholesterolโ€“loweringย effect
  1886. Pre-freezing equilibration for 22 h improves post-thaw sperm functions in cryopreserved ram semen by reducingย cholesterolย efflux
  1887. Prediction of individualized lifetime benefit fromย cholesterolย lowering, blood pressureย lowering, antithrombotic therapy, and smoking cessation in apparently healthy โ€ฆ
  1888. Predictors ofย cholesterolย loweringย with Corn Oil Consumption: Results from a Pooled Analysis of Randomized, Free-living Feeding Trials (P08-112-19)
  1889. Preliminary evaluation of a non-dietary regimen for reducingย cholesterolย levels in the aged.
  1890. Preliminary probiotic and technological characterization of Pediococcus pentosaceus strain KID7 and in vivo assessment of itsย cholesterolโ€“loweringย activity
  1891. Preparation and characterization of immobilized phospholipase A2 on chitosan beads forย loweringย serumย cholesterolย concentration
  1892. Preparation of phytosteryl ornithine ester hydrochloride and improvement of its bioaccessibility andย cholesterol-reducing activity in vitro
  1893. Preparation technology of mixed starter cultures aboutย cholesterolโ€“loweringย effects
  1894. Prescription of lipid-loweringย medications for patients with type 2 diabetes mellitus and risk-associated LDLย cholesterol: a nationwide study of guideline โ€ฆ
  1895. Prevalence of cholelithiasis in men and women ingesting a serum-cholesterolโ€“loweringย diet.
  1896. Prevalence of depression in patients with coronary heart disease (CHD) onย cholesterolย loweringย therapy with pravastatin
  1897. Preventing breast cancer recurrence through reducingย dietary intake of oxidizedย cholesterol: An analytical tool.
  1898. Preventing cardiovascular disease in hypertension: effects ofย loweringย blood pressure andย cholesterol
  1899. Preventing coronary artery disease byย loweringย cholesterolย levels: fifty years from bench to bedside
  1900. Preventionย cholesterolย of Stroke byย loweringย Blood Concentrations
  1901. Prevention of atherosclerosis with low-density lipoproteinย cholesterolย loweringโ€”lipoprotein changes and interactions: the SANDS study
  1902. Prevention of myocardial infarction by reducing serumย cholesterolย levels. High-risk strategies should be limited
  1903. Prevention of stroke byย cholesterolโ€“lowering: a meta-analysis
  1904. Primary prevention and coronary heart disease: the economic benefits ofย loweringย serumย cholesterol.
  1905. Primary prevention of cardiovascular disease: The past, present, and future of blood pressure-andย cholesterolโ€“loweringย treatments
  1906. Primary prevention remains expensive, notwithstanding the consensus onย loweringย serumย cholesterolย levels
  1907. Primary prevention usingย cholesterolโ€“loweringย medications in patients meeting new treatment guidelines: a retrospective cohort analysis
  1908. Primary Prevention Usingย cholesterolโ€“loweringย Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis
  1909. Pro and con: low-density lipoproteinย cholesterolย loweringย is and will be the key to the future of lipid management
  1910. Probiotic Characterization ofย cholesterolโ€“loweringย Lactobacillus fermentum MJM60397
  1911. Probiotic consumption does not enhance theย cholesterolโ€“loweringย effect of soy in postmenopausal women
  1912. PROBIOTIC DEVELOPMENT OF ACID BACTERIA OF LUBRICATED POTENTIAL WASTE REDUCING CHICAGENย cholesterolย BEHAVIOR BROILER STRAIN โ€ฆ
  1913. Probiotics and the BSH-relatedย cholesterolย loweringย mechanism: a Jekyll and Hyde scenario
  1914. Probucol reduces plasma and aortic wall oxysterol levels inย cholesterolย fed rabbits independently of its plasmaย cholesterolย loweringย effect
  1915. Processing method modulates the effectiveness of black beans forย loweringย bloodย cholesterolย in spontaneously hypertensive rats
  1916. Processing of oat: The impact on oatโ€™sย cholesterolย loweringย effect
  1917. Producing of bacterial concentrates with highย cholesterolย loweringย activity
  1918. Production and quantification of eritadenine, aย cholesterolย reducing compound in shiitake (Lentinus edodes)
  1919. Production of apolipoprotein E-rich LDL by the liver. The effect ofย dietaryย cholesterolย and some lipidย loweringย agents.
  1920. Progress and prospects of biological approaches targeting PCSK9 forย cholesterolโ€“lowering, from molecular mechanism to clinical efficacy
  1921. Progress in the Effect of Lactic Acid Bacteria onย cholesterolโ€“loweringย and Its Mechanism [J]
  1922. Progress onย cholesterolโ€“loweringย effect and mechanism of lactic acid bacteria
  1923. Progress on the Mechanism of Lactic Acid Bacteria in Reducingย cholesterol
  1924. Progression of coronary artery calcium and risk of first myocardial infarction in patients receivingย cholesterolโ€“loweringย therapy
  1925. Progression of coronary artery disease predicts clinical coronary events: long-term follow-up from theย cholesterolย loweringย Atherosclerosis Study
  1926. Project ALBA-Creating a marketing strategy for aย cholesterolย loweringย dairy product
  1927. Properties andย cholesterolย loweringย effect ofย cholesterol-reduced milk supplemented with evening primrose oil
  1928. Properties of nanopowdered chitosan and itsย cholesterolย loweringย effect in rats
  1929. Property changes andย cholesterolโ€loweringย effects in evening primrose oilโ€enriched andย cholesterolโ€reduced yogurt
  1930. Proposed mechanisms ofย cholesterolโ€loweringย action of plant sterols
  1931. Proprotein convertase subtilisin/kexin type 9 inhibitor therapyโ€”breakthrough in low-density lipoproteinย cholesterolย lowering, breakdown in value
  1932. Prospective meta-analysis ofย cholesterolโ€“loweringย studies: the Prospective Pravastatin Pooling (PPP) Project and theย cholesterolย Treatment Trialists (CTT) โ€ฆ
  1933. Protective role of soybean lecithin in reducing hypercholesterolemia and DNA fragmentation inducing by highย cholesterolย in adult male rats
  1934. Proucol (DH 581) ์˜๊ณ ย cholesterolย ํ˜ˆ์ฆ์— ๋Œ€ํ•œ ์ž„์ƒ์  ํšจ๊ณผ (Effect of a newย cholesterolย Reducing Agent-Probucol (DH-581) in Korean Patents with โ€ฆ
  1935. Prudent Reducingย diet: Effect on Serumย cholesterol: Study of 111 Obese Men 50-59 Years Old
  1936. Psychological and cognitive function: predictors of adherence withย cholesterolย loweringย treatment
  1937. Psychological aspects of the measures forย loweringย theย cholesterolย level in a population study
  1938. Psychometric properties of the Perceived Therapeutic Efficacy Scale for adhering to aย cholesterolโ€“loweringย diet
  1939. Psyllium augments theย cholesterolโ€“loweringย action of cholestyramine in hamsters by enhancing sterol loss from the liver
  1940. Psyllium Feeding Increases the Rates of Hepatic and Intestinal Sterol Biosynthesis Whileย loweringย the Plasma and Hepaticย cholesterolย Levels in Rats
  1941. Psyllium is superior to wheat dextrin forย loweringย elevated serumย cholesterol
  1942. Purification and characterization of a novelย cholesterolโ€“loweringย protein from the seeds of Senna obtusifolia
  1943. Quantitative comparison of the efficacy of various compounds inย loweringย intracellularย cholesterolย levels in Niemann-Pick type C fibroblasts
  1944. Quercetin activates AMPโ€activated protein kinase by reducing PP2C expression protecting old mouse brain against highย cholesterolโ€induced neurotoxicity
  1945. R230C but notโˆ’ 565C/T variant of the ABCA1 gene is associated with type 2 diabetes in Mexicans through an effect onย loweringย HDL-cholesterolย levels
  1946. Raising HDL-cholesterolย andย loweringย CHD risk: does intervention work?
  1947. Raising high-density lipoproteinย cholesterolย andย loweringย low-density lipoproteinย cholesterolย as adjunctive therapy to coronary artery revascularization
  1948. Randomised placebo controlled trial of effect on mood ofย loweringย cholesterolย concentration
  1949. Randomised trial ofย cholesterolย loweringย in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  1950. Randomized trial of the effects ofย cholesterolโ€“loweringย dietary treatment on psychological function
  1951. Randomized trial of the effects ofย cholesterolโ€“loweringย with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with โ€ฆ
  1952. Rapid and substantialย loweringย of human serumย cholesterolย by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase
  1953. Rapid screening for potentialย cholesterolโ€“loweringย peptides using naturally derived micelle preparation
  1954. Ratio of lathosterol to campesterol in serum predicts theย cholesterolโ€“loweringย effect of sitostanol-supplemented margarine.
  1955. Rationale and design features of a clinical trial examining the effects ofย cholesterolย loweringย and angiotensin-converting enzyme inhibition on coronary atherosclerosis โ€ฆ
  1956. Rationale and design of a secondary prevention trial of increasing serum high-density lipoproteinย cholesterolย and reducing triglycerides in patients with clinically โ€ฆ
  1957. Rationale and design of the Myocardial Ischemia Reduction with Aggressiveย cholesterolย loweringย (MIRACL) study that evaluates atorvastatin in unstable angina โ€ฆ
  1958. Rationale forย cholesterolย lowering
  1959. Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventionalย cholesterolย loweringย and intima media thickness in โ€ฆ
  1960. Rationale, design, and baseline characteristics of a randomized trial to assess the effect ofย cholesterolย loweringย on the progression of aortic stenosis: the Aortic โ€ฆ
  1961. RE: Theย loweringย ofย cholesterolย due to the starch gelatinization of pectin, the solubleย dietary fiber found in garbanzo beans
  1962. Reasons for the lack of salutary effects ofย cholesterolโ€“loweringย interventions in end-stage renal disease populations
  1963. Recent perspectives on the role of nutraceuticals asย cholesterolโ€“loweringย agents
  1964. Reciprocal influence of fermentations and bile acid excretion onย cholesterolโ€“loweringย effect of fermentable carbohydrate
  1965. Reconstituted high-density lipoprotein attenuatesย cholesterolย crystalโ€“induced inflammatory responses by reducing complement activation
  1966. Recovery and determination ofย cholesterolโ€“loweringย compounds from Olea europaea seeds employing pressurized liquid extraction and gas chromatography-mass โ€ฆ
  1967. Recovery and determination ofย cholesterolโ€“loweringย compounds from Olea europaea seeds employing pressurized liquid extraction and gas chromatography-mass โ€ฆ
  1968. Red yeast riceโ€™as aย cholesterolโ€“loweringย substance? Caution is warranted
  1969. Reducing Badย cholesterolย with BAC
  1970. Reducing bloodย cholesterolย by a healthyย diet.
  1971. Reducing bloodย cholesterolย levels in children: what have we learned from the DISC study?
  1972. Reducing bloodย cholesterolย levels in patients with peripheral vascular disease:ย dietitian orย dietย fact sheet?
  1973. Reducing cardiovascular disease risk:ย cholesterolย andย diet
  1974. Reducing cardiovascular risk by targeting high-density lipoproteinย cholesterol
  1975. Reducing cardiovascular risk: trends in risk, risk assessment, andย cholesterolย management.
  1976. Reducingย cholesterolย and atherosclerosis
  1977. Reducingย cholesterolย and atherosclerosis: the importance of cellular adhesion molecules?
  1978. Reducingย cholesterolย and fat intake improves glucose tolerance by enhancing ฮฒ cell function in nondiabetic subjects
  1979. REDUCINGย cholesterolย AND OXIDATIVE DETERIORATION OF IRAQI BEEF PASTIRMA INOCULATED BY LACTIC ACID BACTERIA
  1980. Reducingย cholesterolย does not reduce mortality
  1981. Reducingย cholesterolย Intake: Are the recommendations valid?
  1982. Reducingย cholesterolย levels
  1983. Reducingย cholesterolย levels in elderly persons
  1984. Reducingย cholesterolย Levels in Elderly Persons
  1985. Reducingย cholesterolย Levels in Elderly Persons-Reply
  1986. Reducingย cholesterolย levels to decrease cardiovascular events: the role of new proprotein convertase subtilisin/kexin type 9 inhibitors
  1987. Reducingย cholesterolย to prevent coronary heart disease
  1988. Reducingย cholesterolย with plant stanol esters
  1989. Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy
  1990. Reducingย dietary fat andย cholesterolย consumption: an evaluation of a behaviorally focused nutrition education program
  1991. Reducingย dietary intake of fat andย cholesterolย in children
  1992. Reducingย dietary Intake of Fat andย cholesterolย in Children-Reply
  1993. Reducing eggย cholesterolย throughย dietary addition of ginger and garlic in quails
  1994. Reducing elevated plasma LDLย cholesterol: the central role of the LDL receptor
  1995. Reducing fat andย cholesterolย in foodservice
  1996. Reducing hepatic PKD activity lowers circulating VLDLย cholesterol
  1997. Reducing Hepatic Very-Low-Density Lipoprotein Production by Knockdown of Microsomal Triglyceride Transfer Protein Decreases Transintestinalย cholesterolย โ€ฆ
  1998. Reducing high bloodย cholesterolย in children
  1999. Reducing high bloodย cholesterolย levels: recommendations from the Nationalย cholesterolย Education Program
  2000. Reducing LDLย cholesterolย with exon-skipping antisense oligonucleotides
  2001. Reducing low density lipoprotein-cholesterolย levels by apheresis
  2002. Reducing low-density lipoproteinย cholesterolย levels in an ambulatory care system: results of a multidisciplinary collaborative practice lipid clinic compared with โ€ฆ
  2003. Reducing low-density lipoproteinย cholesterolโ€“treating to target and meeting new European goals
  2004. Reducing Lowโ€Density Lipoproteinย cholesterolย After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the โ€ฆ
  2005. Reducing residual cardiovascular risk: the relevance of raising high-density lipoproteinย cholesterolย in patients onย cholesterolโ€“loweringย treatment
  2006. Reducing risk by raising HDL-cholesterol: the evidence
  2007. Reducing serumย cholesterol
  2008. Reducing serumย cholesterolย levels in women
  2009. Reducing serumย cholesterol. Confusion remains over whom to treat.
  2010. Reducing serumย cholesterol. Lowerย cholesterolย of doubtful benefit to anyone.
  2011. Reducing shell eggย cholesterolย content. I. Overview, genetic approaches, and nutritional strategies
  2012. Reducing shell eggย cholesterolย content. II. Review of approaches utilizing non-nutritiveย dietary factors or pharmacological agents and an examination of emerging โ€ฆ
  2013. Reducing stroke in women with risk factor management: blood pressure andย cholesterol
  2014. Reducing the eggย cholesterolย level by including emulsified sitosterol in standard chickenย diet
  2015. Reducing the risk for stroke in patients with myocardial infarction: a Myocardial Ischemia Reduction with Aggressiveย cholesterolย loweringย (MIRACL) substudy
  2016. Reducing the serumย cholesterolย level with aย dietย high in animal fat.
  2017. Reducing Totalย dietary Fat Without Reducing Saturated Fat Does Not Significantly Lower Total Plasmaย cholesterolย Levels in Normal Males
  2018. Reducing totalย dietary fat without reducing saturated fatty acids does not significantly lower total plasmaย cholesterolย concentrations in normal males
  2019. Reduction of high density lipoproteinย cholesterolย and apolipoprotein AI concentrations by a lipid-loweringย diet
  2020. Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensiveย cholesterolย loweringย or ezetimibe antithrombotic effects โ€ฆ
  2021. Regional myocardial perfusion reserve duringย cholesterolย loweringย therapy compared with PTCA, assessed with PET
  2022. Regions of conformational flexibility in the proprotein convertase PCSK9 and design of antagonists for LDLย cholesterolย lowering
  2023. Regression of atherosclerosis in humans byย loweringย serumย cholesterol
  2024. Regression of atherosclerosis: the clinical and metabolic response toย cholesterolโ€“lowering
  2025. REGRESSION OF CORONARY ARTERY DISEASE ACHIEVED BYย loweringย LDL-cholesterolย LEVELS
  2026. Regulation of hepatic lanosterol 14ฮฑ-demethylase gene expression byย dietaryย cholesterolย andย cholesterolโ€“loweringย agents
  2027. Regulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents forย loweringย bloodย cholesterol
  2028. Relapsing acute pancreatitis induced by re-exposure to theย cholesterolย loweringย agent bezafibrate
  2029. Relationship between low-density lipoproteinย cholesterol, lipidย loweringย agents and the risk of stroke: a meta-analysis of observational studies and randomized โ€ฆ
  2030. Relationship Between Lowโ€Density Lipoproteinย cholesterolย and Lipoprotein (a)ย loweringย in Response to PCSK9 Inhibition With Evolocumab
  2031. Relationship between lowโ€density lipoproteinย cholesterol, free proprotein convertase subtilisin/kexin type 9, and alirocumab levels after different lipidโ€loweringย โ€ฆ
  2032. Relationship between plasmaย cholesterolโ€“loweringย effect of guar gum and its cecal fermentation products in rats
  2033. Relationship between theย cholesterolย ester transfer protein TaqIB polymorphism and the lipid-loweringย effect of atorvastatin in patients with coronary โ€ฆ
  2034. Relationship between total mortality andย cholesterolย reduction as found by meta-regression analysis of randomizedย cholesterolโ€“loweringย trials
  2035. Relationship of self-efficacy toย cholesterolย loweringย andย dietary change in hyperlipidemia,
  2036. Renal safety of intensiveย cholesterolโ€“loweringย treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the โ€ฆ
  2037. Reply to:โ€œAppropriate use ofย cholesterolโ€“loweringย therapyโ€
  2038. Research Advances on Nutritional Approaches for Reducingย cholesterolย Content in Eggs
  2039. Research advances with regards to clinical outcome and potential mechanisms of theย cholesterolโ€“loweringย effects of probiotics
  2040. RESEARCH AND DEVELOPMENT FINAL PROJECT BROSO MUFFIN (loweringย cholesterolย muffin from brown rice flour and soy milk)
  2041. Research on screening ofย cholesterol-reducing lactobacillus.
  2042. Research on screening ofย cholesterol-reducing probiotics from pickle vegetable
  2043. Research on the Effect ofย cholesterolย loweringย in Vitro of Alpinia officinarum Hance Crude Polysaccharide
  2044. Research Progress inย cholesterolโ€“loweringย Functional Bioactives and Mechanism
  2045. Research Progress inย cholesterol-reducing Effect of Plant Saponins and Their Mechanism [J]
  2046. Research progress in the mechanisms ofย loweringย cholesterolย of several common kinds of microorganisms
  2047. Resolvin E1 attenuates atherosclerosis in absence ofย cholesterolโ€“loweringย effects and on top of atorvastatin
  2048. Response by Bonaca and Sabatine to Letters Regarding Article,โ€œLow-Density Lipoproteinย cholesterolย loweringย With Evolocumab and Outcomes in Patients With โ€ฆ
  2049. Response to aย cholesterolโ€“loweringย diet: efficacy is greater in hypercholesterolemic subjects even after adjustment for regression to the mean
  2050. Response to aย cholesterolโ€“loweringย diet: Efficacy Is Greater in Hypercholesterolemic Subjects Even After Adjustment for Regression to the Mean
  2051. Response to Comments from Ntanios et al. Regarding โ€œTheย cholesterolโ€“loweringย Action of Plant Stanol Estersโ€
  2052. Restraint ofย cholesterolย accumulation in tissue pools associated with drastic short-termย loweringย of serumย cholesterolย levels by clofibrate or cholestyramine in โ€ฆ
  2053. Results of recent largeย cholesterolโ€“loweringย trials and implications for clinical management
  2054. Resveratrol protects againstย diet-induced atherosclerosis by reducing low-density lipoproteinย cholesterolย and inhibiting inflammation in apolipoprotein E โ€ฆ
  2055. Reversibility of atherosclerosisโ€“evolving perspectives from two arterial imaging clinical trials: theย cholesterolย loweringย atherosclerosis regression study and the โ€ฆ
  2056. Reversibility of renal injury withย cholesterolย loweringย in hyperlipidemic diabetic mice
  2057. Review ofย cholesterolโ€“loweringย therapy: coronary angiographic and events trials
  2058. Review of clinical studies onย cholesterolโ€“loweringย response to soy protein.
  2059. Review of the major intervention trials ofย loweringย coronary artery disease risk throughย cholesterolย reduction
  2060. REVIEW OF THE STUDIES OF SOY PROTEINS FOR REDUCING SERUMย cholesterol
  2061. Reviews: Fluvastatin: effects beyondย cholesterolย lowering
  2062. Revisiting the effectiveness of the Nationalย cholesterolย Education Programโ€™s Step I and Step IIย diets:ย cholesterolโ€“loweringย diets in a pharmaceutically driven world
  2063. RG 12561 (Dalvastatin): A novel synthetic inhibitor of HMG-CoA reductase andย cholesterolโ€“loweringย agent
  2064. Riboflavin Deficiency Altersย cholesterolย Homeostasis Partly by Reducing Apolipoprotein B100 Synthesis in HepG2 Cells
  2065. Ro 48-8.071, a new 2, 3-oxidosqualene: lanosterol cyclase inhibitorย loweringย plasmaย cholesterolย in hamsters, squirrel monkeys, and minipigs: comparison to โ€ฆ
  2066. Role and classification ofย cholesterolโ€“loweringย functional foods
  2067. Role of beef and beef tallow, an enriched source of stearic acid, in aย cholesterolโ€“loweringย diet
  2068. Role of Berberis lycium in reducing serumย cholesterolย in broilers
  2069. Role ofย cholesterolย 7ฮฑ-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics ofย cholesterolย lowering
  2070. Role ofย dietary Supplements inย loweringย LDL-cholesterol
  2071. Role ofย dietary supplements inย loweringย low-density lipoproteinย cholesterol: a review
  2072. Role of Lipid-loweringย Therapy in Low-Density Lipoproteinย cholesterolย Goal Attainment: Focus on Patients With Acute Coronary Syndrome
  2073. Role of nonstatin therapies for low-density lipoproteinย cholesterolย loweringย in management of atherosclerotic cardiovascular disease risk
  2074. Role of plant sterols inย cholesterolย lowering
  2075. Role of soy protein inย cholesterolโ€“lowering: How good is it?
  2076. Role of sweet orange (Citrus sinensis) waste inย loweringย the meatย cholesterolย and fat of Padjadjaran sheep
  2077. Role of the gut microbiota and their metabolites in modulating theย cholesterolโ€“loweringย effects of citrus pectin oligosaccharides in C57BL/6 mice
  2078. Rosuvastatin could modulate insulin signaling and inhibit atheroclerosis beyond its plasmaย cholesterolโ€“loweringย effect in insulin-resistant mice
  2079. Rosuvastatin increased serum osteocalcin levels independent of its serumย cholesterolโ€“loweringย effect in patients with type 2 diabetes and hypercholesterolemia
  2080. Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasmaย cholesterolโ€“loweringย effect in insulin-resistant mice
  2081. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasmaย cholesterolโ€“loweringย effect in APOE* 3-Leiden transgenic mice: evidence โ€ฆ
  2082. Rosuvastatin: Beyond theย cholesterolโ€“loweringย effect
  2083. RPR 101821, a new potentย cholesterolโ€“loweringย agent: inhibition of squalene synthase and 7-dehydrocholesterolย reductase
  2084. RPR 107393, a potent squalene synthase inhibitor and orally effectiveย cholesterolโ€“loweringย agent: comparison with inhibitors of HMG-CoA reductase
  2085. Safety and effectiveness of combined antihypertensive andย cholesterolโ€“loweringย therapy in high-/very high-risk patients
  2086. Safety and effectiveness of probucol as aย cholesterolย loweringย agent.
  2087. Safety and efficacy of early aggressive versusย cholesterol-driven lipid-loweringย strategies in heart transplantation: a pilot, randomized, intravascular ultrasound study
  2088. Safety and efficacy of long-termย dietย andย dietย plus bile acid-binding resinย cholesterolโ€“loweringย therapy in 73 children heterozygous for familial hypercholesterolemia
  2089. Safety and tolerability ofย cholesterolย loweringย with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
  2090. Safety aspects andย cholesterolโ€“loweringย efficacy of chitosan tablets
  2091. Safety aspects andย cholesterolโ€“loweringย efficacy of low fat dairy products containing plant sterols
  2092. Scandinavian simvastatin survival study (4S): Cost-effectiveness (CE) ofย cholesterolย loweringย treatment
  2093. Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters andย loweringย blood LDLโ€cholesterolย and reduced risk of โ€ฆ
  2094. Scientific opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols andย loweringย blood LDLโ€cholesterolย and reduced risk of (coronary) โ€ฆ
  2095. Scientific Opinion on the substantiation of a health claim related to barley betaโ€glucans andย loweringย of bloodย cholesterolย and reduced risk of (coronary) heart disease โ€ฆ
  2096. Scientific Opinion on the substantiation of a health claim related to oat beta glucan andย loweringย bloodย cholesterolย and reduced risk of (coronary) heart disease โ€ฆ
  2097. Screening and Identification of a Strain of Lactobacillus withย cholesterol-reducing Ability and Its Application in Pickles
  2098. Screening and identification ofย cholesterolโ€“loweringย lactic acid bacteria from Dong minority traditional fermented sour fish and meat
  2099. Screening and identification ofย cholesterol-reducing KF5 strain
  2100. Screening and identification ofย cholesterol-reducing Lactic acid bacteria.
  2101. Screening and molecular characterization ofย cholesterolโ€“loweringย lactic acid bacteria isolated from African oil palm wine (Elaeis guineensis) and corn beer.
  2102. Screening forย cholesterolโ€“loweringย probiotic based on deoxycholic acid removal pathway and studying its functional mechanisms in vitro
  2103. Screening forย cholesterolโ€“loweringย probiotics from lactic acid bacteria isolated from corn silage based on three hypothesized pathways
  2104. Screening of bile salt hydrolase-active lactic acid bacteria for potentialย cholesterolโ€“loweringย probiotic use
  2105. Screening of Bile Salt Hydrolase-active Lactic Acid Bacteria from Philippine Cocowater Kefir as Potentialย cholesterolโ€“loweringย Probiotics
  2106. Screening ofย cholesterolโ€“loweringย Bifidobacterium from Guizhou Xiang pigs, and evaluation of its tolerance to oxygen, acid, and bile
  2107. Screening ofย cholesterolโ€“loweringย Lactic Acid Bacteria and Synergic Effect with Chinese Herbal Medicines
  2108. Screening ofย cholesterol-reducing bifidobacterium in vitro [J]
  2109. Screening ofย cholesterol-reducing lactic acid bacteria and its activity inย cholesterol-reducing
  2110. Screening ofย cholesterol-reducing lactobacillus in vitro [J]
  2111. Screening of indigenous lactic acid bacteria forย cholesterolย loweringย and additional probiotic attributes
  2112. Screening of isolated potential probiotic lactic acid bacteria forย cholesterolย loweringย property and bile salt hydrolase activity
  2113. Screening of lactic acid bacteria withย cholesterolโ€“loweringย and triglyceride-loweringย activity in vitro and evaluation of probiotic function
  2114. Screening of Lactobacillus withย cholesterolโ€“loweringย Activity and Its Application in Inner Mongolian Fermented Sausages
  2115. Secondary Prevention Usingย cholesterolโ€“loweringย Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis
  2116. Secondary prevention with lipidย loweringย therapy in familial hypercholesterolemia: a correlation between new evolution of stenotic lesion and achievedย cholesterolย โ€ฆ
  2117. Selecting and Identificationย cholesterolโ€“loweringย Ability and Acid Bile Tolerance of Lactic Acid Bacteria
  2118. Selection and physico-chemical characteristics of lactic acid bacteria which hadย cholesterolย loweringย activities
  2119. Selection ofย cholesterolโ€“loweringย lactic acid bacteria and its effects on rats fed with high-cholesterolย diet
  2120. Selection of potential probiotic lactobacilli forย cholesterolโ€“loweringย properties and their effect onย cholesterolย metabolism in rats fed a high-lipidย diet
  2121. Selectiveย cholesterolย absorption inhibition: a novel strategy in lipid-loweringย management.
  2122. Selectiveย cholesterolย loweringย gene transfer attenuates the development of pressure overload-induced cardiomyopathy in mice
  2123. Selective inhibition of mammalian lanosterol 14. alpha.-demethylase: a possible strategy forย cholesterolย lowering
  2124. Selenium nanoparticles alleviate hyperlipidemia and vascular injury in ApoE-deficient mice by regulatingย cholesterolย metabolism and reducing oxidative stress
  2125. Separation of high-class alkanols and high-class eicosanoic acids in sugar cane wax and activity of reducing bloodย cholesterol
  2126. Separation of immunomodulatory andย cholesterolโ€“loweringย activities of heterocyclic azaspiranes.
  2127. Separation, Identification and Functional Analysis ofย cholesterolโ€“loweringย and Triglycerid-loweringย Lactic Acid Bacteria
  2128. Sequence variation in NPC1L1 and association with improved LDL-cholesterolย loweringย in response to ezetimibe treatment
  2129. Serumย cholesterolย loweringย effect of triterpene acetate obtained from Lactuca indica
  2130. Serumย cholesterolย loweringย effects and triterpenoids of the herbs of Lactuca indica
  2131. Serumย cholesterolโ€“loweringย Activity of ฮฒ-Sitosterol Laurate Is Attributed to the Reduction of Bothย cholesterolย Absorption and Bile Acids Reabsorption in Hamsters
  2132. Serumย cholesterolโ€“loweringย effect of apple polyphenols in healthy subjects
  2133. Serumย cholesterolโ€“loweringย Effect of Fermented Milk and Effect of Intestinal Microflora Composition on Function of Fermented Milk
  2134. Serumย cholesterolโ€”loweringย Activity of Granulocyte-Macrophage Colony-Stimulating Factor
  2135. Serum lipoproteins of healthy persons fed a low-fatย dietย or a polyunsaturated fatย dietย for three months: a comparison of twoย cholesterolโ€“loweringย diets
  2136. Serum retinol levels throughout 2 years ofย cholesterolโ€“loweringย therapy
  2137. Serum-cholesterolโ€“loweringย effect of metronidazole and possible mechanisms of action
  2138. Shear stress activates mitochondrial oxidative phosphorylation by reducing plasma membraneย cholesterolย in vascular endothelial cells
  2139. Sheffield risk and treatment table forย cholesterolย loweringย for primary prevention of coronary heart disease
  2140. Sheffield Risk and Treatment Table forย cholesterolย loweringย for Primary Prevention of Coronary Heart Disease
  2141. Short term study of sucrose polyester a nonabsorbable fat-like material as aย dietary agent forย loweringย plasmaย cholesterol
  2142. Short-termย cholesterolย loweringย decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary โ€ฆ
  2143. Short-term effect of twoย cholesterolโ€“loweringย diets on sterol excretion in ileostomy patients
  2144. Short-term LDLย cholesterolโ€“loweringย efficacy of plant stanol esters
  2145. Short-term treatment with a 2-carba analog of cyclic phosphatidic acid inducesย loweringย of plasmaย cholesterolย levels in ApoE-deficient mice
  2146. Shouldย cholesterolโ€“loweringย medications be available in Canada without a prescription?
  2147. Should intensiveย cholesterolย loweringย play a role in the management of acute coronary syndromes?
  2148. Should we target HDLย cholesterolย level inย loweringย cardiovascular risk
  2149. Sibu olive inhibits artherosclerosis byย cholesterolย loweringย effect inย cholesterolย fed-rabbit
  2150. Signal transduction via glycosyl phosphatidylinositol-anchored proteins in T cells is inhibited byย loweringย cellularย cholesterol
  2151. Silicon Alleviates Nonalcoholic Steatohepatitis by Reducing Apoptosis in Aged Wistar Rats Fed a Highโ€“Saturated Fat, High-cholesterolย diet
  2152. Similarย cholesterolโ€“loweringย properties of rice bran oil, with varied ฮณโ€“oryzanol, in mildly hypercholesterolemic men
  2153. Simultaneousย loweringย of serum phosphate and LDL-cholesterolย by sevelamer hydrochloride (RenaGel) in dialysis patients.
  2154. Simultaneous treatment of blood pressure andย cholesterolย beats theโ€™SILOโ€™approach inย loweringย cardiovascular risk: results of the CRUCIAL study: opinions in โ€ฆ
  2155. Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent ofย cholesterolโ€“loweringย effects.
  2156. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasmaย cholesterolย lowering
  2157. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent ofย cholesterolย lowering
  2158. Simvastatin reduces endotoxin-induced nuclear factor ฮบB activation and mortality in guinea pigs despiteย loweringย circulating low-density lipoproteinย cholesterol
  2159. Simvastatin reduces human atrial myofibroblast proliferation independently ofย cholesterolย loweringย via inhibition of RhoA
  2160. Simvastatin was cost-effective inย loweringย cholesterolย i coronary heart disease
  2161. Simvastatin, Pravastatin and Lovasting: Three Options forย loweringย cholesterol
  2162. SLCO1B1 polymorphisms affect atorvastatin pharmacokinetics andย cholesterolโ€“loweringย effects in patients with hypercholesterolemia in a microdosing โ€ฆ
  2163. Small interfering RNA to proprotein convertase subtilisin/kexin type 9: transforming LDL-cholesterolโ€“loweringย strategies
  2164. Solubilization of phytosterols in diacylglycerol versus triacylglycerol improves the serumย cholesterolโ€“loweringย effect
  2165. Soluble fibre oat and barley รŸ-glucan enriched products: can we predictย cholesterolโ€“loweringย effects?
  2166. Some aspects of sensitivity and resistance to theย cholesterolย loweringย effect of clofibrate
  2167. Sorghum extract exertsย cholesterolโ€“loweringย effects through the regulation of hepaticย cholesterolย metabolism in hypercholesterolemic mice
  2168. Soy and cardiovascular disease:ย cholesterolย loweringย and beyond
  2169. Soy protein enhances theย cholesterolโ€“loweringย effect of plant sterol esters inย cholesterol-fed hamsters
  2170. Speaking of risk, managing uncertainty: decision-making aboutย cholesterol-reducing treatment in general practice.
  2171. Species specificity in the bloodย cholesterolโ€loweringย effect of YMโ€16638
  2172. Spirulina Improves Antioxidant Status by Reducing Oxidative Stress in Rabbits Fed a High-cholesterolย diet
  2173. Spirulina prevents atherosclerosis by reducing hypercholesterolemia in rabbits fed a high-cholesterolย diet
  2174. Spreads enriched with three different levels of vegetable oil sterols and the degree ofย cholesterolย loweringย in normocholesterolaemic and mildly โ€ฆ
  2175. Stage-specific remodeling of atherosclerotic lesions uponย cholesterolย loweringย in LDL receptor knockout mice
  2176. Stanol esters as aย dietary adjunct toย cholesterolโ€“loweringย therapies
  2177. Status analysis of certified auxiliaryย cholesterolโ€“loweringย health foods in China [J]
  2178. Steroid Hormones andย cholesterolย Metabolism The Mechanism of Serumย cholesterolโ€“loweringย Action of an Anabolic Steroid (HMD)
  2179. Strategies forย cholesterolย loweringย at the worksite
  2180. Structure and action of saikosaponins isolated from Bupleurum falcatum L. II. Metabolic actions of saikosaponins, especially a plasmaย cholesterolโ€“loweringย action.
  2181. Structureโ€“activity studies of protease activating, lipase inhibiting, bile acid binding andย cholesterolโ€“loweringย effects of pre-screened cumin seed bioactive peptides
  2182. Studies on aย cholesterolโ€“loweringย Microcrystalline Phytosterol Suspension in Oil
  2183. Studies onย cholesterolโ€“loweringย Effect and Mechanism of Aerobic Exercise Combined with Oat ฮฒ-glucan on High-Fatย dietย Hamsters
  2184. Studies on screening forย cholesterolโ€“loweringย agents using phenyl-and chromane substituted compounds (authorโ€™s transl)
  2185. Studies on the action mechanism forย cholesterolโ€“loweringย of Lactobacillus which yields bile salt hydrolase from kefir grains
  2186. Studies on the Identification and Antagonistic Properties in the Imitative Gastroenteric Environment in aย cholesterolย Reducing Lactic Acid Bacteria
  2187. Studies on the mechanism ofย loweringย of theย cholesterolย level by ethyl-alpha-p-chlorophenoxy-isobutyrate (clofibrate)(authorโ€™s transl)
  2188. Studies on the plasmaย cholesterolโ€“loweringย component in Coix
  2189. Studies on the reducingย cholesterolย ability of selected probiotic strains in vitro
  2190. Studies on the resistance ofย cholesterolโ€“loweringย of lactic acid bacteria to simulated gastrointestinal circumstance in vitro
  2191. Studies on the Substances Contained in Gyrophora Esculentaย loweringย Plasma and Liverย cholesterolย Levels (Part II)
  2192. Study bolsters case againstย cholesterol; a new study shows that aggressiveย cholesterolโ€“loweringย therapy can halt the growth of lesions and in some cases shrink them
  2193. Study of Chinese Herbal Medicine Additive on Reducingย cholesterolย and Serum Enzyme of Ecotype Rabbits
  2194. Study ofย cholesterolโ€“loweringย effect and safety of simvaglisin on rabbit model of hypercholesterolemia
  2195. Study of Five Alkaloids from Rhizoma Coptidis onย loweringโ€“cholesterol
  2196. Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects ofย loweringย low-density lipoproteinย cholesterolย among 9,438 patients with chronic โ€ฆ
  2197. Study of lipid profile in obese individuals and the effect ofย cholesterolย loweringย agents on them
  2198. Study on Characteristic of Reducingย cholesterolย in Vitro by Lactococcus lactis Isolated from Sauerkraut Juice [J]
  2199. Study on characteristics of growth, screening and identification ofย cholesterol-reducing Lactic acid bacteria
  2200. Study onย cholesterolย loweringย compounds in red yeast rice prepared from thai glutinous rice
  2201. Study onย cholesterolโ€“loweringย and Antioxidative Function of Lactobacillus buchneri PG-7
  2202. Study onย cholesterolโ€“loweringย effect of bile salt hydrolase-active Lactobacillus plantarum
  2203. Study onย cholesterolโ€“loweringย mechanism of Lactobacillus acidophilus by adsorbing and assimilatingย cholesterol
  2204. Study on processing ofย cholesterol-reducing fermented coagulated whole egg beverage [J]
  2205. Study on Reducingย cholesterolย Content in Egg Yolk [J]
  2206. Study on Rosa juice anti-fatigue andย cholesterolย reducing in vitro [J]
  2207. Study on screening and identification ofย cholesterol-reducing lactic acid bacteria and its synergistic effect with traditional Chinese medicine
  2208. Study on theย cholesterol-reducing activity of lactic acid bacteria from giant panda
  2209. Study on theย cholesterol-reducing activity of Lactobacillus casei 21008 in vitro
  2210. Study on theย cholesterol-reducing activity of Lactobacillus casei 21008 in vitro
  2211. Study on theย cholesterol-reducing effects of complex bacteria leaven from kefir grain milk yoghurt in rats.
  2212. Study on the microencapsulation ofย cholesterol-reducing lactobacillus.
  2213. Study on tolerance characteristics of the gastrointestinal tract andย cholesterolโ€“loweringย effects of Lactobacillus plantarum Zhang-LL
  2214. Study the Effect of Some Natural Substances onย loweringย Bloodย cholesterolย in Rats
  2215. Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensiveย cholesterolย loweringย treatment
  2216. Substituting non-HDLย cholesterolย with LDL as a guide for lipid-loweringย therapy increases the number of patients with indication for therapy
  2217. Substrainโ€specificย cholesterolโ€loweringย effects of oats in mice:โ€Clues for mechanism of action?
  2218. Summary of Health Canadaโ€™s Assessment of a Health Claim about Soy Protein andย cholesterolย lowering
  2219. Superactivated Charcoal Versus Cholestyramine forย cholesterolย lowering: A Randomized Crossโ€Over Trial
  2220. Superiority ofย dietary safflower oil over olive oil inย loweringย serumย cholesterolย and increasing hepatic mRNAs for the LDL receptor andย cholesterolย 7ฮฑ-hydroxylase in โ€ฆ
  2221. Superiority of partial ileal bypass over cholestyramine in reducingย cholesterolย in familial hypercholesterolaemia
  2222. Supplementation of hydroxypropyl methylcellulose into yeast leavened all-whole grain barley bread potentiatesย cholesterolโ€“loweringย effect
  2223. Surface tensionย loweringย and dissolution rate of hydrocortisone from solid solutions of selected nโ€acyl esters ofย cholesterol
  2224. Surfactant Protein A Restores The Surface Tension Reducing Capability Of Human Pulmonary Surfactant With Elevated Levels Ofย cholesterol
  2225. Survival of probiotic strains in non-dairy indian spice condiment exhibitingย cholesterolย reducing properties
  2226. Sustained low-density lipoproteinย cholesterolย loweringย with alirocumab in ODYSSEY OUTCOMES
  2227. Switching from High-Efficacy Lipid-loweringย Therapies [Atorvastatin or Rosuvastatin] to Simvastatin and the Results on Low-Density Lipoproteinย cholesterolย โ€ฆ
  2228. Switching from high-efficacy lipid-loweringย therapies to simvastatin and low-density lipoproteinย cholesterolย goal attainment in coronary heart disease/coronary heart โ€ฆ
  2229. Synergeticย cholesterolโ€“loweringย effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters
  2230. Synthesis andย cholesterolย loweringย abilities of novel prebiotic galacto oligosaccharides produced using lactobacilli reverse enzyme synthesis
  2231. Synthesis andย cholesterol-reducing potential of water-soluble phytosterol derivative
  2232. Synthesis and Evaluation of 2โ€Azetidinone and 1Hโ€Pyrroleโ€2,5โ€dione Derivatives asย cholesterolย Absorption Inhibitors for Reducing Inflammation Response and โ€ฆ
  2233. Synthesis and serumย cholesterolโ€“loweringย and uterotropic effects of 15, 16, 17-trisubstituted oestratriene 3-methyl ethers. Part 63: On steroids (authorโ€™s transl)
  2234. Synthesis ofย cholesterol-reducing sterol esters by enzymatic catalysis in bio-based solvents or solvent-free
  2235. Synthesis of multi-lactose-appended ฮฒ-cyclodextrin and itsย cholesterolโ€“loweringย effects in Niemannโ€“Pick type C disease-like HepG2 cells
  2236. Systematic review of green tea epigallocatechin gallate in reducing low-density lipoproteinย cholesterolย levels of humans
  2237. Systematic review on the risk and benefit of differentย cholesterolโ€“loweringย interventions
  2238. Systematic study of the effects ofย loweringย low-density lipoprotein-cholesterolย on regression of coronary atherosclerotic plaques using intravascular ultrasound
  2239. Systolic and pulse blood pressures (but not diastolic blood pressure and serumย cholesterol) are associated with alterations in carotid intimaโ€“media thickness in the โ€ฆ
  2240. Targeted isolation and identification of bioactive compoundsย loweringย cholesterolย in the crude extracts of crabapples using UPLC-DAD-MS-SPE/NMR based on โ€ฆ
  2241. Targeting PCSK9 as a promising new mechanism forย loweringย low-density lipoproteinย cholesterol
  2242. Taxonomic description and genome sequence of Christensenella intestinihominis sp. nov., a novelย cholesterolโ€“loweringย bacterium isolated from human gut
  2243. Ten-year follow-up of familial hypercholesterolemia patients after intensiveย cholesterolโ€“loweringย therapy
  2244. Test on Emerita analoga asย cholesterolย Reducing Agent on Mus musculus BALB/C
  2245. Testing the Relationship betweenย cholesterolย loweringย and Cardiovascular Diseaseโ€”Past, Present, and Prospects
  2246. Th-P16: 306 Fenofibrate increases HDL-cholesterolย by reducing the expression of the cholesteryl ester transfer protein
  2247. The adult patient with a congenital GH deficiency.ย cholesterolโ€“loweringย effects of therapy with biosynthetic GH
  2248. The awareness of the risk of elevatedย cholesterolย levels and knowledge aboutย cholesterolโ€loweringย action in Australia
  2249. The benefit of cinnamon (Cinnamomum burmannii) inย loweringย totalย cholesterolย levels after consumption of high-fat containing foods in white mice (Mus โ€ฆ
  2250. The benefits ofย loweringย cholesterolย in subjects with mild hyperglycemia
  2251. The benefits ofย loweringโ€ averageโ€ย cholesterol
  2252. The benefits of reducingย cholesterolย levels: the need to distinguish primary from secondary prevention 2. Implications for heart disease prevention in Australia
  2253. The benefits of reducingย cholesterolย levels: the need to distinguish primary from secondary prevention: 1. A metaโ€analysis ofย cholesterolโ€loweringย trials
  2254. The challenge ofย loweringย bloodย cholesterolย levels
  2255. Theย cholesterolย derivative of a triantennary galactoside with high affinity for the hepatic asialoglycoprotein receptor: a potentย cholesterolย loweringย agent
  2256. Theย cholesterolย loweringย Atherosclerosis Study (CLAS)
  2257. Theย cholesterolย loweringย Atherosclerosis Study (CLAS): design, methods, and baseline results
  2258. Theย cholesterolย loweringย effect of steroid sequestrants is modulated by large intestine fermentations
  2259. Theย cholesterolย loweringย Effects of Eurycoma longifolia Jack (Tongkat Ali) Root Extract in Male Rats
  2260. Theย cholesterolย loweringย Effects of Strawberry: A Randomized Controlled Trial Establishing Strawberryโ€™s Role in Cardiovascular Health
  2261. Theย cholesterolย loweringย efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial
  2262. Theย cholesterolย loweringย properties of the complex compound simvastatin with glycyrrhizic acid (simvaglyzin) in experimental models
  2263. Theย cholesterolย loweringย property of coriander seeds (Coriandrum sativum): mechanism of action
  2264. Theย cholesterolโ€“loweringย action of plant stanol esters
  2265. Theย cholesterolโ€“loweringย agent methyl-ฮฒ-cyclodextrin promotes glucose uptake via GLUT4 in adult muscle fibers and reduces insulin resistance in obese mice
  2266. Theย cholesterolโ€“loweringย agent methyl-ฮฒ-cyclodextrin promotes glucose uptake via GLUT4 in adult muscle fibers and reduces insulin resistance in obese mice
  2267. Theย cholesterolโ€“loweringย effect of alisol acetates based on HMG-CoA reductase and its molecular mechanism
  2268. Theย cholesterolโ€“loweringย effect of black beans (Phaseolus vulgaris, L.) without hulls in hypercholesterolemic rats
  2269. Theย cholesterolโ€“loweringย effect of black, carioquinha and red beans (Phaseolus vulgaris, L.) in hypercholesterolemic rats
  2270. Theย cholesterolโ€“loweringย Effect of Capsella Bursa-Pastoris Is Mediated via SREBP2 and HNF-1ฮฑ-Regulated PCSK9 Inhibition in Obese Mice and HepG2 Cells
  2271. Theย cholesterolโ€“loweringย effect of coconut flakes in humans with moderately raised serumย cholesterol
  2272. Theย cholesterolโ€“loweringย effect of commercialย dietย fed to germfree and conventional rats
  2273. Theย cholesterolโ€“loweringย effect of dextran-40
  2274. Theย cholesterolโ€“loweringย effect of guar gum in rats is not accompanied by an interruption of bile acid cycling
  2275. Theย cholesterolโ€“loweringย effect of indigestible proteins isolated from pulses
  2276. Theย cholesterolโ€“loweringย effect of oat bran cereals in rats: Influence of processing
  2277. Theย cholesterolโ€“loweringย effect of oats and oat beta glucan: Modes of action and potential role of bile acids and the microbiome
  2278. Theย cholesterolโ€“loweringย effect of plant sterol-containing beverage in hypercholesterolemic subjects with lowย cholesterolย intake
  2279. Theย cholesterolโ€“loweringย effect of the unicellular green alga Scenedesmus acutus 276-3a. I. Effect of drum-dried algal material
  2280. Theย cholesterolโ€“loweringย effect of the unicellular green alga Scenedesmus acutus 276-3a. II. Effect of alga fractions
  2281. Theย cholesterolโ€“loweringย effect of unripe Rubus coreanus is associated with decreased oxidized LDL and apolipoprotein B levels in subjects with borderline โ€ฆ
  2282. Theย cholesterolโ€“loweringย Effects of Legumes Ii: Effects of Fibre, Sterols, Saponins and Isolavones
  2283. Theย cholesterolโ€“loweringย effects of legumes. I: Effects of the major nutrients
  2284. Theย cholesterolโ€“loweringย effects of oat varieties based on their difference in the composition of proteins and lipids
  2285. Theย cholesterolโ€“loweringย potential of whole grains
  2286. Theย cholesterolโ€“loweringย properties of a psyllium-based breakfast cereal in hamsters.
  2287. Theย cholesterolโ€loweringย activity of miracle fruit (Synsepalum dulcificum)
  2288. Theย cholesterolโ€loweringย effect of a breakfast cereal containing psyllium fibre
  2289. Theย cholesterolโ€loweringย effect of guar gum is not the result of a simple diversion of bile acids toward fecal excretion
  2290. The cost-effectiveness ofย cholesterolโ€“loweringย therapy with simvastatin in the primary prevention of coronary heart disease in the Netherlands
  2291. The cost-effectiveness of intensive low-density lipoproteinย cholesterolย loweringย in people with peripheral artery disease
  2292. The costโ€effectiveness of different bloodโ€cholesterolโ€loweringย strategies in the prevention of coronary heart disease
  2293. The development of quantitative nutritional guidelines for a central kitchen: a tool for classifying menu items into diabetic,ย cholesterolโ€“loweringย and weight reduction โ€ฆ
  2294. The Development of Yogurt withย cholesterolโ€“loweringย Effects
  2295. The effect of aย dietary supplement spirulina and bifidobacterium adolescentis on theย cholesterolโ€“loweringย in vitro and in vivo
  2296. The Effect of Age onย cholesterolโ€“loweringย Therapy
  2297. The effect of aggressive and moderateย loweringย of LDL-cholesterolย and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post โ€ฆ
  2298. The effect of aggressiveย loweringย of low-density lipoproteinย cholesterolย levels and low-dose anticoagulation on obstructive changes in saphenous-vein โ€ฆ
  2299. The effect of amaranth flour on plasmaย cholesterolย levels: Another option for cardiovascular riskย lowering?
  2300. The effect ofย cholesterolย loweringย on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia
  2301. The effect ofย cholesterolย loweringย therapy on endothelium-dependent vasodilation in hypercholesterolemia
  2302. The effect ofย cholesterolโ€“loweringย and antioxidant therapy on endothelium-dependent coronary vasomotion
  2303. The effect ofย cholesterolโ€“loweringย treatment on renal function
  2304. The effect ofย cholesterolโ€loweringย agents on hepatic and plasmaย cholesterolย in Niemannโ€Pick disease type C
  2305. The Effect of Evening Primrose Oil on Chemical and Bloodย cholesterolย loweringย Properties of Cheddar Cheese Seoul 139-742, Korea.
  2306. THE EFFECT OF IRANIAN NATIVE FERMENTED MILK AS A PROBIOTIC ONย cholesterolย loweringย IN MALE WISTAR RAT MODEL UNDER STRESS
  2307. THE EFFECT OF IRANIAN NATIVE FERMENTED MILKAS A PROBIOTICONย cholesterolย loweringย INMALE WISTARRATMODEL
  2308. The effect of life and dead cell and cell free extract for same lactic acid bacteria in reducingย cholesterolย and microbial load for buffalo fatty tissue
  2309. The effect of lifestyle physical activity in reducing cardiovascular disease risk factors (blood pressure andย cholesterol) in women: A systematic review
  2310. The effect ofย loweringย cholesterolย on mortality
  2311. The effect ofย loweringย LDLย cholesterolย on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection
  2312. The Effect of Olive Oil Addition into Oatmeal inย loweringย Total Bloodย cholesterolย and LDL (Low Density Lipoprotein) in Wistar Rat
  2313. The effect of plasma-cholesterolโ€“loweringย dietย in male survivors of myocardial infarction. A controlled clinical trial.
  2314. The effect of strawberries in aย cholesterolโ€“loweringย dietary portfolio
  2315. The effect of the intensity of lipidโ€loweringย medications on the LDLย cholesterolย treatment goals of Asian patients with dyslipidaemia in primary care
  2316. THE EFFECT OF TWOย cholesterolโ€“loweringย AGENTS ON PLATELETS IN PATIENTS WITH HYPERcholesterolEMIA
  2317. The effect of two novelย cholesterolโ€“loweringย agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the โ€ฆ
  2318. The Effectiveness of Garcinia Mangostana L. Rind extract in Reducing Totalย cholesterolย Levels in Hypercholesterolemic Male White Mice
  2319. The effectiveness of probiotics, prebiotics, andย dietary fiber on theย loweringย ofย cholesterolย level and improvement of full lipid profile
  2320. The Effectiveness of Stew Carrot (Daucus Carota. L) Onย loweringย Bloodย cholesterolย Levels of White Rat (Rattus Norvegicus)
  2321. The effectiveness of the Mediterraneanย dietย in reducingย cholesterol
  2322. The Effectiveness of The Use of Pelawan Leaf Boiled Water (Tristaniopsis Merguensis (Griff.) as a Traditional Medicine for Reducing Bloodย cholesterol
  2323. The effects ofย cholesterolย loweringย with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo โ€ฆ
  2324. The Effects ofย cholesterolโ€loweringย diets with Lean Beef on Blood Pressure and Vascular Health: Results from the BOLD (Beef in an Optimal Leanย diet) Study
  2325. The effects ofย dietaryย cholesterolโ€“loweringย on psychological symptoms: a randomised controlled study
  2326. The effects ofย loweringย cholesterolย on vasodilation.
  2327. The effects ofย loweringย LDLย cholesterolย with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a โ€ฆ
  2328. The effects ofย loweringย serumย cholesterolย on coronary heart disease risk.
  2329. The efficacy ofย cholesterolโ€“loweringย action and side effects of garlic enteric coated tablets in man
  2330. The efficacy of corn oil inย loweringย the serumย cholesterolย of patients with coronary atherosclerosis.
  2331. The efficacy of evolocumab and other lipid-loweringย therapies (LLT) for the management of low density lipoproteinย cholesterolย (LDL-C): a systematic review and โ€ฆ
  2332. The efficacy of lovastatin inย loweringย cholesterolย in African Americans with primary hypercholesterolemia
  2333. The efficacy of vitamin C supplementation on reducing total serumย cholesterolย in human subjects: a review and analysis of 51 experimental trials
  2334. The emerging concept of โ€œindividualizedย cholesterolโ€“loweringย therapyโ€: A change in paradigm
  2335. The Evaluation of Red Clover (Trifolium Pretense L.) Active Compounds in Application forย loweringย Bloodย cholesterolย Level:[elektroninis iลกteklius]
  2336. The evidence around safe and effective LDLย cholesterolโ€“loweringย therapy in elderly individuals demands validity and clinical relevance
  2337. The Example of aย cholesterol-Reducing Margarine
  2338. The expected cardiovascular benefit of plasmaย cholesterolย loweringย with or without LDL-C targets in healthy individuals at higher cardiovascular risk
  2339. THE EXPERIMENTAL STUDY 0Nย cholesterol-REDUCING EFFECTS AND TOLERANCE PROPERTY OF LACTOBACTERIA ISOLATED FROM KEFIR GRAIN
  2340. The fact and fiction ofย loweringย cholesterolย in the primary prevention of coronary heart disease
  2341. The fetal origins of atherosclerosis: maternal hypercholesterolemia, andย cholesterolโ€loweringย or antioxidant treatment during pregnancy influence in utero โ€ฆ
  2342. The final word about LDL-cholesterolย lowering
  2343. The food matrix and sterol characteristics affect the plasmaย cholesterolย loweringย of phytosterol/phytostanol
  2344. The future direction ofย cholesterolโ€“loweringย therapy
  2345. The future of low-density lipoproteinย cholesterolย in an era of nonfastingย lipid testing and potent low-density lipoproteinย lowering
  2346. The great fat debate: reducingย cholesterol
  2347. The ideal management of bloodย cholesterol: a review of the updated 2013 ACC/AHAย cholesterolย guideline for reducing cardiovascular risk
  2348. The impact of automatic prescriptions on reducing low-density lipoproteinย cholesterolย levels.
  2349. The impact ofย cholesterolย loweringย on patientsโ€™ mood
  2350. THE IMPACT OF DECREASED HIGH-DENSITY LIPOPROTEIN-cholesterolย LEVEL AFTER LIPID-loweringย THERAPY ON THE CLINICAL OUTCOMES IN โ€ฆ
  2351. The Impact of Obesity on the Efficacy of Simvastatin forย loweringย Low-Density Lipoproteinย cholesterolย in a Veteran Population
  2352. The importance ofย loweringย cholesterolย in patients with coronary heart disease
  2353. The Influence of Malting on Nutritional Value andย cholesterolย loweringย Capacity of Chickpeas in Rats
  2354. The influence of physical parameters towards hyperย cholesterolย reducing agent production, lovastatin, under solid substrate fermentation (SSF) condition
  2355. The interpretation ofย cholesterolย balance derived synthesis data and surrogate noncholesterolย plasma markers forย cholesterolย synthesis under lipidย loweringย โ€ฆ
  2356. The LDL-cholesterolโ€“loweringย effects of nano-particled Djulis Grains
  2357. The LDL-receptor and its molecular properties: From theory to novel biochemical and pharmacological approaches in reducing LDL-cholesterol
  2358. The lipidย loweringย effect of the aqueous root extract of Morinda lucida in albino rats fed on a highย cholesterolย diet
  2359. The local effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) on the inflammatory atheroma: beyond LDLย cholesterolย lowering
  2360. The lowโ€density lipoproteinย cholesterolโ€loweringย effect of pravastatin and factors associated with achieving targeted lowโ€density lipoprotein levels in an African โ€ฆ
  2361. THEย loweringย EFFECT OF PANAXYDOL PURIFIED FROM KOREAN RED GINSENG ON BLOOD HIGHย cholesterolย LEVELS IN RATS
  2362. Theย loweringย of plasmaย cholesterolย by sucrose polyester in subjects consumingย diets with 800, 300, or less than 50 mg ofย cholesterolย per day
  2363. The Mechanism of Comparable Serumย cholesterolย loweringย Effects of Pravastatin Sodium, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, between โ€ฆ
  2364. The mechanism of improvement in endothelial function by pravastatin: direct effect or throughย cholesterolย lowering
  2365. The mechanism ofย loweringย cholesterolย absorption by calcium studied by using an in vitro digestion model
  2366. The mechanism of theย cholesterolโ€“loweringย effect of water-insoluble fish protein in ovariectomised rats
  2367. The molecular mechanism of theย cholesterolโ€loweringย effect of dill and kale: The influence of the food matrix components
  2368. The Myocardial Ischemia Reduction with Aggressiveย cholesterolย loweringย (MIRACL) trial: Effects of intensive atorvastatin treatment on early recurrent events after an โ€ฆ
  2369. The need for a new classification ofย cholesterolย loweringย therapies
  2370. The next generation of novel low-density lipoproteinย cholesterolโ€“loweringย agents: proprotein convertase subtilisin/kexin 9 inhibitors
  2371. The nutrient repercussions of adopting an approved serumย cholesterolย loweringย diet
  2372. The okra skin extract and itsย cholesterolโ€“loweringย activities-in vitro study
  2373. The perspective onย cholesterolโ€loweringย mechanisms of probiotics
  2374. The potentialย cholesterolโ€“loweringย and prebiotic effects of bamboo shootย dietary fibers and their structural characteristics
  2375. The predictive ability of lipoproteins and the value ofย loweringย plasmaย cholesterolย in the presence of coronary heart disease
  2376. The rationale forย loweringย serumย cholesterolย levels in American children
  2377. The Regulatory Mechanism and Measures of Reducingย cholesterolย in Eggs
  2378. The Relationship between Structure and Activity in a Novel Series of Serumย cholesterolโ€“loweringย Agents1
  2379. The relationship between weight and response toย cholesterolโ€“loweringย diets in women
  2380. The research and development progress ofย cholesterolโ€“loweringย Lactic acid bacteria
  2381. THE RESEARCH OF SECURITY ONย cholesterol-REDUCING IN ANIMAL-ORIGIN FOOD WITH BIOLOGY MEASURES [J]
  2382. The Response to aย cholesterolโ€“loweringย dietย Instructed by Physicians andย dieticians.
  2383. The revised NWLRC fat intake scale: A quick way to assessย cholesterolโ€“loweringย diets
  2384. The role ofย dietary polyunsaturated fat inย loweringย bloodย cholesterolย in man.
  2385. The role of gut microbiota in the lowโ€density lipoprotein (LDL)ย cholesterolโ€loweringย effects of plant sterol esters
  2386. The role of linoleic acid and its metabolites in theย loweringย of plasmaย cholesterolย and the prevention of cardiovascular disease
  2387. The role of nutrients in aย dietary intervention in improving bloodย cholesterolย profile andย loweringย cardiovascular risk
  2388. The serumย cholesterolย levelย loweringย effect from the underground parts of Rosa rugosa
  2389. The serum LDL/HDLย cholesterolย ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in theย dietย of women
  2390. The state of the art on the mechanisms of lactic acid bacteria in reducingย cholesterol
  2391. The success story of LDLย cholesterolย lowering
  2392. The type of mutation in the low density lipoprotein receptor gene influences theย cholesterolโ€“loweringย response of the HMG-CoA reductase inhibitor simvastatin in โ€ฆ
  2393. The use ofย cholesterolย loweringย medicine for postmenopausal women with estrogen receptor positive breast cancer
  2394. The use ofย cholesterolโ€“loweringย medications after coronary revascularization
  2395. The use ofย cholesterolโ€“loweringย medications and age-related macular degeneration
  2396. The use of DiazaConโ„ข to limit fertility by reducing serumย cholesterolย in female grey squirrels, Sciurus carolinensis
  2397. The value ofย loweringย cholesterolย after myocardial infarction
  2398. The value of surrogate markers to monitorย cholesterolย absorption, synthesis and bioconversion to bile acids under lipidย loweringย therapies
  2399. Therapies that target PCSK9 effective at reducing LDLย cholesterol
  2400. Therapy and prevention of coronary heart diseases throughย loweringย of the serumย cholesterolย levels; third consensusโ€™ย cholesterolโ€˜. Consensus Working Group, CBO
  2401. This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing theirย cholesterolย to effective levels โ€ฆ
  2402. This is a repository copy of Synthesis ofย cholesterol-reducing sterol esters by enzymatic catalysis in bio-based solvents or solvent-free.
  2403. Thyroid hormone ฮฒ receptor activation has additiveย cholesterolย loweringย activity in combination with atorvastatin in rabbits, dogs and monkeys
  2404. Thyroid hormones: a potential ally to LDL-cholesterolโ€“loweringย agents
  2405. Time trends in the use ofย cholesterolโ€“loweringย agents in older adults: the Cardiovascular Health Study
  2406. Tissue selectivity of theย cholesterolโ€“loweringย agents lovastatin, simvastatin and pravastatin in rats in vivo
  2407. Toward individualizedย cholesterolโ€“loweringย treatment in end-stage renal disease
  2408. Transcriptional analysis forย cholesterolโ€“loweringย effects of marine Lactobacillus plantarum Lp10 isolated from kelp
  2409. Transcriptional Induction ofย cholesterolย 7รค-Hydroxylase by Dexamethasone in L35 Hepatoma Cells Requires Sulfhydryl Reducing Agents
  2410. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective inย loweringย LDL-but withoutย loweringย HDLย cholesterol
  2411. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective inย loweringย LDL, withoutย loweringย HDLย cholesterol
  2412. Trattamento ipocolesterolemizzante con nutraceutici: dallo stato dellโ€™arte alla pratica clinica sul territorioย loweringย cholesterolย with nutraceuticals: from the state of the โ€ฆ
  2413. Treadmill exercise inhibits amyloid-ฮฒ generation in the hippocampus of APP/PS1 transgenic mice by reducingย cholesterol-mediated lipid raft formation
  2414. Treating to New Targets (TNT) Study: doesย loweringย low-density lipoproteinย cholesterolย levels below currently recommended guidelines yield incremental clinical โ€ฆ
  2415. Treatment goals for low-density lipoproteinย cholesterolย in the secondary prevention of coronary heart disease: absolute levels or extent ofย lowering?
  2416. Treatment of myocardial infarction and angina. Advice on reducingย cholesterolย should be included.
  2417. Treatment of peptic ulcer with aย cholesterolโ€“loweringย dietary supplement: preliminary report.
  2418. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficientย cholesterolโ€“loweringย enough to inhibit platelets?
  2419. Trends in total and low-density lipoproteinย cholesterolย among US adults: contributions of changes inย dietary fat intake and use ofย cholesterolโ€“loweringย โ€ฆ
  2420. Trends in Utilization and Cost of Low-Density Lipoproteinย cholesterolโ€“loweringย Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D โ€ฆ
  2421. Trimethylamine N-oxide attenuates high-fat high-cholesterolย diet-induced steatohepatitis by reducing hepaticย cholesterolย overload in rats
  2422. Two apolipoprotein E mimetic peptides with similarย cholesterolย reducing properties exhibit differential atheroprotective effects in LDL-R null mice
  2423. Two years after molecular diagnosis of familial hypercholesterolemia: majority onย cholesterolโ€“loweringย treatment but a minority reaches treatment goal
  2424. Ultra heat treatment destroysย cholesterolโ€“loweringย effect of soy protein
  2425. Understanding molecular mechanisms involved in theย cholesterol-reducing action ofย dietary psyllium in rats.
  2426. Understanding newย cholesterolโ€“loweringย agents
  2427. Underutilization of measurement of serum lowโ€density lipoproteinย cholesterolย levels and of lipidโ€loweringย therapy in older patients with manifest atherosclerotic โ€ฆ
  2428. United statesย cholesterolย guidelines 2001: Expanded scope of intensive low-density lipoproteinโ€“loweringย therapy
  2429. Unresolved issues in early trials ofย cholesterolย lowering
  2430. Update of planning tables ofย cholesterolโ€“loweringย therapy orientated to achieve LDL therapeutic targets
  2431. Update on lipid-loweringย therapy and LDL-cholesterolย targets
  2432. Use and outcomes of aย cholesterolโ€“loweringย intervention for rural elderly subjects
  2433. Use of black cumin in layerย dietย asย cholesterolย loweringย agents in egg yolk
  2434. Use of bread and rolls in aย cholesterolย reducingย diet.-2. Part: Results of the controlledย dietary study
  2435. Use ofย cholesterolโ€“loweringย medications in the United States from 1991 to 19971
  2436. Use ofย cholesterolโ€“loweringย Medications of Patients with Myocardial Infarction from 2007-2015 in Cardiology Clinic to โ€œMother Teresaโ€ University Hospital in โ€ฆ
  2437. Use ofย cholesterolโ€“loweringย therapy and related beliefs among middle-aged adults after myocardial infarction
  2438. Use ofย cholesterolโ€“loweringย therapy by elderly adults after myocardial infarction
  2439. Use of lipid-loweringย medications and the likelihood of achieving optimal LDL-cholesterolย goals in coronary artery disease patients
  2440. Use of local isolate of Monascus purpureus for reducing bloodย cholesterolย in Sprague Dawley rat
  2441. Use of starter cultures reducing theย cholesterolย content in meat products
  2442. Usefulness ofย loweringย low-density lipoproteinย cholesterolย to< 70 mg/dl and usefulness of C-reactive protein in patient selection
  2443. Using genetic variants to evaluate the causal effect ofย cholesterolย loweringย on head and neck cancer risk: a Mendelian randomization study
  2444. Utility ofย fastingย essential amino acid plasma levels in formulation of nutritionally adequateย diets III:ย loweringย of rat serumย cholesterolย levels by lysine supplementation
  2445. Utility ofย fastingย essential amino acid plasma levels in formulation of nutritionally adequateย diets IV:ย loweringย of human plasmaย cholesterolย and triglyceride levels by โ€ฆ
  2446. Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDLย cholesterolย in patients with ischaemic stroke or โ€ฆ
  2447. Utilization ofย cholesterolโ€“loweringย Therapies in Patients With Chronic Kidney Disease and Atherosclerotic Cardiovascular Disease (ASCVD). Results From a National โ€ฆ
  2448. Utilization of soybean residue to produce monacolin K-cholesterolย loweringย agent.
  2449. Utilization of Tropical Biomass Resources I. Effect of galactomannan from Leucaena leucocephala de WIT seed toย cholesterolโ€“loweringย in rats
  2450. Utilization of Tropical Biomass Resources. I. Effect of galactomannan from Leucaena leucocephala de Wit seed toย cholesterolโ€“loweringย in rats.
  2451. Utilization of Wheat Germ as Natural Antioxidant and Fat Mimetic to Increase Shelf-Life in Beef Sausage and asย loweringย cholesterolย in Rats
  2452. Value ofย cholesterolย loweringย Medications
  2453. Variation in lipid-loweringย therapy use in patients with low-density lipoproteinย cholesterolโ‰ฅ 190 mg/dL: insights from the National Cardiovascular Data Registry โ€ฆ
  2454. Varying pharmacy benefits with clinical status: the case ofย cholesterolโ€“loweringย therapy
  2455. Vascular effects of estrogen andย cholesterolโ€“loweringย therapies in hypercholesterolemic postmenopausal women
  2456. Very lowย cholesterolย andย cholesterolย lowering. A statement for healthcare professionals from the American Heart Association Task Force onย cholesterolย Issues.
  2457. Vicinal diaryl azole-based urea derivatives as potentialย cholesterolย loweringย agents acting through inhibition of SOAT enzymes
  2458. Vinegars but not acetic acid are effective in reducing plasmaย cholesterolย in hamsters fed a high-cholesterolย diet
  2459. Viscosity rather than quantity ofย dietary fibre predictsย cholesterolโ€“loweringย effect in healthy individuals
  2460. Vitamin C and theย cholesterolโ€“loweringย effect of clofibrate [proceedings]
  2461. What is the role of intensiveย cholesterolย loweringย in the treatment of acute coronary syndromes?
  2462. What Proportion of Patients Admitted with Stroke or Transient Ischemic Attack May Be Suitable for Newerย cholesterolโ€“loweringย Treatment?
  2463. What should be the goal of LDL-cholesterolย loweringย in coronary patients; a fixed level or a percent reduction?
  2464. When to startย cholesterolโ€“loweringย therapy in patients with coronary heart disease: a statement for healthcare professionals from the American Heart Association Task โ€ฆ
  2465. Whey dangke giving in drinking waterย loweringย level ofย cholesterol, triglycerides and lipoproteins of broiler chickens blood.
  2466. Whole wheat flour exertsย cholesterolโ€“loweringย in rats in its native form and after use in bread-making
  2467. Whole-body cryostimulation as an effective way of reducing exercise-induced inflammation and bloodย cholesterolย in young men
  2468. Whyย cholesterolโ€“loweringย diets should still be encouraged in the face of effective pharmaceutical interventions
  2469. Willย cholesterolโ€“loweringย Therapy Increase the Risk of Muscle Injury?
  2470. Will cholesteryl ester transfer protein inhibition succeed primarily byย loweringย low-density lipoproteinย cholesterol? Insights from human genetics and clinical โ€ฆ
  2471. Willย loweringย population levels of serumย cholesterolย affect total mortality? Expectations from the Honolulu Heart Program
  2472. X-ray Crystallographic Studies ofย cholesterolย loweringย Target
  2473. Xanthohumol prevents atherosclerosis by reducing arterialย cholesterolย content via CETP and apolipoprotein E in CETP-transgenic mice
  2474. y isย loweringย LDLย cholesterolย levels reduced fatal coronary events in patients with acute Ml and averageย cholesterolย levels
  2475. Yaobao Xuezhiqing Capsules on Reducingย cholesterolย in Serum
  2476. Zinc intake and plasma zinc level are maintained in men consumingย cholesterolโ€“loweringย diets
  2477. ฮฑ-tocopherol attenuates the triglyceride-andย cholesterolโ€“loweringย effects of rice bran tocotrienol in rats fed a westernย diet
  2478. โ€ฆ -3 fatty acid has effect on improvement of peripheral artery disease in correlation with degree ofย loweringย remnant-like lipoproteinย cholesterolย in hemodialysis patients โ€ฆ
  2479. โ€ฆ -like activity of Alzheimerโ€™s disease ฮฒ-amyloid: Cu-dependent catalytic conversion of dopamine,ย cholesterol, and biological reducing agents to neurotoxic โ€ฆ
  2480. โ€ฆ -term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blockerย cholesterolโ€“loweringย Asymptomatic Plaque Study โ€ฆ
  2481. โ€ฆ -world effectiveness of lipid-loweringย therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterolย โ€ฆ
  2482. โ€ฆ โ€induced hyperhomocysteinemia impairs the antioxidant ability of highโ€density lipoproteins without reducing in vivo macrophageโ€specific reverseย cholesterolย โ€ฆ
  2483. โ€ฆ โ€tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyondย loweringย lowโ€density lipoproteinย cholesterolย in patients with โ€ฆ
  2484. โ€ฆ : INSIGHTS FROM GETTING TO AN IMPROVED UNDERSTANDING OF LOW-DENSITY LIPOPROTEINย cholesterolย AND DYSLIPIDEMIA MANAGEMENT โ€ฆ
  2485. โ€ฆ โ€ รฉs a โ€žcรฉl%โ€ hatรกsossรกgรกnak รถsszehasonlรญtรกsa a hรฉtkรถznapi gyakorlatbanโ€“Az ATTENTION-vizsgรกlat= Two LDL-cholesterolย loweringย strategy: comparison of โ€ฆ
  2486. โ€ฆ (a)ย loweringย by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoproteinย cholesterolย lowering: ODYSSEY OUTCOMES trial
  2487. โ€ฆ (a) particle production as a determinant of plasma lipoprotein (a) concentration across varying apolipoprotein (a) isoform sizes and backgroundย cholesterolโ€loweringย โ€ฆ
  2488. โ€ฆ (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-loweringย therapy and achieving low-density lipoproteinย cholesterolย โ€ฆ
  2489. โ€ฆ (NDA) on the modification of the authorisation of a health claim related to plant sterol esters andย loweringย blood LDLโ€cholesterol; high blood LDLโ€cholesterolย is a risk โ€ฆ
  2490. โ€ฆ ) SEBAGAI BAHAN PENURUN KOLESTEROL PADA MENCIT (Mus musculus BALB/C)(Test on Emerita analoga asย cholesterolย Reducing Agent on Mus โ€ฆ
  2491. โ€ฆ 17โ€“Should tests such as C-reactive protein, carotid intima-media thickness, coronary artery calcification etc. be assessed while guidingย cholesterolโ€“loweringย โ€ฆ
  2492. โ€ฆ a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit ofย cholesterolโ€“loweringย โ€ฆ
  2493. โ€ฆ Acid (EPA), but not other Triglyceride-loweringย Agents, Inhibits Glucose-Induced Changes in Membrane Width andย cholesterolย Domain Formation through a โ€ฆ
  2494. โ€ฆ and Control: Reducing Out-of-Pocket Costs for Cardiovascular Disease Preventive Services for Patients with High Blood Pressure and Highย cholesterol
  2495. โ€ฆ and design of a secondary prevention trial ofย loweringย normal plasmaย cholesterolย levels after acute myocardial infarction: theย cholesterolย and Recurrent Events trial โ€ฆ
  2496. โ€ฆ and its analog, hydroxypropylโ€berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exertย cholesterolโ€loweringย effects in human โ€ฆ
  2497. โ€ฆ and lower better and better? A re-evaluation of the evidence from theย cholesterolย Treatment Trialistsโ€™ Collaboration meta-analysis for low-density lipoproteinย lowering
  2498. โ€ฆ and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoproteinย cholesterolย goal withoutย loweringย high-density lipoproteinย cholesterol
  2499. โ€ฆ and plasma lipidย loweringย effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in highย cholesterolย diet-fed Japanese โ€ฆ
  2500. โ€ฆ and prevention of coronary heart disease byย loweringย serumย cholesterolย levels; from the pioneer work of CD de Langen to the thirdโ€ Dutch Consensus onย cholesterolโ€ โ€ฆ
  2501. โ€ฆ and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatinย cholesterolโ€“loweringย โ€ฆ
  2502. โ€ฆ AND VASCULAR RESPONSE TO LIPID-loweringย THERAPY IN PATIENTS WITH HIGH VERSUS LOW HDL-cholesterol: SERIAL OPTICAL COHERENCE โ€ฆ
  2503. โ€ฆ APPROACH TO LIPIDย loweringย (GOAL) MEDICAL PRACTICE ACTIVITY (MPA) TO ACHIEVE LOW DENSITY LIPOPROTEINย cholesterolย (LDL-C) TARGETS
  2504. โ€ฆ Are Associated with Low-Density Lipoproteinย cholesterol, nonโ€“High-Density Lipoproteinย cholesterol, and ApoB Responses to Lipid-loweringย Therapy in Patients โ€ฆ
  2505. โ€ฆ artery atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) double knockout mice independently of plasmaย cholesterolย lowering
  2506. โ€ฆ as unique sources of soluble and insoluble-bound phenolics: Reducing power, metal chelation and inhibition of oxidation of human LDL-cholesterolย and DNA strand โ€ฆ
  2507. โ€ฆ assessed trial on the role of LDLโ€apheresis in the secondary prevention of coronary heart disease: I. Evaluation of safety andย cholesterolโ€loweringย effects during the โ€ฆ
  2508. โ€ฆ breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependentย cholesterolย โ€ฆ
  2509. โ€ฆ by Apolipoprotein B48 andย cholesterolย Absorption/Synthesis Markers Represents Residual Risks for Coronary Artery Disease during Intensive LDL-loweringย โ€ฆ
  2510. โ€ฆ Cโ€reactive proteinย loweringย with atorvastatin in patients of South Asian compared with European origin: insights from the Achieveย cholesterolย Targets Fast with โ€ฆ
  2511. โ€ฆ cell model to compare the lipid-loweringย effects of pomegranate peel polyphenols with several other plant polyphenols as well as its relatedย cholesterolย efflux โ€ฆ
  2512. โ€ฆ channel blockers with lipid-loweringย therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raisedย cholesterolย โ€ฆ
  2513. โ€ฆย cholesterolย is as tricky asย loweringย it; a federal panel has issued precise recommendations on how and when to treat elevatedย cholesterolย levels, but determining โ€ฆ
  2514. โ€ฆย cholesterolย loweringย for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoproteinย cholesterolย Levels of 190 โ€ฆ
  2515. โ€ฆย cholesterolย loweringย for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoproteinย cholesterolย Levels of 190 โ€ฆ
  2516. โ€ฆย cholesterolย loweringย for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoproteinย cholesterolย Levels of 190 โ€ฆ
  2517. โ€ฆย cholesterolย loweringย for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoproteinย cholesterolย levels of 190 mg โ€ฆ
  2518. โ€ฆย cholesterolย lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal toleratedย cholesterolย โ€ฆ
  2519. โ€ฆ College of Cardiology expert consensus decision pathway on nonstatin therapies for low-density lipoprotein-cholesterolย loweringย in the management of โ€ฆ
  2520. โ€ฆ comparative study of lipid-loweringย effects of guggul and atorvastatin monotherapy in comparison to their combination in highย cholesterolย diet-induced hyperlipidemia โ€ฆ
  2521. โ€ฆ comparison of effectiveness ofย loweringย apolipoprotein B versus low-density lipoproteinย cholesterolย and nonhigh-density lipoproteinย cholesterolย for cardiovascular risk โ€ฆ
  2522. โ€ฆ containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: Its effect on the structure and cellularย cholesterol-reducing capacity of LpA โ€ฆ
  2523. โ€ฆ CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the ฮฒ-Blockerย cholesterolโ€“loweringย Asymptomatic Plaque Study (BCAPS)
  2524. โ€ฆ DARAH DIBANDINGKAN ISOFLAVON= SOY PROTEIN CONSUMPTION IS MORE EFFECTIVE THAN ISOFLAVONE INย loweringย BLOODย cholesterol
  2525. โ€ฆ decreases heart disease; a clinical trial shows, at last, that reducing bloodย cholesterolย reduces the risk of heart disease, providing the missing link in theย cholesterolย โ€ฆ
  2526. โ€ฆ EFFECT OF MACRO ALGA Caulerpa sp. AND Gracilaria sp. EXTRACTย loweringย MALONDIALDEHYDE LEVEL OF WISTAR RATS FED HIGHย cholesterolย โ€ฆ
  2527. โ€ฆ effects of ethanolic extract of Murraya Koenigii Linn. leaves in cognitive deficit aged mice involving possible anticholinesterase andย cholesterolย loweringย โ€ฆ
  2528. โ€ฆ Engineered E. Coli dhs Cells for In-Vitroย loweringย of Plasma Potassium, Phosphate, Magnesium, Sodium, Chloride, Uric Acid,ย cholesterol, And Creatinine: A โ€ฆ
  2529. โ€ฆ events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressiveย cholesterolย loweringย โ€ฆ
  2530. โ€ฆ expect any pleiotropic effect of Proprotein Convertase Subtilisin/Kexin type 9 inhibition for reducing cardiovascular events beyond low-density lipoproteinย cholesterolย โ€ฆ
  2531. โ€ฆ FAMILIAL HYPERcholesterolEMIA PATIENTS ACHIEVE LDL-cholesterolย TARGET DESPITE BEING ON MAXIMAL CONVENTIONAL LIPID-loweringย โ€ฆ
  2532. โ€ฆ for lactic acid bacteria in traditional fermented Tibetan yak milk and evaluating their probiotic andย cholesterolโ€“loweringย potentials in rats fed a high-cholesterolย diet
  2533. โ€ฆ France in relation to the authorization procedure for health claims on plant stanols and plant sterols andย lowering/reducing blood LDLโ€cholesterolย pursuant to Article โ€ฆ
  2534. โ€ฆ FRESH LEAF EXTRACT OF CHROMOLAENA ODORATA (LINN) IN ALBINO WISTAR RATS FED DIFFERENT CONCENTRATIONS OFย cholesterolย โ€ฆ
  2535. โ€ฆ Functional Foods: What Have We Learned? An Examination of the Metamucil, Benefit, and Heartwise Introductions asย cholesterol-Reducing Ready-to-Eat Cereals
  2536. โ€ฆ guidelines forย dietย and lifestyle changes forย cholesterolโ€lowering: the Increasing Adherence of Consumers toย dietย & Lifestyle Changes to Lower (LDL)ย cholesterolย โ€ฆ
  2537. โ€ฆ health claim related to a low fat fermented milk product (Danacolยฎ) enriched with plant sterols/stanols andย lowering/reducing bloodย cholesterolย and reduced risk โ€ฆ
  2538. โ€ฆ in healthy volunteers or hypercholesterolemic subjects using an indirect response model to predict low-density lipoproteinย cholesterolย lowering: support for a โ€ฆ
  2539. โ€ฆ in patients on lipid-loweringย therapies outside Western Europe and North America: findings of the cross-sectional observational Internationalย cholesterolย โ€ฆ
  2540. โ€ฆ in the United States?: Primary, One-year Results of the Getting to an Improved Understanding of Low-density Lipoproteinย cholesterolย and Dyslipidemia Management โ€ฆ
  2541. โ€ฆ increases the efficacy of the American Heart Association (AHA) step Iย cholesterolโ€“loweringย dietย without reducing high density lipoproteinย cholesterolย levels in non โ€ฆ
  2542. โ€ฆ increases the risk of chronic diseases. Thus, the high saturated fat consumption (foods high in saturated and trans fatty acids),ย cholesterol, salt, sugar, refined grains โ€ฆ
  2543. โ€ฆ last year. At my age, 78 years old, I find it hard to take it seriously when my doctor and my children tell me that I should beย loweringย myย cholesterolย and exercising. It โ€ฆ
  2544. โ€ฆ LDLย cholesterolย levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-loweringย therapy
  2545. โ€ฆ LDLย cholesterol: questions from recent meta-analyses and subset analyses of clinical trial data issues from the Interdisciplinary Council on Reducing the Risk for โ€ฆ
  2546. โ€ฆ lecithin-cholesterolย acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein andย loweringย low โ€ฆ
  2547. โ€ฆ Lipid-loweringย Therapy and the Guidelines? Results From a National Survey in the Getting to an Improved Understanding of Low-Density Lipoproteinย cholesterolย โ€ฆ
  2548. โ€ฆ lipoprotein profile in morbidly obese patients by reducing LDLย cholesterol, apoB, and SAA/PON1 ratio, increasing HDLย cholesterol, but has no effect onย cholesterolย โ€ฆ
  2549. โ€ฆ lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. Theย cholesterolย loweringย atherosclerosis PTCA trial โ€ฆ
  2550. โ€ฆ low-carbohydrateย diets more effective than standard carbohydrateย diets inย loweringย cardiovascular risk factors such as blood pressure,ย cholesterol, andย fastingย glucose โ€ฆ
  2551. โ€ฆ Microsomal Triglyceride Transfer Protein Reverses Gallstone Susceptibility in Liver Fatty Acid Binding Protein Knockout Mice by Reducing Canalicularย cholesterolย โ€ฆ
  2552. โ€ฆ no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction withย cholesterolโ€“loweringย โ€ฆ
  2553. โ€ฆ of almonds in aย cholesterolโ€“loweringย dietย improves plasma HDL subspecies andย cholesterolย efflux to serum in normal-weight individuals with elevated LDLย cholesterol
  2554. โ€ฆ of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressiveย cholesterolย loweringย โ€ฆ
  2555. โ€ฆ ofย cholesterolย goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-loweringย โ€ฆ
  2556. โ€ฆ of high-dose atorvastatin in patientsโ‰ฅ 65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressiveย cholesterolย loweringย โ€ฆ
  2557. โ€ฆ of Lactobacillus SP. Using Chitosanโ€Alginateโ€Xanthan Gumโ€ฮฒโ€Cyclodextrin and Characterization of itsย cholesterolย Reducing Potential and Resistance Against pH โ€ฆ
  2558. โ€ฆ of Lactobacillus SP. Using Chitosanรข Alginateรข Xanthan Gumรข รŽยฒรข Cyclodextrin and Characterization of itsย cholesterolย Reducing Potential and Resistance Against โ€ฆ
  2559. โ€ฆ of Low-Density Lipoproteinย cholesterolย Treatment Target in Familial Hypercholesterolemia Patients: A Model Exploring Efficacy of Current and Novel Lipidย loweringย โ€ฆ
  2560. โ€ฆ of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine andย cholesterol-induced neural damages
  2561. โ€ฆ of Patients With Established ASCVD Participating in the Getting to an Improved Understanding of Low-Density Lipoproteinย cholesterolย and Dyslipidemia Management โ€ฆ
  2562. โ€ฆ OF PRIMARY PREVENTION AGAINST REDUCING HYPERTENSION FOCUS ON SUBJECTS WITH HIGH TOTALย cholesterolย AND HIGH TRIGLYCERIDES IN โ€ฆ
  2563. โ€ฆ of results of a nationalย cholesterolย and blood pressure screening with the NHANES II Study: implications for further emphasis on reducing cardiovascular risk among โ€ฆ
  2564. โ€ฆ of the evidence considered by health Canada in the regulatory process to permit addition of plant sterols to selected foods accompanied by aย cholesterolโ€“loweringย โ€ฆ
  2565. โ€ฆ on mung bean (Vigna radiata) and white kidney bean (Phaseolus vulgaris) proteins: Enzymatic hydrolysis,ย cholesterolย loweringย activity and structural โ€ฆ
  2566. โ€ฆ on nitric oxideโ€“dependent function in aorta and corpus cavernosum of diabetic mice: relationship toย cholesterolย biosynthesis pathway inhibition and lipidย lowering
  2567. โ€ฆ on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stableย cholesterolโ€“loweringย โ€ฆ
  2568. โ€ฆ on the modification of the authorisation of a health claim related to plant sterol esters andย loweringย blood LDLโ€cholesterol; high blood LDLโ€cholesterolย is a risk factor โ€ฆ
  2569. โ€ฆ Pan-Asian survey: high low-density lipoproteinย cholesterolย goal attainment rate among hypercholesterolaemic patients undergoing lipid-loweringย treatment in a โ€ฆ
  2570. โ€ฆ particle size of oat bran inhibits degradation and lowers extractability of ฮฒ-glucan in sourdough breadโ€“Potential implications forย cholesterolโ€“loweringย properties in vivo
  2571. โ€ฆ Patients Referred to a Regionalย cholesterolย Treatment Center with LDLย cholesterol>= 70 mg/dl Despite Maximal Toleratedย cholesterolย loweringย Therapy
  2572. โ€ฆ patients referred to a regionalย cholesterolย treatment center with LDLย cholesterolโ‰ฅ 70 mg/dl despite maximal toleratedย cholesterolย loweringย therapy
  2573. โ€ฆ patients referred to a regionalย cholesterolย treatment center with LDLย cholesterolโ‰ฅ 70 mg/dL despite maximal-tolerated LDL-cholesterolโ€“loweringย therapy
  2574. โ€ฆ patients who have average or lower-than-averageย cholesterolย concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trialโ€”Lipidย loweringย Arm (ASCOT-LLA) โ€ฆ
  2575. โ€ฆ patients who have average or lower-than-averageย cholesterolย concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trialโ€”Lipidย loweringย Arm (ASCOT-LLA) โ€ฆ
  2576. โ€ฆ progression of atherosclerosis in coronary bypass grafts is similar in women compared to men following aggressiveย cholesterolย loweringย despite more frequent risk โ€ฆ
  2577. โ€ฆ Question About Myย cholesterolย Levels. My Totalย cholesterolย Level Is Normal (Just Over 200) but My HDL Is Low, Only 28. Should I Be Taking aย cholesterolโ€“loweringย โ€ฆ
  2578. โ€ฆ randomization analysis in three Japanese populations supports a causal role of alcohol consumption inย loweringย low-density lipidย cholesterolย levels and particle โ€ฆ
  2579. โ€ฆ Receptor ฮด Agonist, GW0742, and Ezetimibe Promote Reverseย cholesterolย Transport in Mice by Reducing Intestinal Reabsorption of HDLโ€Derivedย cholesterol
  2580. โ€ฆ reduces liver injury byย loweringย cholesterolย accumulation, improving dysregulatedย cholesterolย synthesis and alleviating inflammation in high-fat, high-cholesterolย and โ€ฆ
  2581. โ€ฆ Results: I. Reduction in Incidence of Coronary Heart Disease, and II. The Relationship of Reduction in Incidence of Coronary Heart Disease toย cholesterolย lowering
  2582. โ€ฆ SAFETY OF ALIROCUMAB AND EVOLOCUMAB, IN ADDITION TO MAXIMAL TOLERATEDย cholesterolย loweringย THERAPY: POST-COMMERCIALIZATION โ€ฆ
  2583. โ€ฆ salt hydrolase (Bsh) activity screening of Lactobacilli: in vitro selection of indigenous Lactobacillus strains with potential bile salt hydrolysing andย cholesterolโ€“loweringย โ€ฆ
  2584. โ€ฆ Saviorโ„ข Heart Savior-โ„ข is a proprietary blend of several well known ingredients that have been known for theirย cholesterolย reducing characteristics and for โ€ฆ
  2585. โ€ฆ severity influence the benefit of atorvastatin treatment in Alzheimerโ€™s disease: results of the Alzheimerโ€™s Diseaseย cholesterolโ€loweringย Treatment (ADCLT) trial
  2586. โ€ฆ simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimerโ€™s disease patients independently ofย cholesterolโ€“loweringย โ€ฆ
  2587. โ€ฆ STONES USING TRANSFORMER STREPTO-COCCUS SALIVARIUS AND MEASURING OF RNA EXPRESSION TOย cholesterolย loweringย GENES
  2588. โ€ฆ subtilisin/kexin type 9 (PCSK9) inhibition with evolocumab: powerful low-density lipoproteinย cholesterolย (LDL-C)ย loweringย and improved cardiovascular โ€ฆ
  2589. โ€ฆ Supplementation Reduces Endothelin-1 Plasma Concentration in Moderately Hypercholesterolemic Individuals Independently of Theirย cholesterolโ€“loweringย โ€ฆ
  2590. โ€ฆ suppresses progesterone production in primary cultured porcine granulosa cells by reducing gene expression of cytochrome P450ย cholesterolย side-chain cleavage โ€ฆ
  2591. โ€ฆ TEA AND MEAT FRUIT AVOCADO SIMVASTATIN COACH AS INTERVENTION INย loweringย TOTALย cholesterolย LEVELS TO HYPERcholesterolEMIA โ€ฆ
  2592. โ€ฆ the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoproteinย cholesterolย in patients with โ€ฆ
  2593. โ€ฆ the Intensity of Lipidย loweringย Therapy Vary by Sex in the United States? Insights From Getting to an Improved Understanding of Low-Density Lipoproteinย cholesterolย โ€ฆ
  2594. โ€ฆ thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensiveย cholesterolโ€“loweringย โ€ฆ
  2595. โ€ฆ TO A REGIONALย cholesterolย TREATMENT CENTER WITH LDLย cholesterolโ‰ฅ 70 MG/DL DESPITE MAXIMAL TOLERATEDย cholesterolย loweringย โ€ฆ
  2596. โ€ฆ UTLISATION IN PATIENTS ON LIPID-loweringย THERAPIES OUTSIDE OF WESTERN EUROPE: FINDINGS OF THE INTERNATIONALย cholesterolย โ€ฆ
  2597. โ€ฆ who have average or lower-than-averageย cholesterolย concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trialโ€“Lipidย loweringย Arm (ASCOT-LLA): a โ€ฆ
  2598. โ€ฆ With LDLย cholesterol> 100 Mg/dl and/or Atherosclerotic Cardiovascular Disease With LDLย cholesterol> 70 Mg/dl Despite Maximal Toleratedย cholesterolย loweringย โ€ฆ
  2599. [Use of bread and rolls in aย cholesterolย reducingย diet.-2. Part: Results of the controlledย dietary study].[German]
  2600. P. 144 Coronary heart disease prevention; How much can we expect fromย cholesterolโ€“loweringย therapy?
  2601. P. 211 Patterns of non compliance toย cholesterolโ€“loweringย therapy assessed by electronic monitoring
  2602. 1) Acupuncture Goes Mainstream 2) American Study Fails to Observe Lipid-loweringย Effects of Garlic? 3) Artichoke for Serumย cholesterolย Reduction? 4) Novel โ€ฆ
  2603. 1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particleย cholesterol
  2604. 12 The economics ofย cholesterolย lowering
  2605. 12-Week Effectiveness and Safety of Low-Density Lipoproteinย cholesterolโ€“loweringย Therapy by Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition in Patients โ€ฆ
  2606. Targeting HMGCoA Reductase and Reducing Bloodย cholesterolย Using Interfering RNA Delivered to the Liver by SV40-Derived Vectors
  2607. 16ย cholesterolย loweringย Vegetable Oil Spreads: Results of a Post Launch Monitoring Programme
  2608. 16, 16-Difluoroestrone derivatives. A new series ofย cholesterolย loweringย agents
  2609. 2013 ACC/AHAย cholesterolย guideline for reducing cardiovascular risk: what is so controversial?
  2610. 22-Hydroxycholesterolย derivatives as HMG CoA reductase suppressors and serumย cholesterolย loweringย agents
  2611. 3 Probiotic characterization and in vitroย cholesterolย loweringย effects of lactic acid bacteria 4 isolated from Thai healthy infants
  2612. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class ofย cholesterolโ€“loweringย agents
  2613. 333-OR: DMHCA Reduces the Development of Diabetic Retinopathy (DR) in db/db Mice byย loweringย cholesterolย Levels and Altering the Transcriptomic Profile of โ€ฆ
  2614. 54 Role of the gut microbiome for theย cholesterolย loweringย effect of atorvastatin
  2615. 769-4ย loweringย ofย cholesterolย With Simvastatin may Prevent Development of Heart Failure in Patients With Coronary Heart Disease
  2616. 7S protein is more effective than total soybean protein isolate in reducing plasmaย cholesterol
Related Posts

Skin Elasticity

Cryolipolysis: Freezing Fat To Death

Glp 1 Agonist

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping